Abstract is: JACC: Cardiovascular Imaging is a peer-reviewed scientific journal published by Elsevier for the American College of Cardiology since 2008. It currently has the highest impact factor among journals with a focus on cardiovascular imaging and it publishes original articles ranging from clinical studies to translational and basic research on novel imaging modalities with potential for future clinical usage. It is indexed by MEDLINE and on PubMed.
| scientific journal | Q5633421 |
| P6981 | ACNP journal ID | 2810058 |
| P8375 | Crossref journal ID | 72864 |
| P6180 | Dimensions Source ID | 1039717 |
| P5963 | Elsevier journal ID | jacc-cardiovascular-imaging |
| P1058 | ERA Journal ID | 124607 |
| P2671 | Google Knowledge Graph ID | /g/11bwf2g2lp |
| P11514 | Great Russian Encyclopedia portal ID | jacc-cardiovascular-imaging-c6e0b7 |
| P236 | ISSN | 1876-7591 |
| 1936-878X | ||
| P7363 | ISSN-L | 1876-7591 |
| P9035 | Muck Rack media outlet ID | imagingonlinejacc |
| P1055 | NLM Unique ID | 101467978 |
| P856 | official website | http://www.journals.elsevier.com/jacc-cardiovascular-imaging/ |
| http://www.sciencedirect.com/science/journal/1936878X | ||
| P10283 | OpenAlex ID | V195556561 |
| P3181 | OpenCitations bibliographic resource ID | 2612 |
| P7662 | Scilit journal ID | 588755 |
| P1156 | Scopus source ID | 11300153407 |
| P17 | country | United States of America | Q30 |
| P495 | country of origin | United States of America | Q30 |
| Kingdom of the Netherlands | Q29999 | ||
| P571 | inception | 2008-01-01 | |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| Science Citation Index Expanded | Q104047209 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiology | Q10379 |
| P123 | publisher | Elsevier BV | Q746413 |
| P1476 | title | JACC: Cardiovascular Imaging | |
| JACC. Cardiovascular imaging |
| Q87843431 | "Almost There": The Princess and the Frog Song |
| Q88737742 | "Much More Than a Tube": The Aneurysmal Ascending Aorta as a Dynamic Entity |
| Q98230865 | "Quadruple Rule-Out" With Computed Tomography in a COVID-19 Patient With Equivocal Acute Coronary Syndrome Presentation |
| Q52985635 | "See No Evil". |
| Q53078771 | (123)I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy. |
| Q40536828 | (18)F-FDG-PET/CTA of Prosthetic Cardiac Valves and Valve-Tube Grafts: Infective Versus Inflammatory Patterns |
| Q52996036 | (18)F-NaF PET Imaging of Early Coronary Artery Calcification. |
| Q92135550 | (Deep) Learning Your Left From Your Right |
| Q90040219 | 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry |
| Q48415403 | 11C-Pittsburgh B PET imaging in cardiac amyloidosis |
| Q89455319 | 123I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy |
| Q42616070 | 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis |
| Q98282923 | 18F-Florbetaben and PET/CT Holds Promise for the Identification and Differentiation Among Cardiac Amyloidosis Entities |
| Q120754862 | 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography in Acute Aortic Syndrome |
| Q43133017 | 18FDG PET and ultrasound echolucency in carotid artery plaques |
| Q91123616 | 2 Steps Forward, 1 Step Back |
| Q93129775 | 2- and 3-Dimensional Myocardial Strain in Cardiac Health and Disease |
| Q101475092 | 2020 SCCT Guideline for Training Cardiology and Radiology Trainees as Independent Practitioners (Level II) and Advanced Practitioners (Level III) in Cardiovascular Computed Tomography: A Statement from the Society of Cardiovascular Computed Tomograp |
| Q58582184 | 2D Flow CMR for Risk Assessment in Coronary Artery Disease: An Alternative to PET? |
| Q47447134 | 2D and 3D Echocardiography-Derived Indices of Left Ventricular Function and Shape: Relationship With Mortality. |
| Q47334130 | 3-Dimensional Echocardiographic Analysis of the Tricuspid Annulus Provides New Insights Into Tricuspid Valve Geometry and Dynamics |
| Q92203155 | 3-Dimensional Echocardiography in Imaging the Tricuspid Valve |
| Q90313927 | 3-Dimensional Echocardiography: Latest Developments and Future Directions |
| Q91465477 | 3-Dimensional Echocardiography: Moving From Pretty Pictures Toward Patient Outcomes |
| Q88583192 | 3-Dimensional Ultrasound in Carotid Stenosis Quantitation and Beyond |
| Q45062796 | 3-Dimensional-Printed Models for TAVR Planning: Why Guess When You Can See? |
| Q84893620 | 3-dimensional echocardiographic assessment of left ventricular dyssynchrony: an alternative viewpoint |
| Q43752722 | 3D Assessment of Features Associated With Transvalvular Aortic Regurgitation After TAVR: A Real-Time 3D TEE Study |
| Q42691880 | 3D CMR mapping of metabolism by hyperpolarized 13C-pyruvate in ischemia-reperfusion |
| Q41006943 | 3D Echocardiography and Level III Training |
| Q87841471 | 3D Echocardiography and Ventricular Unloading With Continuous Flow LVAD: Potential Advantages to Optimize Patient Outcome |
| Q86504355 | 3D Intracardiac Echocardiography During TAVR Without Endotracheal Intubation |
| Q38835533 | 3D Morphological Changes in LV and RV During LVAD Ramp Studies. |
| Q99623487 | 3D Myocardial Mechanical Wave Measurements: Toward In Vivo 3D Myocardial Elasticity Mapping |
| Q53621055 | 3D OCT versus FFR for jailed side-branch ostial stenoses. |
| Q52986661 | 3D Printing in Complex Congenital Heart Disease: Across a Spectrum of Age, Pathology, and Imaging Techniques. |
| Q99623482 | 3D Printing, Computational Modeling, and Artificial Intelligence for Structural Heart Disease |
| Q85195428 | 3D TEE and Systolic Anterior Motion in Hypertrophic Cardiomyopathy |
| Q38197838 | 3D TEE during catheter-based interventions |
| Q84399192 | 3D TEE for evaluation of commissural opening before and during percutaneous mitral commissurotomy |
| Q87431395 | 3D TEE with stereovision for guidance of the transcatheter mitral valve repair |
| Q53020150 | 3D Transthoracic Echocardiography Provides Accurate Cross-Sectional Area of the RV Outflow Tract. |
| Q53598047 | 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. |
| Q83876107 | 3D echocardiographic quantification in functional mitral regurgitation |
| Q85913020 | 3D echocardiography for planning and guidance of interventional closure of VSD |
| Q85649672 | 3D echocardiography for traumatic tricuspid regurgitation |
| Q85039922 | 3D echocardiography of the atrial septum: anatomical features and landmarks for the echocardiographer |
| Q53088981 | 3D echocardiography to evaluate right atrial pressure in acutely decompensated heart failure correlation with invasive hemodynamics. |
| Q51005178 | 3D fusion of LV venous anatomy on fluoroscopy venograms with epicardial surface on SPECT myocardial perfusion images for guiding CRT LV lead placement. |
| Q53671923 | 3D image reconstruction of histopathological structure of atherosclerotic plaque using a novel technique with film tomography. |
| Q53571698 | 3D imaging of device leads: "taking the lead with 3D". |
| Q87408658 | 3D real-time TEE during pulmonary vein isolation in atrial fibrillation |
| Q87112217 | 3D real-time intracardiac echocardiographic visualization of atrial structures relevant to atrial fibrillation ablation |
| Q84948095 | 3D reconstructions of optical frequency domain imaging to improve understanding of conventional PCI |
| Q44557297 | 3D thinking for mini-AVR. |
| Q92747773 | 4-Dimensional Transesophageal Echocardiographic Guidance During TAVR With BASILICA |
| Q50522576 | 4-Dimensionally Guided 3-Dimensional Color-Doppler Ultrasonography Quantifies Carotid Artery Stenosis With High Reproducibility and Accuracy. |
| Q48016600 | 4-[18F]-tetraphenylphosphonium as a PET tracer for myocardial mitochondrial membrane potential |
| Q102319436 | 4D Intracardiac Echocardiography-Guided LA Appendage Closure Under Conscious Sedation: Initial Experience and Procedural Technique |
| Q46427121 | 4D flow CMR in assessment of valve-related ascending aortic disease |
| Q98186778 | 4DCT-Derived Endocardial Left Ventricular Torsion Correlates With CMR Tagging-Derived Torsion in the Same Subjects |
| Q92770888 | 5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects: Results From REFINE SPECT |
| Q35956297 | A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals |
| Q51558262 | A 3D Window on the Achilles' Heel of Transcatheter Aortic Valve Replacement. |
| Q46052265 | A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. |
| Q86514832 | A Bigger Artery Is Not Better: Predicting Coronary Plaque Rupture |
| Q97589596 | A Boosted Ensemble Algorithm for Determination of Plaque Stability in High-Risk Patients on Coronary CTA |
| Q57839374 | A CT Study of Coronary Arteries in Adult Mustard Patients |
| Q92176475 | A CURE for What Ails in Cardiac Resynchronization Therapy: Defibrillator or Pacemaker Only? |
| Q94953572 | A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization |
| Q96615901 | A Clinical Tool to Identify Candidates for Stress-First Myocardial Perfusion Imaging |
| Q53181085 | A Combined Transcatheter Aortic Valve-in-Valve and Pulmonary Valve Implantation. |
| Q52572458 | A Comparison of the Updated Diamond-Forrester, CAD Consortium, and CONFIRM History-Based Risk Scores for Predicting Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: The SCOT-HEART Coronary CTA Cohort. |
| Q92135626 | A Deep Learning Approach for Assessment of Regional Wall Motion Abnormality From Echocardiographic Images |
| Q38730012 | A Highly Predictive Risk Model for Pacemaker Implantation After TAVR. |
| Q93192460 | A Hyperdynamic RV Is an Early Marker of Clinical Decompensation and Cardiac Recovery in Aortic Stenosis With Normal LV Ejection Fraction |
| Q92770998 | A Large Bifurcation Angle Is Strongly Associated With Increased Plaque Volume and Plaque Progression |
| Q98230839 | A Network-Based "Phenomics" Approach for Discovering Patient Subtypes From High-Throughput Cardiac Imaging Data |
| Q91465447 | A New Decade of Old Questions: Steps Toward Demonstrating the Efficacy of Physiologic CAD Evaluation by CT |
| Q89281498 | A New Dimension in Prediction of Cardiovascular Outcomes |
| Q93192385 | A New Threshold for Intervention Based on Left Ventricular Ejection Fraction in Subclinical, Severe Aortic Stenosis: Is 55 the New 50? |
| Q88737804 | A Novel Deep Learning Approach for Automated Diagnosis of Acute Ischemic Infarction on Computed Tomography |
| Q90553896 | A Novel Noninvasive Index to Characterize Right Ventricle Pulmonary Arterial Vascular Coupling in Children |
| Q86691939 | A Picture is Worth a Thousand Questions: Is OCT Ready for Routine Clinical Use? |
| Q100431005 | A Plea Not to Forget Infective Endocarditis in COVID-19 Era |
| Q59295378 | A Prospective Study for Comparison of MR and CT Imaging for Detection of Coronary Artery Stenosis |
| Q114666213 | A Randomized Controlled Trial of Statins to Reduce Inflammation in Unruptured Cerebral Aneurysms |
| Q45067531 | A Randomized Trial of Pocket-Echocardiography Integrated Mobile Health Device Assessments in Modern Structural Heart Disease Clinics |
| Q89934491 | A Randomized Trial of Reminders of Past High BNP to Increase Measurement of LVEF |
| Q89306178 | A Remedy for the Achilles' Heel of Echocardiography? |
| Q92047579 | A Roadmap to Assess Myocardial Work: From Theory to Clinical Practice |
| Q48502252 | A Strain by Any Other Tracking Would Perform as Sweet? |
| Q91123595 | A Subtle Clinical Phenotype of Aortic Limited Intimal Tear Without Hematoma |
| Q89125783 | A Tale of 2 Tests |
| Q46849021 | A clinical model to identify patients with high-risk coronary artery disease |
| Q46011766 | A closer look on the battlefield: the salvaged area at risk as an outcome marker for myocardial reperfusion. |
| Q86141457 | A comprehensive evaluation of left atrial performance using volumetric analysis, strain, and strain rate imaging |
| Q53526721 | A foregone conclusion?: risk stratification in pacemaker-associated endocarditis. |
| Q53105664 | A long-term prognostic value of CT angiography and exercise ECG in patients with suspected CAD. |
| Q46227090 | A long-term prognostic value of coronary CT angiography in suspected coronary artery disease |
| Q46061252 | A microvascular-myocardial diastolic dysfunctional state and risk for mental stress ischemia: a revised concept of ischemia during daily life. |
| Q39988838 | A new era for cardiovascular imaging? Implications of the revoked national coverage decision for CT angiography on future imaging reimbursement |
| Q53037685 | A novel approach to neonatal management of tetralogy of Fallot, with pulmonary atresia, and multiple aortopulmonary collaterals. |
| Q86932861 | A picture (and a video) is worth a… |
| Q45388521 | A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure |
| Q26858966 | A practical guide to multimodality imaging of transcatheter aortic valve replacement |
| Q36285938 | A quantitative pixel-wise measurement of myocardial blood flow by contrast-enhanced first-pass CMR perfusion imaging: microsphere validation in dogs and feasibility study in humans. |
| Q46056363 | A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease The OPTIMIZE Trial |
| Q44133735 | A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. |
| Q43028482 | A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent |
| Q51002294 | A soft computing-based B-line analysis for objective classification of severity of pulmonary edema and fibrosis. |
| Q37438759 | A statement on ethics from the HEART Group |
| Q43243349 | A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images |
| Q58909575 | A “Stable” Coronary Plaque Rupture Documented by Repeated OCT Studies |
| Q82551806 | ACC Imaging Council evolves into a section: a new opportunity for imagers |
| Q85649663 | AFib rotors: are we in the "driver" seat? |
| Q84378453 | ARVC/D task force imaging criteria: it is difficult to get along with the guidelines |
| Q57736153 | ARVC: Imaging Diagnosis Is Still in the Eye of the Beholder⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College |
| Q57182416 | Abnormal Lymphatic Channels Detected by T2-Weighted MR Imaging as a Substrate for Ventricular Arrhythmia in HCM |
| Q50061196 | Abnormal Motion Patterns of the Interventricular Septum |
| Q56965123 | Abnormal Myocardial Perfusion in Kawasaki Disease Convalescence |
| Q128285631 | Abnormal Right Ventricular–Pulmonary Arterial Coupling in Patients With Coarctation of Aorta Presenting With Aortic Stenosis |
| Q46011762 | Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis. |
| Q46056371 | Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. |
| Q52650702 | Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction. |
| Q92021314 | Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease |
| Q44629952 | Absence of coronary artery calcification and all-cause mortality |
| Q61913966 | Absolute Myocardial Blood Flow |
| Q91123587 | Absolute Myocardial Blood Flow in Dilated Cardiomyopathy: Does it Matter? |
| Q90202242 | Absolute Stress Myocardial Blood Flow After Coronary CT Angiography Guides Referral to Invasive Angiography |
| Q45972528 | Absolute figures are better than percentages. |
| Q85649666 | Absolute quantification of myocardial tissue composition: an additional level of complexity or an achievable clinical target? |
| Q37688578 | Accelerated coronary plaque progression and endothelial dysfunction: serial volumetric evaluation by IVUS. |
| Q45354195 | Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis |
| Q37438753 | Accreditation for cardiovascular imaging: setting quality standards for patient care |
| Q86570407 | Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise |
| Q40156131 | Accuracy of J-CTO Score Derived From Computed Tomography Versus Angiography to Predict Successful Percutaneous Coronary Intervention |
| Q40436994 | Accuracy of Noncontrast Quiescent-Interval Single-Shot Lower Extremity MR Angiography Versus CT Angiography for Diagnosis of Peripheral Artery Disease: Comparison With Digital Subtraction Angiography. |
| Q44233114 | Accuracy of OCT in evaluating neointimal thickness after stent implantation |
| Q52957154 | Accuracy of OCT, grayscale IVUS, and their combination for the diagnosis of coronary TCFA: an ex vivo validation study. |
| Q43275225 | Accuracy of cardiac magnetic resonance of absolute myocardial blood flow with a high-field system: comparison with conventional field strength |
| Q82770755 | Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation |
| Q35100347 | Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies. |
| Q51600502 | Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVAD: Role of Diastolic Flow Acceleration and Systolic-to-Diastolic Peak Velocity Ratio of Outflow Cannula. |
| Q86134050 | Accurate conductance-based post-dilation balloon catheter sizing |
| Q43486103 | Achieving Quality in Cardiovascular Imaging II: proceedings from the Second American College of Cardiology -- Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging |
| Q53218976 | Acquiring multiple parameters from multiple tests: the real principle of multimodality imaging. |
| Q62141350 | Acute Adverse Reactions to Gadolinium in CMR |
| Q58816539 | Acute Left Ventricular Remodeling Following Myocardial Infarction |
| Q89306188 | Acute MI and Contrast-Enhanced CMR: We Need the Whole Map of the Archipelago, Not Just Half of It! |
| Q61821002 | Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value |
| Q129444983 | Acute Response of the Noninfarcted Myocardium and Surrounding Tissue Assessed by T2 Mapping After STEMI |
| Q82551744 | Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry |
| Q45303865 | Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent |
| Q48600848 | Acute, Exercise Dose-Dependent Impairment in Atrial Performance During an Endurance Race: 2D Ultrasound Speckle-Tracking Strain Analysis |
| Q87578767 | Adapting to a changing health care environment |
| Q91465493 | Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction |
| Q90566484 | Adding Alirocumab to Rosuvastatin Helps Reduce the Vulnerability of Thin-Cap Fibroatheroma: An ALTAIR Trial Report |
| Q51548412 | Adding dimensions to unimodal cardiac images. |
| Q85749205 | Adding or selecting imaging modalities for incremental diagnosis: a case study of ¹⁸FDG PET/CT in prosthetic valve endocarditis |
| Q47679179 | Additional Diagnostic Value of Combined Angio-Computed Tomography and Fluorodeoxyglucose F-18 Positron Emission Tomography in Infectious Aortitis |
| Q91647826 | Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance |
| Q35230198 | Additional value of transluminal attenuation gradient in CT angiography to predict hemodynamic significance of coronary artery stenosis |
| Q38919709 | Additive Value of Integrated Backscatter IVUS for Detection of Vulnerable Plaque by Optical Frequency Domain Imaging: An Ex Vivo Autopsy Study of Human Coronary Arteries |
| Q93129789 | Addressing the Treatment Dilemma in Asymptomatic Aortic Stenosis: The AVATAR Trial |
| Q33622671 | Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis |
| Q35873442 | Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents |
| Q42905586 | Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance |
| Q53354437 | Adipose tissue detected by multislice computed tomography in patients after myocardial infarction. |
| Q42939300 | Adipose tissue imaging the potential and the challenge |
| Q43175083 | Adrenergic excess, hNET1 down-regulation, and compromised mIBG uptake in heart failure poverty in the presence of plenty |
| Q27692079 | Adult left ventricular noncompaction: reappraisal of current diagnostic imaging modalities. |
| Q90678614 | Advanced Echocardiographic Imaging for Prediction of SCD in Moderate and Severe LV Systolic Function |
| Q91307413 | Advanced Imaging Insights in Apical Hypertrophic Cardiomyopathy |
| Q103042398 | Advances in Risk Stratification of Patients With Coronary Microvascular Dysfunction: Usefulness of Stress Perfusion CMR |
| Q30412201 | Advances in parametric mapping with CMR imaging |
| Q128682305 | Advancing Myocardial Tissue Analysis Using Echocardiography |
| Q53295473 | Advantages of blood pooling in pediatric MR angiography. |
| Q92676897 | Adverse Plaque Characteristics Relate More Strongly With Hyperemic Fractional Flow Reserve and Instantaneous Wave-Free Ratio Than With Resting Instantaneous Wave-Free Ratio |
| Q39639362 | Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression |
| Q88737816 | Afterload Augmentation Can Reveal Concealed Myocardial Ischemic Memory |
| Q51759098 | Afterload Hypersensitivity in Patients With Left Bundle Branch Block. |
| Q92047551 | Afterload and Fibrosis: Aortic Stenosis Co-Conspirators |
| Q50077054 | Age-associated elongation of the ascending aorta in adults |
| Q54594745 | Albumin-Binding MR Probe Detects High-Risk Coronary Plaques in Patients. |
| Q82978108 | Aldosterone blockade in metabolic syndrome: hitting the target or still missing some links? |
| Q99575268 | Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic Resonance |
| Q53934318 | American-Style Football Players as Modern Gladiators: Could Heart Rate Provide All Answers? |
| Q96132220 | Amyloidosis Imaging: Prime Time Biomarker Yet Still a Moving Target |
| Q88088205 | An Asymmetric Wall-Thickening Pattern Predicts Response to Cardiac Resynchronization Therapy |
| Q91307425 | An Onsite CT-FFR Technique Based on TAG: A 1-Hit Wonder or Can We Expect More to Come? |
| Q82428274 | An alternative isovelocity surface model for quantitation of effective regurgitant orifice area in mitral regurgitation with an elongated orifice application to functional mitral regurgitation |
| Q48528660 | An educational intervention reduces the rate of inappropriate echocardiograms on an inpatient medical service |
| Q84058424 | An ounce of prevention with a calcium score scan? |
| Q87408669 | An unfolding view of imaging: when perception becomes unreal! |
| Q84216626 | Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities |
| Q89125792 | Anatomic Characterization of the Aortic Root in Patients With Bicuspid and Tricuspid Aortic Valve Stenosis: Does Fusion of Doppler-Echocardiography and Computed Tomography Resolve Discordant Severity Grading? |
| Q85649660 | Anatomic localization of rapid repetitive sources in persistent atrial fibrillation: fusion of biatrial CT images with wave similarity/cycle length maps |
| Q91465442 | Anatomical and Functional Computed Tomography for Diagnosing Hemodynamically Significant Coronary Artery Disease: A Meta-Analysis |
| Q92203125 | Anatomy and Physiology of the Tricuspid Valve |
| Q37789488 | Anatomy of Right Atrial Structures by Real-Time 3D Transesophageal Echocardiography |
| Q83876140 | Anatomy of pulmonary veins by real-time 3D TEE: implications for catheter-based pulmonary vein ablation |
| Q46010796 | Anatomy trumps all! |
| Q98282920 | Anatomy, Physiology, and Biomechanics: The Dream of Identifying Vulnerable Plaque Remains Alive |
| Q83876144 | Angiographic correlates in type 1 and 2 MI by the universal definition |
| Q84571611 | Angioscopy and OCT in repeated in-stent restenosis in saphenous vein graft |
| Q84378408 | Annular velocities in constrictive pericarditis: annulus and beyond |
| Q88430423 | Annularity of Aorto-Iliac Arterial Calcification and Risk of All-Cause and Cardiovascular Mortality |
| Q85814806 | Annulus instead of LVOT diameter improves agreement between echocardiography effective orifice area and invasive aortic valve area |
| Q38632201 | Anomalous Aortic Origin of Coronary Arteries in the Young: Echocardiographic Evaluation With Surgical Correlation |
| Q83629463 | Another Step Forward in CT Angiography |
| Q58803993 | Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease |
| Q57058565 | Anti-Inflammatory Therapy and Coronary Artery Calcification Over Time |
| Q37085672 | Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis |
| Q91307417 | Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI |
| Q39594493 | Aortic Angulation Attenuates Procedural Success Following Self-Expandable But Not Balloon-Expandable TAVR. |
| Q53765307 | Aortic Dilatation in Repaired Tetralogy of Fallot. |
| Q29300626 | Aortic Size Assessment by Noncontrast Cardiac Computed Tomography: Normal Limits by Age, Gender, and Body Surface Area |
| Q88168501 | Aortic Stenosis Grading and Outcome: New Categories, New Therapeutic Challenges |
| Q89125730 | Aortic Stenosis in Cancer Survivors After Chest Radiation |
| Q50064032 | Aortic Stenosis: No Number Trumps Clinical Judgment |
| Q50781645 | Aortic Stiffness Matters: Ventricular-Arterial Interactions Over Time. |
| Q90678677 | Aortic Valve Area in Aortic Stenosis: A Network Meta-Analysis |
| Q83629598 | Aortic dimensions and stiffness in normal adults |
| Q37391189 | Aortic pulse wave velocity is associated with measures of subclinical target organ damage |
| Q83636977 | Aortic regurgitation: time to reassess timing of valve replacement? |
| Q45938244 | Aortic stenosis: look globally, think globally. |
| Q51767100 | Aortic surgery for ascending aortic aneurysms under 5.0 cm in diameter in the presence of bicuspid aortic valve. |
| Q53021442 | Aortic valve area calculation in aortic stenosis by CT and Doppler echocardiography. |
| Q36036057 | Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population |
| Q114163601 | Apical Rocking and Septal Flash |
| Q98186783 | Apical Sparing Strain Pattern in Danon Disease: Insights From a Global Registry |
| Q50057837 | Apical to Base Gradient of Technetium-99m Pyrophosphate Myocardial Counts in Cardiac Amyloidosis: An Insight Into the Mechanism of Myocardial Strain Gradient, or Merely "Clouds That Mimic Land Before the Sailor's Eye?" |
| Q53360151 | Appearance of acute and chronic coronary occlusions in contrast-enhanced cardiac computed tomography. |
| Q85649657 | Application of 3D Echocardiography to Everyday Practice: Development of Normal Ranges Is Step 1 |
| Q92771074 | Application of Low Tube Potentials in CCTA: Results From the PROTECTION VI Study |
| Q44297677 | Applications of cardiac CT in the tetralogy of Fallot patient |
| Q45247022 | Appropriate use criteria for stress echocardiography: impact of updated criteria on appropriateness ratings, correlation with pre-authorization guidelines, and effect of temporal trends and an educational initiative on utilization |
| Q47584152 | Arch hypoplasia and aneurysm after aortic coarctation repair: abnormal flow may be the link |
| Q46184727 | Are All Individuals With Diabetes Equal, or Some More Equal Than Others? |
| Q53790599 | Are Echocardiography and CMR Really Discordant in Mitral Regurgitation? |
| Q87231543 | Are Microcalcification and Hemosiderin Really Limitations of OCT in Detection of TCFA? |
| Q90202225 | Are Patients With End-Stage Liver Disease Maximally Vasodilated?: Insights From Rubidium-82 PET Dilatory Perfusion |
| Q57786106 | Are Trabeculae and Papillary Muscles an Integral Part of Cardiac Anatomy |
| Q91465432 | Are We Ready to Treat Dilated Cardiomyopathy Differently, Using LGE Guidance? |
| Q84378439 | Are our tools for the identification of TCFA ready and do we know them? |
| Q43825081 | Are the culprit lesions severely stenotic? |
| Q51141530 | Are we up to speed?: from big data to rich insights in CV imaging for a hyperconnected world. |
| Q52604080 | Arrhythmogenic Potential of Border Zone After Myocardial Infarction: Scar Is More Than Just a Healed Wound…. |
| Q53051841 | Arterial 18F-FDG uptake in rheumatoid arthritis correlates with synovial activity. |
| Q104794273 | Arterial Changes Connecting Hypertension to Alzheimer's Disease and Related Dementias |
| Q41002916 | Arterial Remodeling and Endothelial Shear Stress Exhibit Significant Longitudinal Heterogeneity Along the Length of Coronary Plaques. |
| Q27026486 | Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? |
| Q33694342 | Arterial remodeling in [corrected] subclinical carotid artery disease |
| Q46052438 | Arterial spin labeled CMR detects clinically relevant increase in myocardial blood flow with vasodilation |
| Q30416121 | Arterial spin labeling MR imaging reproducibly measures peak-exercise calf muscle perfusion: a study in patients with peripheral arterial disease and healthy volunteers |
| Q102319407 | Artificial Intelligence Aids Cardiac Image Quality Assessment for Improving Precision in Strain Measurements |
| Q62496783 | Artificial Intelligence-Based Assessment of Left Ventricular Filling Pressures From 2-Dimensional Cardiac Ultrasound Images |
| Q91307435 | Artificial Intelligence: From Scientific Curiosity to Clinical Precocity? |
| Q54474640 | Assessing Diastology in Aortic Stenosis: Should We Stress About Strain Rate? |
| Q41432384 | Assessing Hemodynamically Significant CAD by Difference in Contrast Opacification of CT Angiograms: An Exercise in Seeing and Believing |
| Q38280386 | Assessing bioresorbable coronary devices: methods and parameters |
| Q84811062 | Assessing neointimal coverage after DES implantation by 3D OCT |
| Q93192427 | Assessment of Cardiac Iron Overload in Thalassemia With MRI on 3.0-T: High-Field T1, T2, and T2* Quantitative Parametric Mapping in Comparison to T2* on 1.5-T |
| Q46119316 | Assessment of Coronary Calcium Density on Noncontrast Computed Tomography |
| Q85616539 | Assessment of LV Myocardial Scar Before Atrial Fibrillation Ablation |
| Q84085622 | Assessment of LV systolic dyssynchrony in heart failure beyond a snapshot |
| Q48502265 | Assessment of Left Ventricular Function by Echocardiography: The Case for Routinely Adding Global Longitudinal Strain to Ejection Fraction |
| Q91647697 | Assessment of Mechanisms of Acute Coronary Syndromes and Composition of Culprit Plaques in Patients With and Without Diabetes |
| Q100431002 | Assessment of Multivessel Coronary Artery Disease Using Cardiovascular Magnetic Resonance Pixelwise Quantitative Perfusion Mapping |
| Q93192520 | Assessment of Myocardial Fibrosis Using Multimodality Imaging in Severe Aortic Stenosis: Comparison With Histologic Fibrosis |
| Q46652502 | Assessment of Post-Procedural Aortic Regurgitation After TAVR: An Intraprocedural TEE Study |
| Q38723500 | Assessment of Prosthetic Valve Function After TAVR. |
| Q91123632 | Assessment of Subclinical Atherosclerosis in Smokers: Does Lower Risk Mean Low Risk? |
| Q90948496 | Assessment of Subclinical Left Ventricular Dysfunction in Aortic Stenosis |
| Q44649814 | Assessment of coronary artery stenosis severity and location: quantitative analysis of transmural perfusion gradients by high-resolution MRI versus FFR. |
| Q84560930 | Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT |
| Q37485361 | Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score |
| Q48854805 | Assessment of dyssynchronous wall motion during acute myocardial ischemia using velocity vector imaging |
| Q86321432 | Assessment of early post-infarction pericardial injury by CMR |
| Q47291403 | Assessment of echocardiographic left atrial size: how accurate do we need to be? |
| Q46011755 | Assessment of graft patency during coronary artery bypass graft surgery: mitigating the risk. |
| Q48718000 | Assessment of lung ultrasound artifacts (B-lines): incremental contribution to echocardiography in heart failure? |
| Q84378413 | Assessment of mitral stenosis: role of real-time 3D TEE |
| Q53056363 | Assessment of mitral valve anatomy and geometry with multislice computed tomography. |
| Q83200597 | Assessment of mitral valve prolapse by 3D TEE angled views are key |
| Q43260665 | Assessment of myocardial edema by computed tomography in myocardial infarction |
| Q39295961 | Assessment of myocardial ischemic memory using persistence of post-systolic thickening after recovery from ischemia |
| Q39253400 | Assessment of myocardial ischemic memory using speckle tracking echocardiography |
| Q43160392 | Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking |
| Q28081869 | Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme |
| Q82770769 | Assessment of percutaneous catheter treatment of paravalvular prosthetic regurgitation |
| Q83179371 | Assessment of radiofrequency ablation lesions by CMR imaging after ablation of idiopathic ventricular arrhythmias |
| Q46470478 | Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography |
| Q94867872 | Assessment of subendocardial function with myocardial contrast echocardiography |
| Q37779642 | Assessment of subendocardial structure and function |
| Q37250151 | Assessment of the Radiation Effects of Cardiac CT Angiography Using Protein and Genetic Biomarkers |
| Q30454918 | Assessment of the accuracy and reproducibility of RV volume measurements by CMR in congenital heart disease |
| Q52572454 | Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study. |
| Q40279611 | Association Between High-Sensitivity Cardiac Troponin Levels and Myocardial Ischemia During Mental Stress and Conventional Stress. |
| Q63915333 | Association Between IVUS Findings and Adverse Outcomes in Patients With Coronary Artery Disease |
| Q38677656 | Association Between Myocardial Mechanics and Ischemic LV Remodeling |
| Q87331812 | Association Between Nonstenosing Carotid Artery Plaque on MR Angiography and Acute Ischemic Stroke |
| Q92176456 | Association Between Recreational Cannabis Use and Cardiac Structure and Function |
| Q52983596 | Association Between Sedentary Time and Coronary Artery Calcium. |
| Q93192448 | Association Between TTE Appropriateness, Echocardiographic Findings, and Clinical Outcomes |
| Q85039892 | Association Between Visceral Adipose Tissue Area and Coronary Plaque Morphology Assessed by CT Angiography |
| Q43615917 | Association between bicuspid aortic valve phenotype and patterns of valvular dysfunction and bicuspid aortopathy: comprehensive evaluation using MDCT and echocardiography |
| Q33852790 | Association between coronary artery calcification progression and microalbuminuria: the MESA study |
| Q47447152 | Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction |
| Q47296938 | Association of Active and Passive Components of LV Diastolic Filling With Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Mechanistic Insights From Spironolactone Response |
| Q98282927 | Association of Asymptomatic Diastolic Dysfunction Assessed by Left Atrial Strain With Incident Heart Failure |
| Q34030638 | Association of CMR-measured LA function with heart failure development: results from the MESA study |
| Q85623176 | Association of Exercise Intolerance in Type 2 Diabetes With Skeletal Muscle Blood Flow Reserve |
| Q91123641 | Association of Hemodynamic Severity With Plaque Vulnerability and Complexity of Coronary Artery Stenosis: A Combined Optical Coherence Tomography and Fractional Flow Reserve Study |
| Q48600860 | Association of Insulin Resistance and Glycemic Metabolic Abnormalities With LV Structure and Function in Middle Age: The CARDIA Study |
| Q56985842 | Association of Myocardial T1-Mapping CMR With Hemodynamics and RV Performance in Pulmonary Hypertension |
| Q41190274 | Association of Patient Beliefs and Preferences With Subsequent Testing After Initial Evaluation for Ischemic Heart Disease |
| Q92135540 | Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors |
| Q92586209 | Association of Statin Use With Cardiovascular Outcomes by Coronary Calcium: MESA |
| Q36074394 | Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population. |
| Q54017801 | Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. |
| Q85252961 | Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study |
| Q45927721 | Association of myocardial deformation with mortality independent of myocardial ischemia and left ventricular hypertrophy. |
| Q34139914 | Association of plaque composition and vessel remodeling in atherosclerotic renal artery stenosis: a comparison with coronary artery disease |
| Q36186702 | Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis |
| Q51154386 | Asymmetric Longitudinal Lesion Geometry: Expanding Clinical Applications of Biomechanics. |
| Q54259663 | Asymptomatic Aortic Stenosis: From Flights of Stairs to Exercise Testing to Exercise Echocardiography? |
| Q90040168 | Asymptomatic Left Ventricular Diastolic Dysfunction: Predicting Progression to Symptomatic Heart Failure |
| Q48000129 | Asymptomatic Severe Aortic Stenosis in the Elderly. |
| Q87131037 | Asymptomatic cardiovascular risk assessment: the road less traveled |
| Q39640350 | Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study |
| Q33863379 | Atherosclerosis in ancient Egyptian mummies: the Horus study. |
| Q52707584 | Atherosclerosis, Stenosis, and Ischemia: One Primary, One Secondary, and One Tertiary. |
| Q44499278 | Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study |
| Q34978684 | Atherosclerotic plaque characteristics by CT angiography identify coronary lesions that cause ischemia: a direct comparison to fractional flow reserve |
| Q43113905 | Atherosclerotic plaque imaging: the last frontier for cardiac magnetic resonance |
| Q83629636 | Atherosclerotic plaque, adventitia, perivascular fat, and carotid imaging |
| Q87408656 | Atherosclerotic versus nonatherosclerotic evaluation: the Yin and Yang of cardiovascular imaging in advanced chronic kidney disease |
| Q37438810 | Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. |
| Q47374454 | Athletic Left Atrial Dilation: Size Matters? |
| Q96615861 | Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy |
| Q49721128 | Atrial Fibrillation Begets Mitral Regurgitation, or Is it Vice Versa? |
| Q58811854 | Atrial Function in Patients Undergoing CRT |
| Q50188173 | Atrial Strain Assessment in Left Ventricular Diastolic Dysfunction |
| Q97589589 | Atrial Strain in Heart Failure: Yet Another Scoring System for AF, Ready for Prime Time? |
| Q83636979 | Atrial dilation and altered function are mediated by age and diastolic function but not before the eighth decade |
| Q87296789 | Atrial function as a guide to timing of intervention in mitral valve prolapse with mitral regurgitation |
| Q90040181 | Auditing the Auditor: The March of Science and the Need to Refresh Guidelines |
| Q92676874 | Augmentation of Tissue Perfusion in Patients With Peripheral Artery Disease Using Microbubble Cavitation |
| Q95561355 | Autofluorescence: A New NIR on the Block |
| Q44562886 | Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR. |
| Q63387470 | Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks |
| Q53990757 | Automated Cardiac Volumetric Analysis: One Step Closer to Incorporating 3D TTE Into Routine Daily Workflow. |
| Q92038098 | Automated Coronary Plaque Characterization With Intravascular Optical Coherence Tomography and Smart-Algorithm Approach: Virtual Histology OCT |
| Q91647819 | Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology |
| Q88631901 | Automated Pixelwise Perfusion Mapping by CMR: When Many Small Steps Make a Giant Leap |
| Q92569237 | Automated Quantification in Echocardiography |
| Q88114549 | Automated Quantification of Coronary Plaque Volume From CT Angiography Improves CV Risk Prediction at Long-Term Follow-Up |
| Q51679402 | Automated quantification of stenosis severity on 64-slice CT: a comparison with quantitative coronary angiography. |
| Q38418247 | Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification Without Hematocrit Sampling |
| Q85097966 | Avoiding patient-prosthesis mismatch is TAVI a new solution? |
| Q50057892 | B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study. |
| Q48717982 | B-lines: to count or not to count? |
| Q37438798 | B-type natriuretic peptides and echocardiographic measures of cardiac structure and function |
| Q91123612 | Back to the Future: Mitral Annular Plane Systolic Excursion on Cardiac Magnetic Resonance |
| Q92176463 | Baseline Global Longitudinal Strain Is Associated With All-Cause Mortality After Transcatheter Aortic Valve Replacement |
| Q33626995 | Baseline subclinical atherosclerosis burden and distribution are associated with frequency and mode of future coronary revascularization: multi-ethnic study of atherosclerosis |
| Q98629432 | Between a Rock and a Hard Place: Calcium Supplements, Calcified Atheroma, and Cardiovascular Disease Risk |
| Q53958815 | Beyond Ejection Fraction: Adding Strain to the Armamentarium. |
| Q84748283 | Beyond the glass ceiling--achieving gender equity in risk stratification for cardiovascular imaging |
| Q84948101 | Bibliographic metrics at JACC: cardiovascular imaging an opportunity for audit and reflection |
| Q53117292 | Bicuspid aortic valve and aortopathy: see the first, then look at the second. |
| Q42372024 | Bicuspid aortic valve phenotype and aortopathy: nomenclature and role of aortic hemodynamics. |
| Q36318589 | Bicuspid aortic valve: inter-racial difference in frequency and aortic dimensions. |
| Q94953578 | Big MAC, Hold the Valve |
| Q90040229 | Biomechanical Stress Profiling of Coronary Atherosclerosis: Identifying a Multifactorial Metric to Evaluate Plaque Rupture Risk |
| Q53374662 | Bioresorbable coronary devices: advances illuminated by imaging. |
| Q92505490 | Blood Flow Reserve at Common Caffeine Levels |
| Q38785625 | Blood Pressure and LV Remodeling Among American-Style Football Players |
| Q99575265 | Body Composition, Natriuretic Peptides, and Adverse Outcomes in Heart Failure With Preserved and Reduced Ejection Fraction |
| Q92747825 | Bone Scintigraphy Imaging for Transthyretin Cardiac Amyloidosis: Still Much to Learn |
| Q92038042 | Boot-Shaped Heart After Robotic Coronary Assist Bypass Surgery |
| Q30861658 | Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients |
| Q37216101 | Breaking America's dependence on imported molybdenum |
| Q92411372 | Breast Arterial Calcium: A Game Changer in Women's Cardiovascular Health? |
| Q90202260 | Breast Cancer Treatment and Diastolic Dysfunction: Should We Worry About Relaxing in Cardio-Oncology? |
| Q53345213 | Bridging the detection gap chasm of risk: where can computed tomography angiography take us? |
| Q91018969 | Bringing Order to Disorder: Is Image Entropy the Answer? |
| Q58564589 | Building Bridges in Cardiology and Radiology: Why Collaboration Is the Future of Cardiovascular Imaging |
| Q91320395 | Building Coronary Lesion-Specific Predictive Models Using the Proper Prognostic Parameters: A Look Into the Computational Hemodynamics of the Matter |
| Q91018908 | Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting |
| Q83629437 | Business aspects of cardiovascular computed tomography: tackling the challenges |
| Q40567189 | CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines |
| Q52983595 | CACS and the Frequency of Stress-Induced Myocardial Ischemia During MPI: A Meta-Analysis. |
| Q96615910 | CAD Severity on Cardiac CTA Identifies Patients With Most Benefit of Treating LDL Cholesterol to ACC/AHA and ESC/EAS Targets |
| Q44268703 | CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol |
| Q88297966 | CAD-RADS: A Giant First Step Toward a Common Lexicon? |
| Q48275967 | CATCH a Glimpse of the Future |
| Q51137909 | CATCHing the High-Risk Coronary Plaques by Magnetic Resonance Imaging. |
| Q92176420 | CMR DENSE and the Seattle Heart Failure Model Inform Survival and Arrhythmia Risk After CRT |
| Q92135587 | CMR Fingerprinting for Myocardial T1, T2, and ECV Quantification in Patients With Nonischemic Cardiomyopathy |
| Q39004812 | CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia |
| Q57058558 | CMR Global Longitudinal Strain: A Better Tool for Unraveling the Links to Heart Failure Mortality |
| Q53120733 | CMR Guidance for Recanalization of Coronary Chronic Total Occlusion. |
| Q49896806 | CMR Mapping For Myocarditis: Coming Soon to a Center Near You. |
| Q53075271 | CMR Predictors of Mitral Regurgitation in Mitral Valve Prolapse |
| Q92771026 | CMR Should Be a Mandatory Test in the Contemporary Evaluation of "MINOCA" |
| Q91894910 | CMR and CT of the Patient With Cardiac Devices: Safety, Efficacy, and Optimization Strategies |
| Q88927443 | CMR and Intracardiac Echocardiography for Detecting LA/LAA Thrombus |
| Q57743979 | CMR and LV Noncompaction∗ |
| Q87286660 | CMR and amyloid cardiomyopathy: are we getting closer to the biology? |
| Q83636993 | CMR assessment of myocarditis in patients with cardiac symptoms during H1N1 viral infection |
| Q43975072 | CMR detects subclinical cardiomyopathy in mother-carriers of Duchenne and Becker muscular dystrophy |
| Q85098002 | CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease |
| Q92047596 | CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography |
| Q61913959 | CMR for Sudden Cardiac Death Risk Stratification |
| Q83179374 | CMR for mapping the missing dimension in ventricular tachycardia ablation |
| Q52844152 | CMR for the diagnosis of right heart disease. |
| Q38010852 | CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials |
| Q83220110 | CMR imaging for diastolic hemodynamic assessment fantasy or reality? |
| Q82551767 | CMR imaging in constrictive pericarditis: is seeing believing? |
| Q35724779 | CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession |
| Q53618172 | CMR imaging of extracellular volume and myocardial strain in hypertensive heart disease. |
| Q39450583 | CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis |
| Q37633748 | CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis |
| Q82978164 | CMR imaging: creating contrast without cosmetics... |
| Q103042419 | CMR in Evaluating Valvular Heart Disease: Diagnosis, Severity, and Outcomes |
| Q92524533 | CMR in Nonischemic Myocardial Inflammation: Solving the Problem of Diagnosing Myocarditis or Still Diagnostic Ambiguity? |
| Q87408657 | CMR in assessment of cardiac masses: primary benign tumors |
| Q49191763 | CMR in myocarditis: valuable tool, room for improvement |
| Q51715266 | CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. |
| Q98282913 | CMR in the Era of COVID-19: Evaluation of Myocarditis in the Subacute Phase |
| Q92770979 | CMR in the Evaluation of Diastolic Dysfunction and Phenotyping of HFpEF: Current Role and Future Perspectives |
| Q85814794 | CMR in the assessment of cardiac masses: primary malignant tumors |
| Q51588955 | CMR mapping techniques for myocardium at risk: next step into a bright future? |
| Q44994061 | CMR of amyloidosis: looking between the sheets |
| Q37634312 | CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy |
| Q42235768 | CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. |
| Q89254880 | CMR to Evaluate Bioprosthetic Aortic Stenosis? |
| Q83220140 | CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy |
| Q58853065 | CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis |
| Q63258733 | CMR-Based and Time-Shift Corrected Pressure Gradients Provide Good Agreement to Invasive Measurements in Aortic Coarctation |
| Q87841467 | CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation |
| Q98186784 | CMR-Derived Ventricular Global Function Index in Patients Late After the Fontan Operation |
| Q41733401 | CMR-Verified Lower LA Strain in the Presence of Regional Atrial Fibrosis in Atrial Fibrillation |
| Q61657804 | CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy |
| Q85814811 | CMR-based characterization of cardiac amyloidosis |
| Q87425673 | CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia |
| Q83461327 | CMR-based quantitative myocardial perfusion: pixel-wise and pound-wise |
| Q51724697 | CMR-guided approach to localize and ablate gaps in repeat AF ablation procedure. |
| Q87408650 | CMR-guided targeting of gaps after initial pulmonary vein isolation |
| Q85346949 | CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF |
| Q45992430 | CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. |
| Q90553993 | CONSERVE Your Energy and Resources |
| Q97881528 | COVID-19 "Fulminant Myocarditis" Successfully Treated With Temporary Mechanical Circulatory Support |
| Q34771590 | CRT improves LV filling dynamics: insights from echocardiographic particle imaging velocimetry |
| Q84560920 | CRT optimization: don't forget the atrium! |
| Q103042404 | CT Angiographic and Plaque Predictors of Functionally Significant Coronary Disease and Outcome Using Machine Learning |
| Q84399174 | CT Angiography by reduced tube voltage more than a single step |
| Q26800066 | CT Angiography for Revascularization of CTO: Crossing the Borders of Diagnosis and Treatment |
| Q38877134 | CT Angiography for the Detection of Coronary Artery Stenoses in Patients Referred for Cardiac Valve Surgery: Systematic Review and Meta-Analysis |
| Q46056498 | CT Angiography for the Prediction of Hemodynamic Significance in Intermediate and Severe Lesions: Head-to-Head Comparison With Quantitative Coronary Angiography Using Fractional Flow Reserve as the Reference Standard |
| Q52984412 | CT Coronary Angiography in Kidney Transplantation Candidates. |
| Q92676929 | CT FFR for Ischemia-Specific CAD With a New Computational Fluid Dynamics Algorithm: A Chinese Multicenter Study |
| Q52981956 | CT Imaging of Bicuspid Aortic Valve Disease for TAVR. |
| Q92676861 | CT Perfusion Versus Coronary CT Angiography in Patients With Suspected In-Stent Restenosis or CAD Progression |
| Q85749195 | CT angiography and ¹⁸F-FDG-PET fusion imaging for prosthetic heart valve endocarditis |
| Q53213770 | CT angiography for all patients with inconclusive noninvasive test? Clinical perspective: "not yet". |
| Q83629525 | CT angiography in children: it is accurate, but is it safe? |
| Q53083518 | CT angiography-fluoroscopy fusion imaging for percutaneous transapical access. |
| Q46117583 | CT assessment of coronary artery disease: trends and clinical implications |
| Q87431376 | CT defined atherosclerotic plaque type and severity: using the results of the diagnostic microscope to sharpen the clarity of peering through the prognostic telescope |
| Q35632921 | CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging |
| Q53279277 | CT for the Transapical Off-Pump Mitral Valve Repair With Neochord Implantation Procedure. |
| Q33664857 | CT image-based engineering analysis of transcatheter aortic valve replacement |
| Q53087816 | CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism. |
| Q47967668 | CT-Detected Growth of Coronary Artery Calcification in Asymptomatic Middle-Aged Subjects and Association With 15 Biomarkers. |
| Q51248067 | CT-SYNTAX score: a feasibility and reproducibility Study. |
| Q46569563 | CV imaging for fellows in training: challenges and opportunities |
| Q38114231 | CV imaging: what was new in 2012? |
| Q44717232 | CV risk of secondhand tobacco exposure: is it all smoke and mirrors? |
| Q87638562 | CZT-SPECT: Reaching its Potential |
| Q92176483 | Calcific Aortic Stenosis: An Evolution of Thoughts |
| Q52989699 | Calcified Constrictive Pericarditis: Prevalence, Distribution Patterns, and Relationship to the Myocardium. |
| Q87431399 | Calcified nodules: an underrated mechanism of coronary thrombosis? |
| Q34300909 | Calcium scoring in patients with a history of Kawasaki disease |
| Q54941822 | Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis? |
| Q92569262 | Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? |
| Q35648851 | Can Computational Simulation Quantitatively Determine Mitral Valve Abnormalities? |
| Q39171421 | Can Functional Testing for Ischemia and Viability Guide Revascularization? |
| Q104794272 | Can Left Atrial Strain Forecast Future Fibrillation? |
| Q61913945 | Can Magnetic Spins Determine the Cause of an Electrical Storm? ∗ |
| Q46557387 | Can PET/MR Imaging Assess Coronary Artery Plaque Biology? |
| Q92176431 | Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy?: Impact of Temporal and Observer Variability |
| Q54547282 | Can Stress CMR Impact Care in the Era After COURAGE and FAME-2? |
| Q96615872 | Can Stress Cardiac Magnetic Resonance Identify Potential Survival Benefit With Revascularization in Stable Ischemic Heart Disease? |
| Q57735860 | Can a MR Imaging Scanner Accurately Measure Hematocrit to Determine ECV Fraction?∗ |
| Q45944749 | Can a Machine Learn Better Than Humans? |
| Q37915740 | Can a teaching intervention reduce interobserver variability in LVEF assessment: a quality control exercise in the echocardiography lab. |
| Q87131026 | Can calcium supplementation improve stress echocardiography? |
| Q42410385 | Can cardiac magnetic resonance myocardial scar features affect treatment decisions for patients with coronary artery disease and heart failure? |
| Q46023654 | Can carotid plaque predict coronary plaque? |
| Q43064454 | Can contrast-enhanced cardiac magnetic resonance assess inflammation of the coronary wall? |
| Q83863118 | Can lung comets be counted as "objects"? |
| Q42721726 | Can we still rely on the ECG for detecting past myocardial injury? |
| Q53014761 | Capturing maximal coronary vasodilation for myocardial perfusion imaging: is timing everything? |
| Q86184427 | Cardiac "Morphomics": Do We Need to Measure LV Mass and Geometry in Everyone? |
| Q38759216 | Cardiac 3D Printing and its Future Directions |
| Q47817922 | Cardiac Amyloidosis Presenting as Severe Mitral Regurgitation |
| Q92176424 | Cardiac Amyloidosis: Is This the Tip of the Iceberg? |
| Q89728072 | Cardiac Amyloidosis: Mimics, Multimodality Imaging Diagnosis, and Treatment |
| Q92676964 | Cardiac CT After Coronary Revascularization: Enough to Make a Difference? |
| Q51507314 | Cardiac CT With Delayed Enhancement in the Characterization of Ventricular Tachycardia Structural Substrate: Relationship Between CT-Segmented Scar and Electro-Anatomic Mapping. |
| Q88802048 | Cardiac CTA for Evaluation of Prosthetic Valve Dysfunction |
| Q58564573 | Cardiac Computed Tomography 2.0: Adding Physiology to Anatomy |
| Q57815519 | Cardiac Computed Tomography in Troponin-Positive Chest Pain: Sometimes the Answer Lies in the Late Iodine Enhancement or Extracellular Volume Fraction Map |
| Q51067275 | Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation. |
| Q88747658 | Cardiac Dysautonomia and Survival in Hereditary Transthyretin Amyloidosis |
| Q39128756 | Cardiac Imaging for Assessing Low-Gradient Severe Aortic Stenosis |
| Q98629447 | Cardiac Imaging for Coronary Heart Disease Risk Stratification in Chronic Kidney Disease |
| Q98230856 | Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint |
| Q38588650 | Cardiac Imaging to Evaluate Left Ventricular Diastolic Function |
| Q92855879 | Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation |
| Q98231728 | Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging |
| Q101373546 | Cardiac Involvement in the COVID-19 Pandemic: Hazy Lessons From Cardiac Imaging? |
| Q44103406 | Cardiac MRI Findings Suggest Myocarditis in Severe Ebola Virus Disease. |
| Q103042333 | Cardiac MRI Prediction of Recovery in Children With Acute Myocarditis |
| Q97565987 | Cardiac Magnetic Resonance Characterization of Myocarditis-Like Acute Cardiac Syndrome in COVID-19 |
| Q96615888 | Cardiac Magnetic Resonance Feature Tracking Global Longitudinal Strain and Prognosis After Heart Transplantation |
| Q104504907 | Cardiac Magnetic Resonance Findings in Patients Recovered From COVID-19: Initial Experiences in Elite Athletes |
| Q90313920 | Cardiac Magnetic Resonance Fingerprinting: Technical Overview and Initial Results |
| Q100431003 | Cardiac Magnetic Resonance Imaging in Danon Disease Cardiomyopathy |
| Q90553794 | Cardiac Magnetic Resonance Imaging in Athletes: Acquiring the Bigger Picture |
| Q92411321 | Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension |
| Q49896741 | Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Prediction of Cardiovascular Events Following Myocardial Infarction |
| Q50064000 | Cardiac Magnetic Resonance Myocardial Perfusion After Arterial Switch for Transposition of Great Arteries. |
| Q90554019 | Cardiac Magnetic Resonance Normal Reference Values of Biventricular Size and Function in Male Athlete's Heart |
| Q92038089 | Cardiac Magnetic Resonance Parametric Mapping Following Heart Transplantation: Moving Beyond Acute Rejection and Coronary Allograft Vasculopathy Assessment |
| Q92771060 | Cardiac Magnetic Resonance T1 Mapping for Cardiac Amyloidosis: The Best Way Forward |
| Q91018929 | Cardiac Magnetic Resonance T1 Mapping in Cardiac Amyloidosis |
| Q92411349 | Cardiac Magnetic Resonance as a Window Into Cardiac Allograft Tissue Health: A Step Toward Freedom From Endomyocardial Biopsies |
| Q90202206 | Cardiac Magnetic Resonance for Evaluating Nonculprit Lesions After Myocardial Infarction: Comparison With Fractional Flow Reserve |
| Q98282916 | Cardiac Magnetic Resonance to Enhance Phenotypic Characterization of HFpEF |
| Q58867575 | Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome |
| Q89243988 | Cardiac Myxoma: The Great Mimicker |
| Q37764498 | Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. |
| Q37854200 | Cardiac PET: a versatile, quantitative measurement tool for heart failure management |
| Q101137700 | Cardiac Phenotypes and Markers of Adverse Outcome in Elite Athletes With Ventricular Arrhythmias |
| Q57743921 | Cardiac Remodeling |
| Q88927437 | Cardiac Remodeling in American-Style Football Players: Field Position Matters |
| Q92051256 | Cardiac Sarcoidosis: Remembering the Forgotten Right Ventricle |
| Q61657807 | Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles |
| Q114013982 | Cardiac Sympathetic Activity by 123I-Meta-Iodobenzylguanidine Imaging in Women With Coronary Microvascular Dysfunction |
| Q87754213 | Cardiac Sympathetic Disturbance in Takotsubo Cardiomyopathy: Primary Etiology or a Compensatory Response to Heart Failure? |
| Q47623515 | Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases |
| Q39988831 | Cardiac chamber volumes, function, and mass as determined by 64-multidetector row computed tomography: mean values among healthy adults free of hypertension and obesity |
| Q53360149 | Cardiac computed tomography to visualize typical variants of the right-sided origin of the left main coronary artery. |
| Q53925932 | Cardiac imaging and cardiac resynchronization therapy: time to get in phase. |
| Q38136831 | Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death |
| Q38018742 | Cardiac imaging modalities with ionizing radiation: the role of informed consent |
| Q30487233 | Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy |
| Q87482693 | Cardiac magnetic resonance features of biopsy-proven endomyocardial diseases |
| Q37945803 | Cardiac magnetic resonance in hypertrophic cardiomyopathy |
| Q83629653 | Cardiac magnetic resonance in the world of the cardiac electrophysiologist: the road to real-time cardiac magnetic resonance |
| Q46056311 | Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis |
| Q83179369 | Cardiac remodeling in obesity: time for a new paradigm |
| Q46146123 | Cardiac resynchronization therapy devices guided by imaging technology |
| Q45436011 | Cardiac resynchronization: the flow of activation sequence |
| Q47231453 | Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy |
| Q87883240 | Cardiac strain as a universal biomarker: interpreting the sounds of uneasy heart muscle cells |
| Q37686799 | Cardiac sympathetic imaging with mIBG in heart failure |
| Q84392196 | Cardiac ultrasound imaging in acute care settings |
| Q100426512 | Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis |
| Q46326868 | Cardiac-Specific Conversion Factors to Estimate Radiation Effective Dose From Dose-Length Product in Computed Tomography |
| Q83629384 | Cardiologists: do we have the right to call ourselves physiologists? |
| Q36677950 | Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease |
| Q57095877 | Cardiopulmonary changes in healthy children residing at high altitude in China |
| Q90857293 | Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients |
| Q90553581 | Cardiovascular Health of Offspring of Diabetic Mothers From the Fetal Through Late-Infancy Stages |
| Q91170719 | Cardiovascular Imaging Driven by Technical Advances Needs to be Grounded in Value |
| Q85896797 | Cardiovascular Imaging Research: Time to Think Beyond Risk Prediction? |
| Q90678655 | Cardiovascular Imaging Techniques to Assess Microvascular Dysfunction |
| Q94545820 | Cardiovascular Imaging Through the Prism of Modern Metrics |
| Q50138523 | Cardiovascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Fibroinflammatory Disorders |
| Q89141614 | Cardiovascular Imaging of Women: We Have Come a Long Way But Still Have a Ways to Go |
| Q91170715 | Cardiovascular Magnetic Resonance Imaging in Aortic Regurgitation |
| Q90857300 | Cardiovascular Magnetic Resonance in the Oncology Patient |
| Q48959001 | Cardiovascular imaging in the pediatric population |
| Q39226602 | Cardiovascular imaging payment and reimbursement systems: understanding the past and present in order to guide the future |
| Q87112239 | Cardiovascular imaging physician certification in the era of multimodality imaging |
| Q53360182 | Cardiovascular imaging quality-more than a pretty picture! |
| Q37707595 | Cardiovascular imaging research at the crossroads |
| Q87408653 | Cardiovascular imaging utilization: boom or bust? |
| Q37751414 | Cardiovascular imaging with computed tomography: responsible steps to balancing diagnostic yield and radiation exposure |
| Q83629501 | Cardiovascular magnetic resonance characterization of mitral valve prolapse |
| Q42674754 | Cardiovascular magnetic resonance imaging: is only one shop worth the stop? |
| Q38424167 | Carotid FDG Uptake Improves Prediction of Future Cardiovascular Events in Asymptomatic Individuals |
| Q48270803 | Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH. |
| Q45980766 | Carotid artery OCT in cerebral infarction. |
| Q83629412 | Carotid atherosclerosis and magnetic resonance imaging |
| Q38232754 | Carotid intima-media thickness and plaque in cardiovascular risk assessment |
| Q39587000 | Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study |
| Q92524521 | Case-Based Imaging Curriculum |
| Q52677894 | Catecholamine Levels and Cardiac Sympathetic Hyperactivation-Disruption in Takotsubo Syndrome. |
| Q40970609 | Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis |
| Q36784068 | Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network |
| Q40241196 | Change in Carotid Plaque Components: A 4-Year Follow-Up Study With Serial MR Imaging |
| Q90554199 | Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study |
| Q92047563 | Changes in Myocardial Native T1 and T2 After Exercise Stress: A Noncontrast CMR Pilot Study |
| Q53360126 | Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas' cardiomyopathy. |
| Q53113282 | Changes in preventive medical therapies and CV risk factors after CT angiography. |
| Q89432555 | Changing Paradigms for Bioprosthetic Valves: Yearly Surveillance Echocardiographic Studies Early Post-Op and Routine Anticoagulation |
| Q85295615 | Changing physician behavior using the AUC: an ongoing challenge |
| Q91465418 | Changing the Tide of Left Atrial Inflow: Improved Pulmonary Vein Patterns Predict Smooth Sailing After Percutaneous Mitral Valve Repair |
| Q39639368 | Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes |
| Q90040184 | Characterization and Trajectory of Coronary Artery Calcium Percentiles: The Dallas Heart Study |
| Q27310092 | Characterization and quantification of vortex flow in the human left ventricle by contrast echocardiography using vector particle image velocimetry |
| Q90553696 | Characterization of 18-Fluorodeoxyglucose Uptake Pattern in Infective Endocarditis After Transcatheter Aortic Valve Implantation |
| Q52848931 | Characterization of acute myocardial infarction by magnetic resonance imaging. |
| Q45986057 | Characterization of complex coronary artery stenosis morphology by coronary computed tomographic angiography. |
| Q84058441 | Characterization of hyperintense plaque with noncontrast T(1)-weighted cardiac magnetic resonance coronary plaque imaging: comparison with multislice computed tomography and intravascular ultrasound |
| Q53360130 | Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. |
| Q92411335 | Characterization of the Surgically Modified RVOT Using Magnetic Resonance Angiography in Adults Late After Tetralogy of Fallot Repair |
| Q87112208 | Characterization of ventricular myocardium in atrial fibrillation: looking where the light is best |
| Q95561378 | Characterizing the Hyperemia-Induced Mechanical Stress Acting on the Plaque |
| Q43243353 | Chasing the elusive pressure-volume relationships |
| Q46041657 | Chemotherapy-Induced Valvular Heart Disease |
| Q39114927 | Childhood obesity: impact on cardiac geometry and function |
| Q103042315 | Chronic Ablation Lesions on CMR: Is Black a Red Herring? |
| Q93192444 | Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study |
| Q30439253 | Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice |
| Q84571605 | Chronic kidney disease as a potent risk modifier for CAD in diabetics |
| Q92047507 | Classification of Culprit Ruptured Plaque Morphologies in Patients With STEMI: An OCT Study |
| Q40950263 | Classification of coronary atherosclerotic plaques ex vivo with T1, T2, and ultrashort echo time CMR. |
| Q53237632 | Climbing Mount Everest "Because It's There!". |
| Q114163600 | Clinical Characteristics and Prognostic Importance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy |
| Q34517904 | Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging |
| Q53520600 | Clinical Imaging of ACS With Ruptured or Intact Fibrous Caps. |
| Q41127319 | Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study. |
| Q92176493 | Clinical OCT-Based Polarization Assessment of Coronary Artery Disease: Bending Light to Reveal Atherosclerosis Pathology |
| Q38801304 | Clinical Outcomes and Imaging Findings in Women Undergoing TAVR. |
| Q89281505 | Clinical PET Flow Reserve Imaging: Is There Precision to Treat Patients or Populations? |
| Q99575269 | Clinical Risk Score to Predict Early Left Ventricular Thrombus After ST-Segment Elevation Myocardial Infarction |
| Q50057847 | Clinical Significance of Right Ventricular Longitudinal Function Parameters After Aortic Valve Replacement. |
| Q92047588 | Clinical Use of CT-Derived Fractional Flow Reserve in the Emergency Department |
| Q47824262 | Clinical Use of Coronary CTA-Derived FFR for Decision-Making in Stable CAD. |
| Q47840710 | Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease |
| Q87590144 | Clinical Utility of Combined Optical Coherence Tomography and Near-Infrared Spectroscopy for Assessing the Mechanism of Very Late Stent Thrombosis |
| Q48595835 | Clinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF. |
| Q91647734 | Clinical and Computed Tomography Angiographic Predictors of Coronary Lesions That Later Progressed to Chronic Total Occlusion |
| Q92047513 | Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients With Systemic Sclerosis |
| Q39309085 | Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study |
| Q86762730 | Clinical and echocardiographic variables associated with LA septal pouch |
| Q37693455 | Clinical applications of left ventricular opacification |
| Q83179378 | Clinical benefits of noninvasive testing: coronary computed tomography angiography as a test case |
| Q83200588 | Clinical characteristics, vascular function, and inflammation in women with angina in the absence of coronary atherosclerosis: the Dallas Heart Study |
| Q83629587 | Clinical coronary chemograms and lipid core containing coronary plaques |
| Q42969234 | Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging |
| Q44930112 | Clinical outcome of isolated tricuspid regurgitation. |
| Q53598043 | Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study. |
| Q46195311 | Clinical pacing post-conditioning during revascularization after AMI. |
| Q85749186 | Clinical utility and prognostic value of appropriateness criteria in stress echocardiography for the evaluation of valvular heart disease |
| Q37901196 | Clinical utility of multimodality LA imaging: assessment of size, function, and structure |
| Q48433048 | Clinical utility of single-beat E/e' obtained by simultaneous recording of flow and tissue Doppler velocities in atrial fibrillation with preserved systolic function |
| Q62083154 | Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis |
| Q47620876 | Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study |
| Q40676096 | Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression. |
| Q92038107 | Colocalization of Intracoronary Lipid-Rich Plaques and Calcifications: An Integrated NIRS-IVUS Analysis |
| Q89455304 | Color Paucity as a Marker of Transcatheter Valve Thrombosis |
| Q33167835 | Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC. |
| Q53132851 | Combined CT coronary angiography and stress myocardial perfusion imaging for hemodynamically significant stenoses in patients with suspected coronary artery disease: a comparison with fractional flow reserve. |
| Q53647523 | Combined IVUS and NIRS detection of fibroatheromas: histopathological validation in human coronary arteries. |
| Q50138536 | Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor |
| Q89306191 | Combined Pulmonary Vein and LA/LAA Thrombus Assessment: Can CMR Kill Two Birds With One Stone? |
| Q43243351 | Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol |
| Q43586147 | Combined use of OCT and IVUS in spontaneous coronary artery dissection |
| Q53797516 | Combining volumetry with external pressure transducer. |
| Q39171414 | Comparative Effectiveness Trials of Imaging-Guided Strategies in Stable Ischemic Heart Disease |
| Q90384188 | Comparative Effectiveness of CT-Derived Atherosclerotic Plaque Metrics for Predicting Myocardial Ischemia |
| Q89125764 | Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease |
| Q26827495 | Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging |
| Q48819102 | Comparative mechanical activation mapping of RV pacing to LBBB by 2D and 3D speckle tracking and association with response to resynchronization therapy |
| Q39507170 | Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography |
| Q93192437 | Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy |
| Q89432562 | Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial |
| Q92747743 | Comparing Risk Scores in the Prediction of Coronary and Cardiovascular Deaths: Coronary Artery Calcium Consortium |
| Q87431383 | Comparing prognostic value of imaging agents and imaging techniques |
| Q96615916 | Comparison Between ESC and Duke Criteria for the Diagnosis of Prosthetic Valve Infective Endocarditis |
| Q92037994 | Comparison Between the Performance of Quantitative Flow Ratio and Perfusion Imaging for Diagnosing Myocardial Ischemia |
| Q90566420 | Comparison of Echocardiographic Assessment of Tricuspid Regurgitation Against Cardiovascular Magnetic Resonance |
| Q52990870 | Comparison of Echocardiography and CT for the Assessment of Aortic Stenosis Valve Area. |
| Q93192464 | Comparison of Insonation-Augmented Physical Examination With Standard Physical Examination in Detecting Severe Left-Sided Valve Disease |
| Q58775630 | Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART |
| Q57815531 | Comparison of [F]-FDG and [F]-NaF Positron Emission Tomography on Culprit Carotid Atherosclerosis: A Prospective Study |
| Q85814802 | Comparison of coronary magnetic resonance and computed tomography angiography for prediction of cardiovascular events |
| Q53804831 | Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. |
| Q48031283 | Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure |
| Q84058470 | Comparison of in vivo carotid 3.0-T magnetic resonance to B-mode ultrasound imaging and histology in a porcine model |
| Q48824811 | Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis |
| Q45972530 | Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. |
| Q44042636 | Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR. |
| Q49896682 | Comparison of the Diastolic Stress Test With a Combined Resting Echocardiography and Biomarker Approach to Patients With Exertional Dyspnea: Diagnostic and Prognostic Implications |
| Q42858835 | Comparison of the Extent and Severity of Myocardial Perfusion Defects Measured by CT Coronary Angiography and SPECT Myocardial Perfusion Imaging |
| Q44306776 | Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching |
| Q46056339 | Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study |
| Q91730593 | Competency in Cardiovascular Imaging Training: The Journey Toward a Data-Driven Approach |
| Q91730586 | Competency-Based Medical Education: Do the Cardiac Imaging Training Guidelines Have it Right? |
| Q47942105 | Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis |
| Q90678610 | Complex Highways on the Translational Roadmap for Therapeutic Ultrasound-Targeted Microbubble Cavitation: Where Are We Now? |
| Q87408662 | Complexity of assessment and management of Tako-Tsubo cardiomyopathy |
| Q88927440 | Compound Ultrasound Strain Imaging for Noninvasive Detection of (Fibro)Atheromatous Plaques: Histopathological Validation in Human Carotid Arteries |
| Q90202209 | Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy |
| Q47563787 | Comprehensive Cardiac CT With Myocardial Perfusion Imaging Versus Functional Testing in Suspected Coronary Artery Disease: The Multicenter, Randomized CRESCENT-II Trial |
| Q98629446 | Comprehensive Cardiovascular Magnetic Resonance Diastolic Dysfunction Grading Shows Very Good Agreement Compared With Echocardiography |
| Q89125774 | Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function |
| Q48536103 | Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects |
| Q53127885 | Comprehensive Imaging in Women With Organic Mitral Regurgitation: Implications for Clinical Outcome. |
| Q84748274 | Comprehensive characterization of constrictive pericarditis using multiparametric CMR |
| Q87668473 | Comprehensive dobutamine stress CMR versus echocardiography in LBBB and suspected coronary artery disease |
| Q51062744 | Compressed sensing single-breath-hold CMR for fast quantification of LV function, volumes, and mass. |
| Q99348960 | Compromised Cardiomyocyte Integrity or Cytosolic Leak?: What Does CMR Tell Us About Exercise-Induced Troponin Release? |
| Q91783618 | Computed Tomography Angiography-Based Risk Discrimination: An Established Bright Future for Prognostication |
| Q90948488 | Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR): An Expert Consensus Document of the Society of Cardiovascular Computed Tomography |
| Q88742612 | Computed Tomography Score of Aortic Valve Tissue May Predict Cerebral Embolism During Transcatheter Aortic Valve Implantation |
| Q92747794 | Computed Tomography and Fluoroscopic Angiography in Management of Left Ventricular Assist Device Outflow Graft Obstruction |
| Q49896728 | Computed Tomography for Diagnosis and Classification of Bicuspid Aortic Valve Disease in Transcatheter Aortic Valve Replacement. |
| Q92135582 | Computed Tomography-Derived Fractional Flow Reserve: A Needed ADVANCE or Expensive Nicety? |
| Q53360191 | Computed tomographic angiographic morphology of invasively proven complex coronary plaques. |
| Q53360145 | Computed tomographic angiography and the Atlantic. |
| Q53056367 | Computed tomography to analyze mitral valve: an answer in search of a question. |
| Q51679749 | Conceptual New Biomechanical Approaches to Identify Coronary Plaques at Risk of Disruption. |
| Q83629584 | Concordance between actual and expected coronary artery distribution |
| Q53113465 | Concurrent chemo-radiotherapy potentiates vascular inflammation: increased FDG uptake in head and neck cancer patients. |
| Q54600684 | Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure. |
| Q52982114 | Confounders in FDG-PET/CT Imaging of Suspected Prosthetic Valve Endocarditis. |
| Q103042372 | Congenital Portosystemic Shunts: Clinical Presentations, Imaging, Case Selection, and Feasibility of Transcatheter Closure |
| Q43260662 | Connectivity of radiotracers to vasodilators is thallium the missing link? |
| Q87638556 | Consequences of Vascular Calcification: Implications for Bioresorbable Vascular Scaffolds |
| Q84567950 | Consideration of patient safety using real-time 3D TEE during LA pulmonary vein ablation |
| Q92676968 | Considerations for Clinical Trials Targeting the Myocardial Interstitium |
| Q94956998 | Contemporary Multimodality Imaging for Cardiovascular Behçet Disease |
| Q90857297 | Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy |
| Q84378449 | Contemporary imaging of the pericardium |
| Q104794270 | Continuing Advances and Challenges of Structural Heart Imaging |
| Q43028480 | Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR. |
| Q46056317 | Contractile reserve: are we beginning to understand it? |
| Q86405725 | Contractility: still searching after all these years |
| Q93192468 | Contrast Echocardiographic Perfusion Imaging in Clinical Decision-Making for Cardiac Masses in Patients With a History of Extracardiac Malignant Tumor |
| Q56965173 | Contrast Enhancement Imaging in Coronary Arteries in SLE |
| Q50641658 | Contrast Ultrasound Ischemic Memory Imaging: Path to Clinical Translation. |
| Q82919233 | Contrast echocardiography: over-achievement in research, under-achievement in practice? |
| Q40140132 | Contrast echocardiography: past, present, and...future? |
| Q47337807 | Contrast-Enhanced CMR Overestimates Early Myocardial Infarct Size: Mechanistic Insights Using ECV Measurements on Day 1 and Day 7. |
| Q85896799 | Contrast-Enhanced TEE During Thoracic Endovascular Aortic Repair Procedure |
| Q56986480 | Contrast-Enhanced Ultrasound Imaging Detects Intraplaque Neovascularization in an Experimental Model of Atherosclerosis |
| Q90554134 | Contrast-Enhanced Ultrasound Reveals That Lipoprotein Apheresis Improves Myocardial But Not Skeletal Muscle Perfusion |
| Q88734645 | Contrast-Specific Imaging Without Contrast: An Echocardiographic Technique for the Detection of Myocardial Scar |
| Q34953897 | Contrast-enhanced C-arm CT evaluation of radiofrequency ablation lesions in the left ventricle |
| Q54170728 | Contrast-enhanced CMR imaging of ventricular tachycardia isthmus sites to guide ablation: an approach in evolution. |
| Q82978153 | Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations |
| Q86587382 | Contrast-enhanced CMR in HCM: what lies behind the bright light of LGE and why it now matters |
| Q37326054 | Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus |
| Q82917130 | Contrast-enhanced ultrasound and the enigma of plaque neovascularization |
| Q37773054 | Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques |
| Q54806435 | Contribution of Noninvasive Imaging to the Diagnosis and Follow-Up of Takotsubo Cardiomyopathy |
| Q38873688 | Contribution of PET Imaging to the Diagnosis of Septic Embolism in Patients With Pacing Lead Endocarditis |
| Q84948067 | Contribution of ventricular diastolic dysfunction to pulmonary hypertension complicating chronic systolic heart failure |
| Q91616167 | Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes |
| Q91730598 | Core Competencies in Cardiac CT for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement |
| Q91730604 | Core Competencies in Echocardiography for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement |
| Q92676952 | Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future |
| Q38964692 | Coronary Artery Axial Plaque Stress and its Relationship With Lesion Geometry: Application of Computational Fluid Dynamics to Coronary CT Angiography. |
| Q101373493 | Coronary Artery Calcification and Complications in Patients With COVID-19 |
| Q50188181 | Coronary Artery Calcification and its Progression: What Does it Really Mean? |
| Q88583195 | Coronary Artery Calcification: A Janus-Faced Biomarker? |
| Q39284456 | Coronary Artery Calcification: From Mechanism to Molecular Imaging |
| Q41206488 | Coronary Artery Calcium Improves Risk Classification in Younger Populations |
| Q45998861 | Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression: Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis. |
| Q53641899 | Coronary Artery Calcium Progression and Residual Risk. |
| Q88006096 | Coronary Artery Calcium Progression: Increasing CAC Is Associated With Increased Events |
| Q48182915 | Coronary Artery Calcium Scanning: Past, Present, and Future |
| Q46250564 | Coronary Artery Calcium Scanning: The Agatston Score and Beyond |
| Q49896670 | Coronary Artery Calcium Scores and Atherosclerotic Cardiovascular Disease Risk Stratification in Smokers: MESA. |
| Q57815548 | Coronary Artery Calcium Scoring: Do We Need More Prognostic Data Prior to Adoption in Clinical Practice? |
| Q38644239 | Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology? |
| Q40087028 | Coronary Artery Calcium Volume and Density: Potential Interactions and Overall Predictive Value: The Multi-Ethnic Study of Atherosclerosis |
| Q93192506 | Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy |
| Q47447142 | Coronary Artery Calcium and Long-Term Risk of Death, Myocardial Infarction, and Stroke: The Walter Reed Cohort Study |
| Q92176488 | Coronary Artery Calcium and Prevention Guidelines: Time for a Change (Again) |
| Q89380891 | Coronary Artery Calcium and Shared Decision Making |
| Q102319447 | Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention |
| Q90040141 | Coronary Artery Calcium: From the Power of 0 to >1,000 |
| Q53708910 | Coronary Artery Calcium: Need for More Clarity in Guidelines. |
| Q31127951 | Coronary Artery Disease - Reporting and Data System (CAD-RADS): An Expert Consensus Document of SCCT, ACR and NASCI: Endorsed by the ACC. |
| Q48050034 | Coronary Artery Disease Testing: Past, Present, and Future |
| Q47992578 | Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions |
| Q46457690 | Coronary Atherosclerosis T1-Weighed Characterization With Integrated Anatomical Reference: Comparison With High-Risk Plaque Features Detected by Invasive Coronary Imaging. |
| Q91647724 | Coronary Atherosclerosis in Athletes: Exploring the Role of Sporting Discipline |
| Q42695910 | Coronary CT Angiography With PET Perfusion Imaging: Hybrid or Hype? |
| Q88583212 | Coronary CT Angiography and Bioresorbable Vascular Scaffolds: Is There Clarity? |
| Q57740077 | Coronary CT Angiography and Comparative Effectiveness Research |
| Q53373113 | Coronary CT Angiography in Asymptomatic Type 2 Diabetic Patients: First Do No Harm? |
| Q102319416 | Coronary CT Angiography in Pediatric and Young Adult Coronary Allograft Vasculopathy: Single-Center Experience |
| Q84948072 | Coronary CT angiography in Takayasu arteritis |
| Q84085802 | Coronary CT angiography: an established, not emerging, basis of diagnosis and risk stratification |
| Q53190934 | Coronary CT angiography: from sensitivity to specificity. |
| Q91307439 | Coronary CTA-Based CAD-RADS Reporting System and the PROMISE to Predict Cardiac Events |
| Q104278750 | Coronary Calcium Score in COVID-19 Hospitalized Patients |
| Q93192515 | Coronary Calcium and Selection for Risk Reduction: Reverend Bayes Has His Say |
| Q92411393 | Coronary Calcium in Type 1 Diabetes: To Screen or Not to Screen? |
| Q53753391 | Coronary Computed Tomographic Angiography Can Predict Chronic Total Occlusion Recanalization Success: Where Do We Go From Here? |
| Q89125787 | Coronary Computed Tomography Angiography Versus Stress Echocardiography in Acute Chest Pain: A Randomized Controlled Trial |
| Q49574137 | Coronary Computed Tomography Angiography to Predict Successful Percutaneous Coronary Intervention for Chronic Total Occlusion: Ready for Prime Time? |
| Q90202222 | Coronary Flow Reserve by Cardiac Magnetic Resonance Imaging in Patients With Diabetes Mellitus |
| Q51679753 | Coronary MR Imaging: Moving From Lumenography to Plaque Assessment. |
| Q90566404 | Coronary Magnetic Resonance Angiography: Technical Innovations Leading Us to the Promised Land? |
| Q113871716 | Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease |
| Q93080599 | Coronary Microvascular Dysfunction: Clinical Considerations and Noninvasive Diagnosis |
| Q92038005 | Coronary Physiology: Simulations Can't Beat the Real Thcing! |
| Q46000375 | Coronary Plaque Burden and Adverse Plaque Characteristics Are Increased in Healthy Relatives of Patients With Early Onset Coronary Artery Disease. |
| Q92676922 | Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events |
| Q47242952 | Coronary Plaque Microstructure and Composition Modify Optical Polarization: A New Endogenous Contrast Mechanism for Optical Frequency Domain Imaging |
| Q53062134 | Coronary artery calcification and family history of myocardial infarction in the Dallas heart study. |
| Q34626188 | Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study |
| Q83220135 | Coronary artery calcium scanning should be used for primary prevention: pros and cons |
| Q38456425 | Coronary artery calcium scanning: past, present, and future |
| Q48924377 | Coronary artery calcium score, distribution, and future revascularization |
| Q43598426 | Coronary artery calcium: the cup is 96% full |
| Q83629459 | Coronary artery function: out of the cath lab and into the magnet |
| Q46755271 | Coronary artery ostial atresia: diagnosis of conotruncal anastomotic collateral rings using CT angiography |
| Q37874820 | Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis |
| Q39553302 | Coronary calcification and the risk of heart failure in the elderly: the Rotterdam Study. |
| Q82552470 | Coronary embolization following balloon dilation of lipid-core plaques |
| Q46011749 | Coronary flow reserve and pharmacologic stress perfusion imaging: beginnings and evolution. |
| Q51198288 | Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. |
| Q85445645 | Coronary flow velocity reserve and survival |
| Q87578733 | Coronary involvement in lupus patients: getting sharper pictures with advanced vascular imaging? |
| Q54142083 | Coronary microvascular dysfunction in systemic lupus erythematosus identified by CMR imaging. |
| Q26861073 | Coronary microvascular dysfunction, microvascular angina, and treatment strategies |
| Q39988818 | Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction |
| Q84058449 | Coronary plaque characterization by T(1)-weighted cardiac magnetic resonance |
| Q44008326 | Coronary plaque characterization by computed tomographic angiography: present promise and future hope |
| Q44500926 | Coronary plaque composition and post-PCI complications in NSTEMI. |
| Q51352499 | Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. |
| Q86321375 | Coronary plaque erosion: recognition and management |
| Q39707225 | Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization? |
| Q53299952 | Coronary stent fracture: clinical use of image enhancement. |
| Q30448743 | Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. |
| Q38322573 | Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. |
| Q46833809 | Coronary venous aneurysm in patients without cardiac arrhythmia as detected by MDCT: an anatomic variant or a pathologic entity |
| Q34061425 | Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients |
| Q56879182 | Correction |
| Q57058556 | Correction |
| Q57483421 | Correction |
| Q57726129 | Correction |
| Q59076493 | Correction |
| Q63258742 | Correction |
| Q95388377 | Correction |
| Q95392493 | Correction |
| Q95392496 | Correction |
| Q95410192 | Correction |
| Q95423688 | Correction |
| Q95423698 | Correction |
| Q95431655 | Correction |
| Q95482242 | Correction |
| Q95482250 | Correction |
| Q95499109 | Correction |
| Q95530716 | Correction |
| Q95565145 | Correction |
| Q95565148 | Correction |
| Q95573262 | Correction |
| Q95577815 | Correction |
| Q95577821 | Correction |
| Q95584361 | Correction |
| Q95588433 | Correction |
| Q30541074 | Correction of pulmonary arteriovenous malformation using image-based surgical planning |
| Q85195424 | Correlating Multimodality Imaging and Pathological Validation in Heart Failure |
| Q90553536 | Correlating Pathology to Imaging: Improved Insights Into Peripheral Artery Disease? |
| Q52983802 | Correlation Among Coronary CT Findings, Sex, and Events: Should We Wait to CONFIRM? |
| Q30436195 | Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. |
| Q84948084 | Correlation of angiographic late loss with neointimal proliferation in stents evaluated by OCT and histology in porcine coronary arteries |
| Q36411354 | Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function |
| Q61913978 | Correspondence Between the 17-Segment Model and Coronary Arterial Anatomy Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging |
| Q94953587 | Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes |
| Q51569625 | Cost-effectiveness of coronary computed tomography and cardiac stress imaging in the emergency department: a decision analytic model comparing diagnostic strategies for chest pain in patients at low risk of acute coronary syndromes. |
| Q90313955 | Could Breast Arterial Calcification Predict the Risk of Coronary Artery Disease? |
| Q88088236 | Could Deep Learning Change Our Working Lives? |
| Q90202244 | Coupling Advanced Imaging With Computational Vascular Diagnostics: Has the Endgame Begun? |
| Q84733772 | Cracking the mysteries of diastolic function in atrial fibrillation: new technology for an old problem |
| Q43947374 | Culprit vessel localization on stress ECG testing |
| Q64938269 | Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights. |
| Q86940745 | Current State of Advanced Cardiovascular Imaging Training in the United States |
| Q90678638 | DE-MDCT Predicts Regional Functional Improvement After Reperfused AMI |
| Q96132211 | DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker |
| Q99416594 | Dapagliflozin Improves Left Ventricular Myocardial Longitudinal Function in Patients With Type 2 Diabetes |
| Q49721083 | Dark-Blood Delayed Enhancement Cardiac Magnetic Resonance of Myocardial Infarction |
| Q49721169 | Dark-Blood Late-Enhancement Imaging Improves Detection of Myocardial Infarction |
| Q54600662 | De-novo thrombus formation and latent ligation failure following LAA exclusion. |
| Q101137743 | Dead Pool: A Non-Regurgitant Volume Overload Among Patients With Barlow Mitral Valve Prolapse |
| Q86940724 | Dealing With Unintended Consequences: Continuous-Flow LVADs and Aortic Insufficiency |
| Q57058582 | Decision Making With Imaging in Asymptomatic Aortic Regurgitation |
| Q49896782 | Decreased Exercise Tolerance in Stage B Heart Failure: A Shade of Grey |
| Q102319415 | Decreased Global Strains of LV in Asymptomatic Female Duchenne Muscular Dystrophy Gene Carriers Using CMR-FT |
| Q52650704 | Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT: A Multicenter Study. |
| Q90678627 | Deep Learning in Quantitative PET Myocardial Perfusion Imaging: A Study on Cardiovascular Event Prediction |
| Q114163598 | Deep Learning of Coronary Calcium Scores From PET/CT Attenuation Maps Accurately Predicts Adverse Cardiovascular Events |
| Q46946438 | Deeper Into Cardiac Amyloid: Potential for Improved Outcomes |
| Q88352828 | Defining Inflammatory Levels of Carotid Artery and Aortic 18FDG Uptake: Implications for Clinical Trial Design and Individual Patient Management |
| Q97589590 | Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study |
| Q42652506 | Defining left ventricular apex-to-base twist mechanics computed from high-resolution 3D echocardiography: validation against sonomicrometry |
| Q43665708 | Defining normative values for 3D LV volumes: the devil is in the details |
| Q53772437 | Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. |
| Q87408654 | Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance |
| Q49721020 | Definition of Left Ventricular Segments for Cardiac Magnetic Resonance Imaging |
| Q39639385 | Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses |
| Q61651923 | Definitions of Outcome, Response and Effect in Imaging Research to Avoid Confusion |
| Q53473236 | Delayed disruption of a bioresorbable vascular scaffold. |
| Q82552434 | Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis |
| Q85445720 | Delayed plaque enhancement by CT angiography |
| Q53449125 | Delayed transcatheter heart valve migration and failure. |
| Q35815356 | Delayed-enhanced MR scar imaging and intraprocedural registration into an electroanatomical mapping system in post-infarction patients |
| Q92047630 | Demonstrating the Superiority of a Superior Test…Not Always Easy! |
| Q87286679 | Demystifying imaging laboratory accreditation |
| Q50683191 | Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position. |
| Q87590179 | Deranged Myocyte Microstructure in Situs Inversus Totalis Demonstrated by Diffusion Tensor Cardiac Magnetic Resonance |
| Q47755108 | Derivation and Evaluation of Age-Specific Multivariate Reference Regions to Aid in Identification of Abnormal Filling Patterns: The HUNT and VaMIS Studies. |
| Q94953565 | Detailed CAD Phenotyping by Angiography, Dynamic Perfusion and Scar Imaging Sharpens CT Prognostic Power |
| Q96132206 | Detailed Understating of Cardiac Amyloidosis by CMR: Towards Personalized Medicine |
| Q91647798 | Detecting Coronary Inflammation With Perivascular Fat Attenuation Imaging: Making Sense From Perivascular Attenuation Maps |
| Q84560921 | Detecting LV thrombi: "T'ain't what you do (it's the way that you do it)" |
| Q85896794 | Detecting Skeletal Microvascular Flow Abnormalities in Diabetes: Could Microvascular Recruitment Be a Fundamental Problem? |
| Q45907408 | Detecting diffuse myocardial fibrosis with CMR: the future has only just begun. |
| Q38107309 | Detection and imaging of cardiac allograft vasculopathy |
| Q50506041 | Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. |
| Q87638567 | Detection of Cardiac Sarcoidosis: A Balancing Act Between Symptoms and Imaging Findings |
| Q54034111 | Detection of Coronary Stenosis at Rest Using BOLD-CMR. |
| Q47362924 | Detection of Deep Venous Thrombosis Using a Pocket-Size Ultrasound Examination Device |
| Q39728348 | Detection of LA and LAA Thrombus by CMR in Patients Referred for Pulmonary Vein Isolation |
| Q41104272 | Detection of Mycotic Aneurysms of Lower Limbs by Whole-Body (18)F-FDG-PET. |
| Q33872992 | Detection of coronary artery stenoses by low-dose, prospectively ECG-triggered, high-pitch spiral coronary CT angiography |
| Q36821404 | Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions |
| Q53360135 | Detection of left atrial appendage thrombus by cardiac computed tomography: a word of caution. |
| Q51841007 | Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. |
| Q54545583 | Detection of liquid phase cholesteryl ester in carotid atherosclerosis by 1H-MR spectroscopy in humans. |
| Q83661395 | Detection of patent foramen ovale by 3D echocardiography |
| Q45082421 | Detection of pulmonary congestion by chest ultrasound in dialysis patients |
| Q46056354 | Detection of subendocardial ischemia in the left anterior descending coronary artery territory with real-time myocardial contrast echocardiography during dobutamine stress echocardiography |
| Q51841004 | Detection of vulnerable coronary artery plaques: lesion level risk assessment within the coronary arterial tree? |
| Q43098195 | Detection of vulnerable coronary plaques by color fluorescent angioscopy |
| Q61650959 | Determinants and Functional Significance of Myocardial Perfusion Reserve in Severe Aortic Stenosis |
| Q92411343 | Determinants of Bioprosthetic Aortic Valve Degeneration |
| Q90202239 | Determinants of Exercise Capacity and Myocardial Perfusion Reserve in Asymptomatic Patients With Aortic Stenosis |
| Q82978141 | Determinants of FDG uptake in atherosclerosis |
| Q90678705 | Determinants of Intima-Media Thickness in the Young: The ALSPAC Study |
| Q98629440 | Determinants of LV Dilatation in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function: A CMR Study |
| Q61913974 | Determinants of Myocardial Salvage During Acute Myocardial Infarction |
| Q41036073 | Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging |
| Q90566426 | Determinants of Outcome in Patients With Left Ventricular Impairment and Moderate Aortic Stenosis |
| Q43292400 | Determinants of occurrence of aortic sclerosis in an aging population |
| Q53117285 | Determination of the aortic annulus plane in CT imaging-a step-by-step approach. |
| Q51818504 | Determining that aortic valve stenosis is severe: back-to-the-future: physical examination and aortic valve area index/energy loss index < or =0.6 cm2/m2. |
| Q86542161 | Developing imaging biomarkers for myocardial involvement in amyloidosis: challenge and opportunity |
| Q47801132 | Development and Progression of Coronary Artery Calcification |
| Q46288115 | Development and Validation of a Simple-to-Use Nomogram for Predicting 5-, 10-, and 15-Year Survival in Asymptomatic Adults Undergoing Coronary Artery Calcium Scoring |
| Q88737778 | Development of a Risk Score Based on Aortic Calcification to Predict 1-Year Mortality After Transcatheter Aortic Valve Replacement |
| Q37388557 | Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study |
| Q37686805 | Development of mIBG as a cardiac innervation imaging agent |
| Q83832425 | Devices, biology, imaging, and the regulatory processes... |
| Q90566441 | Diabetes and Hypertension Associate Differently with the Risk of Ascending Thoracic Aortic Aneurysm: A CT study of 21,295 patients |
| Q102319454 | Diabetic Cardiomiopathy Progression is Triggered by miR122-5p and Involves Extracellular Matrix: A 5-Year Prospective Study |
| Q61650950 | Diagnosing Cardiac Allograft Vasculopathy |
| Q88813866 | Diagnosing HFpEF: On Track at Last? |
| Q102319395 | Diagnosing Transthyretin Cardiac Amyloidosis by Technetium 99m Pyrophosphate: A Test in Evolution |
| Q84068345 | Diagnosing patent foramen ovale: too little or too much? |
| Q45276572 | Diagnosis and management of STEMI arising from plaque erosion |
| Q56578358 | Diagnosis of Cardiac Device–Related Infective Endocarditis After Device Removal |
| Q52990868 | Diagnosis of Coronary Disease and Icing on the Cake. |
| Q40086696 | Diagnosis of Infective Endocarditis After TAVR: Value of a Multimodality Imaging Approach |
| Q88737783 | Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure |
| Q85195432 | Diagnosis of patent foramen ovale |
| Q96615905 | Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses |
| Q49896890 | Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis |
| Q53835965 | Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds. |
| Q92047558 | Diagnostic Accuracy of FDG PET/CT in Suspected LVAD Infections: A Case Series, Systematic Review, and Meta-Analysis |
| Q38885536 | Diagnostic Accuracy of Myocardial Perfusion Imaging With CZT Technology: Systemic Review and Meta-Analysis of Comparison With Invasive Coronary Angiography. |
| Q53020145 | Diagnostic Accuracy of Rapid Kilovolt Peak-Switching Dual-Energy CT Coronary Angiography in Patients With a High Calcium Score. |
| Q94953568 | Diagnostic Accuracy of [11C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis |
| Q90202253 | Diagnostic Accuracy of a Fast Computational Approach to Derive Fractional Flow Reserve From Coronary CT Angiography |
| Q99623495 | Diagnostic Applications of Ultrasmall Superparamagnetic Particles of Iron Oxide for Imaging Myocardial and Vascular Inflammation |
| Q91320388 | Diagnostic Differentiation Between Arrhythmogenic Cardiomyopathy and Athlete's Heart by Using Imaging |
| Q52991691 | Diagnostic Imaging, Radiation Exposure, and Carcinogenic Risk: Let's Be Realistic, Reasonable, and Rational. |
| Q39746851 | Diagnostic Performance of 3D Bull's Eye Display of SPECT and Coronary CTA Fusion |
| Q88737802 | Diagnostic Performance of Coronary CTA in Intermediate-to-High-Risk Patients for Suspected Acute Coronary Syndrome: Results From an Emergency Department Registry |
| Q44380805 | Diagnostic Performance of Coronary CT Angiography and Myocardial Perfusion Imaging in Kidney Transplantation Candidates |
| Q91123584 | Diagnostic Performance of Dobutamine Stress Echocardiography in End-Stage Liver Disease |
| Q49896828 | Diagnostic Performance of Fully Automated Pixel-Wise Quantitative Myocardial Perfusion Imaging by Cardiovascular Magnetic Resonance |
| Q43896385 | Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography: A Meta-Analysis |
| Q53001867 | Diagnostic Performance of Myocardial CT Perfusion Imaging With or Without Coronary CT Angiography. |
| Q92676819 | Diagnostic Specificity of Basal Inferoseptal Triangular Late Gadolinium Enhancement for Identification of Cardiac Sarcoidosis |
| Q98629434 | Diagnostic Uncertainty in Prosthetic Valve Endocarditis: Value of 18F-FDG PET/CT and the Need for Standardization |
| Q91647857 | Diagnostic Value of Advanced Imaging Modalities for the Detection and Differentiation of Prosthetic Valve Obstruction: A Systematic Review and Meta-Analysis |
| Q92411328 | Diagnostic Value of Native T1 Mapping in Arrhythmogenic Right Ventricular Cardiomyopathy |
| Q58008756 | Diagnostic Value of Pre-Contrast T1 Mapping in Acute and Chronic Myocardial Infarction |
| Q49721149 | Diagnostic Value of Transluminal Attenuation Gradient for the Presence of Ischemia as Defined by Fractional Flow Reserve and Quantitative Positron Emission Tomography |
| Q52878265 | Diagnostic accuracy of CMR in biopsy-proven acute myocarditis. |
| Q84948093 | Diagnostic accuracy of CT angiography to assess coronary stent thrombosis as determined by intravascular OCT |
| Q53343790 | Diagnostic accuracy of computed tomography angiography in patients after bypass grafting: comparison with invasive coronary angiography. |
| Q54392556 | Diagnostic accuracy of coronary computed tomography angiography as interpreted on a mobile handheld phone device. |
| Q27025416 | Diagnostic accuracy of myocardial magnetic resonance perfusion to diagnose ischemic stenosis with fractional flow reserve as reference: systematic review and meta-analysis |
| Q34293709 | Diagnostic accuracy of stress perfusion CMR in comparison with quantitative coronary angiography: fully quantitative, semiquantitative, and qualitative assessment |
| Q93192376 | Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic Regurgitation |
| Q94953583 | Diagnostic and Prognostic Value of Ergonovine Echocardiography for Noninvasive Diagnosis of Coronary Vasospasm |
| Q37516786 | Diagnostic and prognostic value of absence of coronary artery calcification |
| Q48854769 | Diagnostic capability and reproducibility of strain by Doppler and by speckle tracking in patients with acute myocardial infarction |
| Q86542151 | Diagnostic coronary angiography is getting old! |
| Q53190937 | Diagnostic optimization of coronary CT angiography. |
| Q47749578 | Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis |
| Q87883233 | Diagnostic problem of LV hypertrabeculation/noncompaction? |
| Q52847539 | Diagnostic value of CMR in patients with biomarker-positive acute chest pain and unobstructed coronary arteries. |
| Q53075033 | Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease. |
| Q86542168 | Diagnostic value of quantitative CMR in patients suspected of having myocarditis: a question of timing |
| Q92771005 | Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods |
| Q93192403 | Diastolic Function Assessment Revisited: Is Big Data Analysis Going to be a Big Hit? |
| Q92524507 | Diastolic Function Evaluation: What Can We Learn From Machine Learning? |
| Q91894985 | Diastolic Function Gets Personal |
| Q92770894 | Diastolic Stress Test: Invasive and Noninvasive Testing |
| Q90636156 | Diastolic Stress Testing: Have You Considered Isometric Handgrip Echocardiography? |
| Q48031222 | Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations |
| Q83636984 | Diastolic dysfunction and computed tomography |
| Q87638571 | Diastology: Don't Throw Out the MAC |
| Q51449425 | Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. |
| Q91307444 | Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA |
| Q53419376 | Differences in Underlying Culprit Lesion Morphology Between Men and Women: An IVUS Analysis From the ADAPT-DES Study. |
| Q33897585 | Differential branch pulmonary artery regurgitant fraction is a function of differential pulmonary arterial anatomy and pulmonary vascular resistance |
| Q91018963 | Differentiating Primary From Secondary Hypertrophy Based on the Coronary Lumen Volume to Myocardial Mass Relationship |
| Q85295620 | Differentiation of cardiac masses by CMR: judging a character by the company it keeps |
| Q53238524 | Diffuse LV Myocardial Fibrosis and its Clinical Associations in Adults With Repaired Tetralogy of Fallot. |
| Q98629454 | Diffuse Myocardial Fibrosis and Diastolic Function in Aortic Stenosis |
| Q46177831 | Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping |
| Q61727640 | Diffuse Myocardial Fibrosis in Aortic Stenosis |
| Q90678644 | Diffusion Tensor Cardiovascular Magnetic Resonance Imaging: A Clinical Perspective |
| Q88088231 | Diffusion Tensor Cardiovascular Magnetic Resonance of Microstructural Recovery in Dilated Cardiomyopathy |
| Q64043656 | Diffusion-Weighted Magnetic Resonance Imaging Detects Vessel Wall Inflammation in Patients With Giant Cell Arteritis |
| Q84731038 | Digging deeper with CT imaging: slice-by-micro slice... |
| Q40364806 | Digital Mammography and Screening for Coronary Artery Disease |
| Q57781214 | Diminished Global Longitudinal Strain Predicts Late Allograft Failure in Pediatric Heart Transplant Recipients |
| Q88088222 | Direct Stiffness Measurements by Echocardiography: Does the Search for the Holy Grail Come to an End? |
| Q34808565 | Direct T2 quantification of myocardial edema in acute ischemic injury |
| Q49191610 | Direct assessment of normal mechanical mitral valve orifice area by real-time 3D echocardiography |
| Q44381072 | Direct measurement of multiple vena contracta areas for assessing the severity of mitral regurgitation using 3D TEE. |
| Q85097978 | Direct visualization of regurgitant orifice by CMR reveals differential asymmetry according to etiology of mitral regurgitation |
| Q53037682 | Disagreement Between Different Definitions of Coronary Artery Calcium Progression. |
| Q53642957 | Discordance between ischemia and stenosis, or PINSS and NIPSS: are we ready for new vocabulary? |
| Q50641134 | Discordant Grading of Aortic Stenosis Severity: Echocardiographic Predictors of Survival Benefit Associated With Aortic Valve Replacement. |
| Q102319397 | Disease Staging and Outcome in Pulmonary Hypertension: Deciphering the Right Pattern |
| Q47869470 | Disparate patterns of left ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. |
| Q92771010 | Disparity of Dispersion in Predicting Ventricular Arrhythmias |
| Q52982818 | Display of 3D Multimodality Cardiac Images With 2D Polar Maps: Simplicity Can Be a Virtue. |
| Q92771046 | Disproportionate Functional Mitral Regurgitation: Advancing a Conceptual Framework to Clinical Practice |
| Q57293559 | Distance of Lipid Core–Rich Plaques From the Ostium by NIRS in Nonculprit Coronary Arteries |
| Q50204578 | Distinguishing Active Vasculitis From Sterile Inflammation and Graft Infection: A Call for a More Specific Imaging Target |
| Q99623489 | Distinguishing Proportionate and Disproportionate Subtypes in Functional Mitral Regurgitation and Left Ventricular Systolic Dysfunction |
| Q90948534 | Distribution and Prognostic Significance of Left Ventricular Global Longitudinal Strain in Asymptomatic Significant Aortic Stenosis: An Individual Participant Data Meta-Analysis |
| Q53461068 | Diversity of Lesion Morphology in CTEPH Analyzed by OCT, Pressure Wire, and Angiography. |
| Q93192478 | Do 2-Dimensional Speckle Tracking Indexes Have Sufficient Reproducibility to Be Used in Clinical Practice When Image Acquisition and Severity of LV Dysfunction Are Taken Into Account? |
| Q91123717 | Do Guideline-Based Indications Result in an Outcome Penalty for Patients With Severe Aortic Regurgitation? |
| Q88737760 | Do We Need Independent Data Monitoring Boards and Adaptive Designs for Diagnostic Outcome Trials? |
| Q90857317 | Do We Need Independent Data Monitoring Boards and Adaptive Designs for Papers About Methodology of Strain Measurement? |
| Q99348958 | Do We See "Mona Lisa Smiles" in Different Angles by Pathology, Angiography, and OCT? |
| Q35871403 | Do imaging studies performed in physician offices increase downstream utilization?: an empiric analysis of cardiac stress testing with imaging |
| Q83461318 | Do we need a new prescription to view myocardial perfusion? |
| Q86718876 | Do we need to expand our field of view for imaging of atherosclerosis? |
| Q87080757 | Do you belong to the ACC CV imaging member section? |
| Q61650563 | Dobutamine Stress CMR: Can We Predict Outcome?⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology |
| Q30480018 | Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease |
| Q86140267 | Dobutamine stress echocardiography for risk stratification of patients with low-gradient severe aortic stenosis undergoing TAVR |
| Q46056324 | Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy |
| Q92676957 | Does "Vulnerable" Atherosclerotic Plaque Modify Coronary Blood Flow?: How Myths Perpetuate |
| Q96132225 | Does Diastolic Dysfunction Precede Systolic Dysfunction Following Contemporary Breast Cancer Therapy? |
| Q90040155 | Does Left Atrial Mechanical Dysfunction Contribute to a Thrombogenic Atrial Myopathy? |
| Q99348956 | Does Surgical Treatment of Coarctation in Adults Result in Better Outcomes Compared With the Transcatheter Approach? |
| Q87331737 | Does Uncontrolled Platelet Activation Promote Coronary Artery Disease? |
| Q53014764 | Does a shortened hyperemia with regadenoson stress pose a concern for quantitative Rb-82 PET imaging? Optimization of regadenoson PET imaging. |
| Q83200595 | Does cardiac sympathetic innervation imaging fulfill an unmet need for managing atrial fibrillation? |
| Q37579385 | Does coronary flow trump coronary anatomy? |
| Q53551013 | Does dobutamine stress perfusion imaging solve the riddle of ischemia in LBBB? |
| Q46917543 | Does low pre-test probability of coronary artery disease reflect overuse of stress testing? |
| Q53473246 | Does neointimal characterization following DES implantation predict long-term outcomes? |
| Q90554042 | Does the Idea of Percutaneous Tricuspid Valve Replacement Need Repair? |
| Q90566454 | Does the Right Go Wrong During Cardiac Resynchronization Therapy? |
| Q39446661 | Does the Routine Availability of CT-Derived FFR Influence Management of Patients With Stable Chest Pain Compared to CT Angiography Alone?: The FFRCT RIPCORD Study. |
| Q46056335 | Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation? |
| Q47919846 | Doppler Echocardiography for the Estimation of LV Filling Pressure in Patients With Mitral Annular Calcification |
| Q53261360 | Dose Optimization in Coronary CTA |
| Q63727210 | Dose-Dependent Effect of Caffeine on Adenosine-Induced Myocardial Stress Perfusion in Rubidium-82 Positron-Emission Tomography/Computed Tomography |
| Q90313939 | Double Face of Statins at the Crossroad of Coronary Atherosclerotic Plaque and Aortic Valve Calcification? |
| Q89934524 | Duo Cum Faciunt Idem, Non Est Idem |
| Q53150013 | Dynamic Changes in LV Radius as a Marker of Septal Configuration for Predicting RV Failure Following LVAD Implantation. |
| Q59689402 | Dynamic Myocardial CT Perfusion Imaging for Evaluation of Myocardial Ischemia as Determined by MR Imaging |
| Q90040175 | Dynamic Stress Computed Tomography Perfusion With a Whole-Heart Coverage Scanner in Addition to Coronary Computed Tomography Angiography and Fractional Flow Reserve Computed Tomography Derived |
| Q90384199 | Dynamic Stress Perfusion CT: 2 Out of 3 Ain't Bad? |
| Q44053651 | Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial |
| Q43852775 | Dysfunction of bileaflet aortic prosthesis: accuracy of echocardiography versus fluoroscopy. |
| Q46011760 | Dysglycemia and acute myocardial infarction: the role of echocardiography. |
| Q44285044 | Dyssynchrony and the risk of ventricular arrhythmias |
| Q87431405 | Dyssynchrony measurements to predict functional recovery after CRT: too good to be true? |
| Q100431006 | E-Consult Protocoling to Improve the Quality of Cardiac Stress Tests |
| Q84085793 | EBV Infection as a Cause of VT: Evaluation by CMR |
| Q98629441 | ECG-Gated Cardiac FDG PET Acquisitions Significantly Improve Detectability of Infective Endocarditis |
| Q33924354 | ECG-Triggered, Single Cardiac Cycle, High-Speed, 3D, Intracoronary OCT |
| Q45072512 | ECV for Patients With Aortic Stenosis: Which Patient Will Benefit? |
| Q53124389 | EP goes imaging. |
| Q38525849 | Early Bioprosthetic Valve Failure: A Pictorial Review of Rare Causes |
| Q89125741 | Early Changes in Myocardial Mechanics Detected by 3-Dimensional Speckle Tracking Echocardiography in Patients Treated With Low Doses of Anthracyclines |
| Q90553657 | Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging |
| Q90553605 | Early Detection of Increased Risk for Atrial Fibrillation Recurrence Based on Intra-Atrial Dyssynchrony |
| Q53121123 | Early Diastolic Strain Rate in Relation to Systolic and Diastolic Function and Prognosis in Aortic Stenosis. |
| Q57806438 | Early Echocardiographic Deformation Analysis for the Prediction of Sudden Cardiac Death and Life-Threatening Arrhythmias After Myocardial Infarction |
| Q46209344 | Early Gadolinium Enhancement for Determination of Area at Risk: A Preclinical Validation Study |
| Q58029860 | Early Identification of Transthyretin-Related Hereditary Cardiac Amyloidosis∗ |
| Q102319453 | Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms |
| Q87919862 | Early Phase 99Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis |
| Q50063993 | Early Prosthetic Valve Dysfunction Due to Bioprosthetic Valve Thrombosis: The Role of Echocardiography |
| Q47421836 | Early Reperfusion Can Reduce Infarction Size but not Salvaged Myocardial Size in Acute Myocardial Infarction Rats. |
| Q90553490 | Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement |
| Q49896865 | Early Strut Coverage in Patients Receiving Drug-Eluting Stents and its Implications for Dual Antiplatelet Therapy: A Randomized Trial. |
| Q43275226 | Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention |
| Q43260664 | Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size |
| Q58844484 | Early identification and monitoring progression of Chagas' cardiomyopathy with SPECT myocardial perfusion imaging |
| Q37438804 | Early use of contrast in cardiac magnetic resonance |
| Q37707593 | Echo/Doppler evaluation of hemodynamics after aortic valve replacement: principles of interrogation and evaluation of high gradients |
| Q41810382 | Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR. |
| Q93192488 | Echocardiographic Assessment of Transcatheter Aortic Valve Hemodynamics: More Tools for the Toolbox |
| Q92855898 | Echocardiographic Assessment of the Right-Sided Heart for Surveillance of Patients With Pulmonary Arterial Hypertension |
| Q90202257 | Echocardiographic Data in Artificial Intelligence Research: Primer on Concepts of Big Data and Latent States |
| Q99575262 | Echocardiographic Evaluation of Hemodynamics in Heart Transplant Recipients |
| Q51182534 | Echocardiographic Features of the Fully Magnetically Levitated LVAD. |
| Q87331741 | Echocardiographic Findings and Clinical Correlation With Cardiac Myxoma |
| Q30276554 | Echocardiographic Ischemic Memory Imaging Through Complement-Mediated Vascular Adhesion of Phosphatidylserine-Containing Microbubbles |
| Q90678672 | Echocardiographic Prediction of Ventricular Arrhythmias: The Dispersion in Patients With Moderate Left Ventricular Systolic Dysfunction |
| Q53793859 | Echocardiographic Predictors of Mortality in Adults With a Fontan Circulation. |
| Q91018940 | Echocardiographic Surveillance of Valvular Heart Disease in Different Sociodemographic Groups |
| Q84567941 | Echocardiographic assessment of right ventricular function: how to account for tricuspid regurgitation and pulmonary hypertension |
| Q87073889 | Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy |
| Q51698002 | Echocardiographic dyssynchrony and health status outcomes from cardiac resynchronization therapy: insights from the PROSPECT trial. |
| Q37773053 | Echocardiographic evaluation of patent foramen ovale prior to device closure |
| Q46056291 | Echocardiographic guidance in treatment of cardiogenic shock complicating transient left ventricular apical ballooning syndrome |
| Q27310075 | Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement |
| Q28083155 | Echocardiographic imaging of procedural complications during self-expandable transcatheter aortic valve replacement |
| Q53056358 | Echocardiographic patient selection for cardiac resynchronization therapy: betting on a dead horse? |
| Q53056354 | Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy. |
| Q46962942 | Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation |
| Q53728573 | Echocardiographic-Derived Strain-Area Loop of the Right Ventricle is Related to Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension. |
| Q98629455 | Echocardiography First, but Here Comes CMR for Grading Left Ventricular Diastolic Function |
| Q46056362 | Echocardiography contrast for image optimization: beyond confidence, it is a matter of accuracy |
| Q84893617 | Echocardiography for percutaneous heart pumps |
| Q48657663 | Echocardiography for the "superior doctor": a call to action in the management of heart failure. |
| Q51594583 | Echocardiography in Clinical Trials for TAVR: Getting to the Core of the Matter. |
| Q37438779 | Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies |
| Q27021994 | Echocardiography in liver transplant candidates |
| Q37615629 | Echocardiography in percutaneous valve therapy |
| Q35802753 | Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study |
| Q91123599 | Echocardiography-Fluoroscopy Fusion Imaging for Guidance of Congenital and Structural Heart Disease Interventions |
| Q37808821 | Echocardiography-Guided Biventricular Pacemaker Optimization |
| Q89306174 | Echocardiography-X-Ray Image Fusion |
| Q87593721 | Educational intervention to reduce outpatient inappropriate echocardiograms: a randomized control trial |
| Q91894958 | Effect of Caffeine Ingestion on Relative Myocardial Blood Flow Imaging |
| Q92747848 | Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis |
| Q57335126 | Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain |
| Q50057840 | Effect of Early Pitavastatin Therapy on Coronary Fibrous-Cap Thickness Assessed by Optical Coherence Tomography in Patients With Acute Coronary Syndrome: The ESCORT Study |
| Q89934487 | Effect of Elliptical LV Outflow Tract Geometry on Classification of Aortic Stenosis in a Multidisciplinary Heart Team Setting |
| Q113871717 | Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction |
| Q50483953 | Effect of Experience and Training on the Concordance and Precision of Strain Measurements. |
| Q50064015 | Effect of Mitral Valve Repair on Mitral Valve Leaflets Strain: A Pilot Study |
| Q92038035 | Effect of PCSK-9 Inhibitors on Lipid-Rich Vulnerable Coronary Plaque Assessed by Near-Infrared Spectroscopy |
| Q39171868 | Effect of Sex and Sporting Discipline on LV Adaptation to Exercise. |
| Q49896722 | Effect of Traditional Heart Failure Risk Factors on Myocardial Dysfunction in Adult Survivors of Childhood Cancer. |
| Q30408532 | Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis |
| Q53084187 | Effect of recommendations on interobserver consistency of diastolic function evaluation. |
| Q56773735 | Effective dose of PET/CT in informed consent forms |
| Q57622370 | Effects of Age, Diet, and Type 2 Diabetes on the Development and FDG Uptake of Atherosclerotic Plaques |
| Q57725629 | Effects of Statins on Coronary Atherosclerotic Plaques |
| Q43260663 | Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics |
| Q46056351 | Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results |
| Q87578758 | Effects of blood T1 on extracellular volume calculation |
| Q46011751 | Effects of left bundle branch block and right ventricular pacing on assessing myocardial viability by positron emission tomography. |
| Q53142391 | Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. |
| Q53213764 | Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy. |
| Q47771026 | Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History |
| Q51917557 | Electroanatomic relationships in patients with primum atrioventricular septal defect. |
| Q87431379 | Electrocardiographic Q-wave "remodeling" in reperfused ST-segment elevation myocardial infarction: validation study with CMR |
| Q84733783 | Electrocardiographic measures of myocardial function and necrosis |
| Q82552427 | Electrophysiology follows anatomy? |
| Q100431012 | Embolic Stroke of Undetermined Source: The Association With Carotid Intraplaque Hemorrhage |
| Q88333111 | Emergence of Integrated Cardiac Magnetic Resonance/Positron Emission Tomography Imaging as the Preferred Imaging Modality in Cardiac Sarcoidosis |
| Q48195889 | Emergence of plaque erosion as an important clinical entity |
| Q49721134 | Emerging Sex Differences in Aortic Stenosis |
| Q53526717 | Emerging role of MDCT in planning complex structural transcatheter intervention |
| Q37993985 | Emerging trends in CV flow visualization |
| Q101137751 | Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study |
| Q53787123 | Employment Status After Training in Advanced CV Imaging. |
| Q48031275 | Empowering physical examination: the "laying on" of ultrasound |
| Q45938238 | End of the road for delayed hyperenhancement cardiac magnetic resonance? |
| Q50683197 | Endocardial surface area tracking for assessment of regional LV wall deformation with 3D speckle tracking imaging. |
| Q92203168 | Endothelial Cell Coverage on the Leaflet After Transcatheter Aortic Valve Replacement |
| Q57823545 | Endothelial Shear Stress and Plaque Erosion: A Computational Fluid Dynamics and Optical Coherence Tomography Study |
| Q58328005 | Enface Reconstruction of VSD on RV Septal Surface Using Real-Time 3D Echocardiography |
| Q102319401 | Enforcing Quality in Strain Imaging Through AI-Powered Surveillance |
| Q92176445 | Enhanced Diagnosis of Severe Aortic Stenosis Using Artificial Intelligence: A Proof-of-Concept Study of 530,871 Echocardiograms |
| Q90040152 | Enhanced Multifactorial Biomechanical Stress Metrics to Predict Plaque Rupture: Rapid Assessment of Morphology and Plaque Structural Stress |
| Q87431389 | Enhancing risk prediction with PET coronary flow reserve: can it be clinically useful? |
| Q84569495 | Enhancing the prognostic value of cardiac imaging with multimodal risk assessment |
| Q85954359 | Eosinophil-Mediated Cardiac Injury Possibly Due to Dimethyl Fumarate |
| Q88285416 | Ephemeral Effusive Constrictive Pathophysiology |
| Q93192456 | Epicardial Adipose Tissue and Myocardial Fibrosis in Aortic Stenosis Relationship With Symptoms and Outcomes: A Study Using Cardiac Magnetic Resonance Imaging |
| Q99623485 | Epicardial Adipose Tissue in Patients With Stable Chest Pain: Insights From the PROMISE Trial |
| Q90923880 | Epicardial Adipose Tissue: An Independent Predictor of Post-Operative Adverse Cardiovascular Events (CTA VISION Substudy). |
| Q54510835 | Epicardial Fat Volume and the Risk of Atrial Fibrillation in the General Population Free of Cardiovascular Disease. |
| Q45164475 | Epicardial adipose tissue and progression of coronary artery calcium: cause and effect or simple association? |
| Q47767547 | Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades |
| Q50447676 | Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI. |
| Q45927713 | Establishing the prognostic value of Rb-82 PET myocardial perfusion imaging: a step in the right direction. |
| Q90553917 | Estimating Pre-Test Probability of Coronary Artery Disease: Battle of the Scores in an Evolving CAD Landscape |
| Q44587877 | Ethnic Difference in Proximal Aortic Stiffness: An Observation From the Dallas Heart Study |
| Q40932177 | Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study |
| Q98186775 | Evaluating Syncope: Does a Prior Normal Transthoracic Echocardiogram Negate the Need for Another Echocardiogram? |
| Q90678687 | Evaluation of Disease Progression in Arrhythmogenic Cardiomyopathy: The Change of Echocardiographic Deformation Characteristics Over Time |
| Q48449579 | Evaluation of LV diastolic function from color M-mode echocardiography. |
| Q56986556 | Evaluation of Pulmonary Artery Stiffness in Pulmonary Hypertension With Cardiac Magnetic Resonance |
| Q91307410 | Evaluation of a Deep Learning-Based Automated CT Coronary Artery Calcium Scoring Algorithm |
| Q84569490 | Evaluation of left atrial degeneration for the prediction of atrial fibrillation: usefulness of integrated backscatter transesophageal echocardiography |
| Q36776701 | Evaluation of mitral valve dynamics |
| Q38476990 | Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance |
| Q30277168 | Evidence Base for Quality Control Activities in Cardiovascular Imaging |
| Q86971415 | Evidence of a Direct Effect of Myocardial Steatosis on LV Hypertrophy and Diastolic Dysfunction in Adult and Adolescent Obesity |
| Q82551797 | Evolution and clinical importance of fibrosis in HCM |
| Q43575368 | Evolution and revolution in CMR imaging |
| Q102319446 | Evolution of Myocardial Dysfunction in Asymptomatic Patients at Risk of Heart Failure |
| Q39665054 | Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging |
| Q40743264 | Ex vivo cryoimaging for plaque characterization |
| Q53035749 | Examining Achilles' heel: improving response rates with cardiac resynchronization therapy. |
| Q92676993 | Exercise CMR T1 Mapping for Myocardial Ischemia Testing: No Gad, No Drugs, No Problem? |
| Q92047608 | Exercise Capacity Is Reduced in Cancer Survivors Previously Treated With Anthracycline-Based Chemotherapy Despite a Preserved Cardiac Output Response |
| Q99623496 | Exercise E/e' Is a Determinant of Exercise Capacity and Adverse Cardiovascular Outcomes in Chronic Kidney Disease |
| Q49574129 | Exercise Echocardiography in Aortic Stenosis: A Happy End? |
| Q92411281 | Exercise Is Good for the Heart But Not for the Inflamed Pericardium? |
| Q88114567 | Exercise Is Medicine: Proof . . . and Possibilities? |
| Q88217138 | Exercise Testing in Paradoxical Low-Flow Aortic Stenosis: Where Is the Truth? |
| Q39216466 | Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes |
| Q45769399 | Exercise radionuclide ventriculography for predicting post-operative left ventricular function in chronic aortic regurgitation |
| Q38187719 | Exercise testing in asymptomatic severe aortic stenosis |
| Q102319400 | Exercise-Induced Arrhythmogenic (Right Ventricular) Cardiomyopathy Is Real…If You Consider It |
| Q45330708 | Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis |
| Q52982675 | Expanding CT Application to Myocardial Tissue Characterization. |
| Q90202214 | Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support |
| Q83629639 | Exploring left ventricular isovolumic shortening and stretch mechanics: "The heart has its reasons...". |
| Q100431009 | Extended Validation of Novel 3D Quantitative Coronary Angiography-Based Software to Calculate vFFR: The Fast Extend Study |
| Q92524538 | Extensive Coronary Artery Calcifications: No Longer Primary Prevention! |
| Q84058489 | Extensive fulminant multivalvular infective endocarditis |
| Q44933221 | Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty |
| Q51645450 | Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. |
| Q44576240 | Extent of thoracic aortic atheroma burden and long-term mortality after cardiothoracic surgery: a computed tomography study |
| Q57646716 | Extracardiac findings: what is a cardiologist to do? |
| Q92135609 | Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1 |
| Q101137729 | Extracellular Volume Imaging in Aortic Stenosis During Routine Pre-TAVR Cardiac Computed Tomography |
| Q53470369 | Extracellular Volume and Cardiac Mechanics: Have We Found a Missing Puzzle Piece? |
| Q96615832 | Extracellular Volume and Global Longitudinal Strain Both Associate With Outcomes But Correlate Minimally |
| Q101373451 | Extracellular Volume and Global Longitudinal Strain Mirroring the Interstitial and Contractile Domains of Cardiac Vulnerability |
| Q91730618 | Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? |
| Q50188160 | Extracellular Volume in Dilated Cardiomyopathy: Interstitial Fibrosis and More? |
| Q104504889 | Extracellular Volume in Primary Mitral Regurgitation |
| Q84969345 | Extracellular space measurements with CMR imaging |
| Q52650695 | FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome. |
| Q53473241 | FDG PET/CT imaging for LVAD associated infections. |
| Q40363031 | FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease |
| Q53037689 | FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity. |
| Q90566436 | FDG-PET/CT for the Detection of Infection Following Aortic Root Replacement Surgery |
| Q46724136 | FFR Derived From Coronary CT Angiography: Solving the Calcification Dilemma of Coronary CT Angiography |
| Q46695313 | FFR Derived From Coronary CT Angiography in Nonculprit Lesions of Patients With Recent STEMI. |
| Q58564618 | FFR Versus SPECT to Diagnose Coronary Artery Disease: Toward a Tailored Approach |
| Q83461322 | FFR and coronary flow reserve: friends or foes? |
| Q90040248 | FFR-CT and CT Myocardial Perfusion Imaging: Friends or Foes? |
| Q53728894 | FFR-Derived From Coronary CT Angiography Using Workstation-Based Approaches. |
| Q90553846 | Fabry Disease: Cardiomyopathy Staging |
| Q90040138 | Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease |
| Q88742609 | Family History of CHD Is Associated With Severe CAC in South Asians: Comparing the MASALA and MESA Studies |
| Q84571612 | Fat around the heart |
| Q30654975 | Fat deposition in dilated cardiomyopathy assessed by CMR. |
| Q48689891 | Fate of Coronary Chronic Total Occlusion Recanalization via Subintimal Tracking With Bioresorbable Vascular Scaffolds: A Temporary Cage for a Permanent New Lumen? |
| Q89281517 | Fate of Nonculprit Plaques in Patients With STEMI Undergoing Primary PCI Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study |
| Q87408660 | Fatigue crack growth under pulsatile pressure and plaque rupture |
| Q48499558 | Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach. |
| Q101137717 | Feasibility and Prognostic Value of Vasodilator Stress Perfusion CMR in Patients With Atrial Fibrillation |
| Q90553746 | Feasibility and Safety of Intracoronary Imaging for Diagnosing Spontaneous Coronary Artery Dissection |
| Q92038074 | Feasibility and Safety of Transnasal Transesophageal Echocardiography Guiding Left Atrial Appendage Closure Without General Anesthesia |
| Q47622333 | Feasibility and accuracy of 3DTEE versus CT for the evaluation of aortic valve annulus to left main ostium distance before transcatheter aortic valve implantation |
| Q44564802 | Feasibility and acute efficacy of radiofrequency ablation of cavotricuspid isthmus-dependent atrial flutter guided by real-time 3D TEE. |
| Q89728089 | Feasibility of Computed Tomography Perfusion for Detection of Cardiac Allograft Rejection Following Heart Transplantation |
| Q43098198 | Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina |
| Q36757456 | Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo |
| Q53082227 | Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. |
| Q44023660 | Feasibility of intercity and trans-Atlantic telerobotic remote ultrasound: assessment facilitated by a nondedicated bandwidth connection |
| Q53314175 | Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography. |
| Q51401890 | Feasibility, accuracy, and reproducibility of real-time full-volume 3D transthoracic echocardiography to measure LV volumes and systolic function: a fully automated endocardial contouring algorithm in sinus rhythm and atrial fibrillation. |
| Q97589595 | Feature Tracking Myocardial Strain Incrementally Improves Prognostication in Myocarditis Beyond Traditional CMR Imaging Features |
| Q45059619 | Feature Tracking by CMR: A "Double Feature"? |
| Q92747806 | Feature Tracking by Cardiovascular Magnetic Resonance Imaging: The New Gold Standard for Systolic Function? |
| Q48505902 | Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients with Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement |
| Q91285314 | Feature-Tracking Global Longitudinal Strain Predicts Mortality in Patients With Preserved Ejection Fraction: A Multicenter Study |
| Q47174524 | Female Athlete's Heart: Appropriate Scaling to Body Size May Resolve Diagnostic Conundrums |
| Q60197006 | Femoral Plaque Echogenicity and Cardiovascular Risk in Claudicants |
| Q94953562 | Ferumoxytol MR Angiography: A Novel Technique for Assessing Iliac Vasculature in Potential Kidney Transplant Recipients |
| Q92411288 | Ferumoxytol-Enhanced CMR for Vasodilator Stress Testing: A Feasibility Study |
| Q84560937 | Fibrin thrombus in unstable angina and NSTEMI |
| Q88407747 | Fibromuscular Dysplasia: Looking Beyond the "String of Beads" |
| Q101137711 | Finding the "Golden Moment" for TAVR: Look Below the Valve |
| Q53035740 | Finding the sweet spot for CRT. |
| Q91647849 | First Clinical Experience With 3-Dimensional Echocardiographic Transillumination Rendering |
| Q93192380 | First-Phase Ejection Fraction Is a Powerful Predictor of Adverse Events in Asymptomatic Patients With Aortic Stenosis and Preserved Total Ejection Fraction |
| Q93192412 | First-Phase Ejection Fraction: The FEV1 of the Heart? |
| Q53295479 | First-pass and steady-state MR angiography of thoracic vasculature in children and adolescents. |
| Q53515354 | Fixing the Prevention Gap Using Imaging-Guided Risk Estimates. |
| Q42557760 | Flare spots in intravascular optical coherence tomography images of bioabsorbable stents |
| Q53091498 | Flow acceleration time and ratio of acceleration time to ejection time for prosthetic aortic valve function. |
| Q83200585 | Flow propagation analysis computer or eyeball? |
| Q86378692 | Fluoroscopy-guided aortic root imaging for TAVR: "follow the right cusp" rule |
| Q49721010 | Focal Fibrosis in the Endurance Athlete's Heart: Running Scarred or Running Scared? |
| Q104504893 | Focal Replacement and Diffuse Fibrosis in Primary Mitral Regurgitation: A New Piece to the Puzzle |
| Q104794268 | Focus Issue on Imaging For Best Outcomes in Structural Heart Interventions |
| Q89125735 | Focus on the Perimeter and Skip the Balloon: Can Atrial Septal Defect Be Percutaneously Closed Without Balloon Sizing in the Era of 3-Dimensional Echocardiography? |
| Q91616159 | Focused Cardiac Ultrasonography |
| Q91616712 | Focused Issue on Computed Tomography |
| Q57815552 | Follow-Up Echocardiography of the Right Ventricle in Pulmonary Arterial Hypertension: Straining to See a Difference |
| Q38860445 | Follow-Up of Pulmonary Hypertension With Echocardiography |
| Q99348962 | Forecasting Preventive Care Effectiveness With Imaging |
| Q92747727 | Four-Dimensional Intracardiac Echocardiography in Transcatheter Tricuspid Valve Repair With the MitraClip System |
| Q51288133 | Free-breathing 3 T magnetic resonance T2-mapping of the heart. |
| Q101373528 | Frequency of Pulmonary Embolism in Patients With COVID-19 |
| Q49721113 | From Lab to Life: Cardiac Biomarker Measurement in the Intact Heart by Means of Hyperpolarized13C-Carbon CMR. |
| Q48600839 | From Metabolic Exposome to Onset of Diabetic Cardiomyopathy |
| Q87331786 | From Newton to the Coronaries: Computational Fluid Dynamics Has Entered the Clinical Scene |
| Q47949946 | From Plaque Burden to Plaque Composition: Toward Personalized Risk Assessment |
| Q53422750 | From Plaque Morphology to Ischemia: Pushing the Limits of Spatial Resolution. |
| Q53759606 | From Recognized to Novel Quantitative CMR Biomarkers of LV Recovery: A Paradigm Shift in Acute Myocardial Infarction Imaging. |
| Q85649682 | From adequate evidence to optimal evidence |
| Q46019191 | From better understood pathogenesis to superior molecular imaging, and back... |
| Q46232833 | Full Circle on Pulmonary Flow Dynamics in Pulmonary Arterial Hypertension. |
| Q92047525 | Fully Automated, Quality-Controlled Cardiac Analysis From CMR: Validation and Large-Scale Application to Characterize Cardiac Function |
| Q39762504 | Functional Assessment of Bioprosthetic Aortic Valves by CMR. |
| Q89210613 | Functional Assessment of Chronic Total Occlusions: Can CMR Imaging Add Value? |
| Q38632207 | Functional Evaluation of Coronary Disease by CT Angiography. |
| Q63727170 | Functional Impact of Atherosclerosis on Epicardial Coronary Conductance Vessels Assessed With MDCT |
| Q38772964 | Functional Implication of Mitral Annular Disjunction in Mitral Valve Prolapse: A Quantitative Dynamic 3D Echocardiographic Study. |
| Q92505494 | Functional Interpretation of Coronary Stenoses by Cardiac CT and the Many Ways to Skin That Cat |
| Q57815537 | Functional Significance of Coronary Stenosis: Is it About the Real or Virtual Physiology? |
| Q50069994 | Fused whole-heart coronary and myocardial scar imaging using 3-T CMR. Implications for planning of cardiac resynchronization therapy and coronary revascularization |
| Q64924002 | Fusiform Appearance of Myocardial Bridging Detected by OCT. |
| Q85039927 | Fusion Images: More Informative Than the Sum of Individual Images? |
| Q88430436 | Fusion Imaging During the Interventional Closure of Patent Foramen Ovale and Atrial Septal Defects: Mandatory or Superfluous? |
| Q86964144 | Fuzzy or Sharp Borders of Acute Myocardial Ischemia and Infarction? |
| Q42571665 | Gadolinium can depict area at risk and myocardial infarction: a double-edged sword? |
| Q92770942 | Gadolinium-Free Cardiovascular Magnetic Resonance Stress T1 Mapping in Patients With Chronic Kidney Disease |
| Q82552457 | Gated SPECT myocardial perfusion imaging for the prediction of incident heart failure an old dog learns a new trick |
| Q36784060 | Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World: Findings From the INCAPS Registry |
| Q51352493 | Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. |
| Q53065964 | Gender difference in the prognostic value of CTA? |
| Q84811058 | Genotype-specific pattern of LV involvement in ARVD/C |
| Q84567931 | Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR |
| Q37656361 | Geometric characterization of patient-specific total cavopulmonary connections and its relationship to hemodynamics. |
| Q89580399 | Getting Shorter Predicts Living Longer: The Remarkable Success of Ventricular Strain as a Prognostic Marker |
| Q82428309 | Getting closer for high-resolution vascular MRI |
| Q85649670 | Getting good vibes: the therapeutic power of microbubbles and ultrasound |
| Q58582178 | Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events |
| Q49896695 | Global Left Atrial Strain as a Predictor of Silent Atrial Fibrillation Following Dual Chamber Cardiac Implantable Electronic Device Implantation |
| Q92505470 | Global Longitudinal Shortening: A Positive Step Towards Reducing Confusion Surrounding Global Longitudinal Strain |
| Q41118317 | Global Longitudinal Strain Is a Superior Predictor of All-Cause Mortality in Heart Failure With Reduced Ejection Fraction. |
| Q91647803 | Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease |
| Q90040191 | Global Longitudinal Strain by CMR Feature Tracking Is Associated With Outcome in HFPEF |
| Q53794127 | Global Longitudinal Strain in Asymptomatic Chronic Aortic Regurgitation: The Missing Piece for the Watchful Waiting Puzzle? |
| Q41280699 | Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 study |
| Q50221267 | Going Green for Vulnerable Plaque Detection? |
| Q83629601 | Googling the coronary: fiberoptics and a computer provide the answers |
| Q92176459 | Gout Is Associated With Increased Coronary Artery Calcification and Adverse Cardiovascular Outcomes |
| Q83179361 | Grading severity of mitral regurgitation by echocardiography: science or art? |
| Q44422922 | Great vessel and coronary artery anatomy in transposition and other coronary anomalies: a universal descriptive and alphanumerical sequential classification |
| Q84969336 | HFpEF, diastolic suction, and exercise |
| Q87235308 | Handheld Ultrasound is a Valuble Bedside Tool Which Can Supplement the Bedside Cardiac Exam but not Replace It |
| Q48208650 | Handheld ultrasound versus physical examination in patients referred for transthoracic echocardiography for a suspected cardiac condition |
| Q53876946 | Handheld ultrasound: accurate diagnosis at a lower cost? |
| Q53470375 | Healing After Myocardial Infarction: A Loosely Defined Process. |
| Q39507179 | Healthcare reform for imagers: finding a way forward now. |
| Q87331766 | Heart Rate Is an Important Consideration for Cardiac Imaging of Diastolic Function |
| Q98230849 | Heart and Lung Multimodality Imaging in COVID-19 |
| Q37731638 | Heart failure with normal ejection fraction: the complementary roles of echocardiography and CMR imaging |
| Q98230870 | Heart-COVID-19 Lung Interactions: More Common Cause for Right Ventricular Dysfunction Than We Thought |
| Q54245374 | Heartbeat OCT and Motion-Free 3D In Vivo Coronary Artery Microscopy. |
| Q84567944 | Helical structure of ventricular anatomy by diffusion tensor cardiac MR tractography |
| Q88737790 | Hemodynamic Optimization Following Biventricular Device Implant: Do We Still Need an Echocardiogram? |
| Q61651731 | Hemodynamic Stress Echocardiography in Patients Supported With a Continuous-Flow Left Ventricular Assist Device |
| Q100502932 | Hemodynamic and Prognostic Validation of Novel Combined Algorithm to Assess Diastolic Function and Filling Pressures |
| Q33162512 | Hemodynamic patterns for symptomatic presentations of severe aortic stenosis |
| Q84392192 | Hemorrhage in the myocardium following infarction |
| Q92047519 | Heterogeneity of Plaque Structural Stress Is Increased in Plaques Leading to MACE: Insights From the PROSPECT Study |
| Q84058465 | Heterogeneity of acute heart transplant rejection can be visualized by cellular and functional cardiac magnetic resonance |
| Q42777237 | Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis |
| Q84058432 | Heterogeneous onset of myocardial relaxation in subendocardial and subepicardial layers assessed with tissue strain imaging: comparison of normal and hypertrophied myocardium |
| Q102319456 | Heterogenous Distribution of Risk for Cardiovascular Disease Events in Patients With Stable Ischemic Heart Disease |
| Q49721105 | High Frame-Rate Contrast Echocardiography: In-Human Demonstration. |
| Q89580446 | High Mortality in the Group of Takotsubo Syndrome in Patients With "MINOCA": So High, A Clarification |
| Q89210661 | High Platelet Reactivity and Intrastent Thrombi Assessed by OCT After DES |
| Q102323773 | High Prevalence of Pericardial Involvement in College Student Athletes Recovering From COVID-19 |
| Q30450312 | High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study |
| Q90678660 | High-Definition IVUS Versus OCT to Assess Coronary Artery Disease and Results of Stent Implantation |
| Q86134043 | High-Intensity Plaques on Noncontrast T1-Weighted Imaging as a Predictor of Periprocedural Myocardial Injury |
| Q88297960 | High-Output Heart Failure in Sickle Cell Anemia |
| Q103042436 | High-Resolution Cardiac Magnetic Resonance Imaging Techniques for the Identification of Coronary Microvascular Dysfunction |
| Q90384148 | High-Resolution Contrast-Enhanced Micro-Computed Tomography to Identify the Cardiac Conduction System in Congenitally Malformed Hearts: Valuable Insight From a Hospital Archive |
| Q92747873 | High-Resolution Late Gadolinium Enhancement Magnetic Resonance for the Diagnosis of Myocardial Infarction With Nonobstructed Coronary Arteries |
| Q104504897 | High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study |
| Q52988665 | High-Risk Plaque Features on Coronary CT Angiography. |
| Q63915311 | High-Sensitivity Troponin I Is Associated With High-Risk Plaque and MACE in Stable Coronary Artery Disease |
| Q88088212 | High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial |
| Q93192365 | High-Sensitivity Troponin and Coronary Artery Disease Severity: A Bridge Too Far? |
| Q53085544 | High-pitch thoracic CT with simultaneous assessment of coronary arteries: effect of heart rate and heart rate variability on image quality and diagnostic accuracy. |
| Q40140138 | High-resolution ultrasound perfusion imaging of therapeutic angiogenesis |
| Q46056360 | High-speed myocardial perfusion imaging initial clinical comparison with conventional dual detector anger camera imaging |
| Q46056358 | High-speed myocardial perfusion imaging: dawn of a new era in nuclear cardiology? |
| Q92676850 | Histological Evidence for Impaired Myocardial Perfusion Reserve in Severe Aortic Stenosis |
| Q90553560 | Histopathologic Characterization of Peripheral Arteries in Subjects With Abundant Risk Factors: Correlating Imaging With Pathology |
| Q102319398 | Histopathological Characterization of High-Intensity Signals in Coronary Plaques on Noncontrast T1-Weighted Magnetic Resonance Imaging |
| Q33922644 | Hospital-level variation in use of cardiovascular testing for adults with incident heart failure: findings from the cardiovascular research network heart failure study |
| Q91320373 | How Active Is Active Surveillance in Asymptomatic Patients With Primary Mitral Regurgitation? |
| Q102319450 | How Do Adrenergic Tumors Affect Left Ventricular Remodeling and Function?: A "Loaded" Question |
| Q91406535 | How Do We Reconcile Echocardiography, Computed Tomography, and Hybrid Imaging in Assessing Discordant Grading of Aortic Stenosis Severity? |
| Q52984808 | How Exactly Do You Measure That Aorta?: Lessons From Multimodality Imaging. |
| Q50057823 | How Quickly We Forget |
| Q90080792 | How Should Physicians Assess Myocardial Contraction?: Redefining Heart Failure With a Preserved Ejection Fraction |
| Q86141416 | How close is close enough? |
| Q47343450 | How should infarct size be measured on LGE sequences? A call for a change in the guidelines |
| Q51647038 | How to Decipher OCT After PCI. |
| Q53151344 | How to Distinguish Between Myocarditis and Sarcoidosis Based on CMR Imaging. |
| Q90678649 | How to Image Cardiac Amyloidosis: A Practical Approach |
| Q88333090 | How to Mend a Broken Heart? |
| Q48689879 | How to define end-diastole and end-systole?: Impact of timing on strain measurements |
| Q53618169 | How to detect and treat coronary fibroatheromas: the synergy between IVUS and NIRS. |
| Q58909948 | Human “Nuclear” Mitochondrial Cardiomyopathy |
| Q92038025 | Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis |
| Q47719399 | Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. |
| Q129041082 | Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis |
| Q49721098 | Hyperpolarized [1,4-13C2]Fumarate Enables Magnetic Resonance-Based Imaging of Myocardial Necrosis |
| Q100431015 | Hypertensive Exposure Markers by MRI in Relation to Cerebral Small Vessel Disease and Cognitive Impairment |
| Q64951710 | Hypertrabeculation as a Noncompaction Phenotype in Dilated Cardiomyopathy Defined by Contrast Echocardiography. |
| Q48031214 | Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members |
| Q47864379 | Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging |
| Q87286667 | ICE-classification of interatrial septum anatomy in patients with R → L shunt |
| Q44521675 | IVC diameter in patients with chronic heart failure: relationships and prognostic significance |
| Q90024235 | IVOCT Has a Bright Future in the Identification of Vulnerable Plaques |
| Q84948097 | IVUS and OCT: either or survivor … |
| Q34321234 | IVUS detection of vasa vasorum blood flow distribution in coronary artery vessel wall |
| Q53117019 | IVUS, OCT, and Coronary Artery Calcification: Is There a Bone of Contention? |
| Q50025698 | IVUS-Guided Versus OCT-Guided Coronary Stent Implantation: A Critical Appraisal |
| Q90678699 | Identification and Quantification of Cardiovascular Structures From CCTA: An End-to-End, Rapid, Pixel-Wise, Deep-Learning Method |
| Q51762205 | Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics. |
| Q62083156 | Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy |
| Q51809886 | Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography. |
| Q98282918 | Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients |
| Q88747683 | Identifying Patients at Risk for LVOT Obstruction in Mitral Valve-in-Valve Implantation |
| Q89210607 | Illustration of the Resorption Process Between 2 Different Overlapping Bioresorbable Scaffolds |
| Q57744110 | Image Feature Determinants of Global and Segmental Circumferential Ventricular Strain From Cine CMR |
| Q85039897 | Image Fusion: Is It Merely the Blending of Pretty Pictures? |
| Q87841424 | Image Integration to Guide Wireless Endocardial LV Electrode Implantation for CRT |
| Q53261363 | Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial. |
| Q47749592 | Image quality and radiation exposure with prospectively ECG-triggered axial scanning for coronary CT angiography: the multicenter, multivendor, randomized PROTECTION-III study |
| Q92747789 | Imaging Aspects of Pediatric Cardiac Tumors |
| Q92203132 | Imaging Assessment of Tricuspid Regurgitation Severity |
| Q89455901 | Imaging Asymptomatic Individuals for Coronary Disease |
| Q95561350 | Imaging Atherosclerosis for Global Predictive Health and Wellness |
| Q104504903 | Imaging Atherosclerosis in Great Apes |
| Q88088199 | Imaging Biomechanical Endothelial Forces With Coronary Computed Tomography: A Positive Step, But Not Yet the Jewel in the Crown in the Quest for Vulnerable Plaque Prediction |
| Q92676855 | Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study |
| Q92855909 | Imaging Challenges in Tricuspid Regurgitation and Right Ventricular Failure |
| Q92047644 | Imaging Fibrosis in Aortic Stenosis: Coming of Age? |
| Q98282925 | Imaging Guidance for Transcatheter Mitral Valve Intervention on Prosthetic Valves, Rings, and Annular Calcification |
| Q57623005 | Imaging Highlights From the European Society of Cardiology, American Society of Nuclear Cardiology, and Heart Failure Society of America |
| Q98629448 | Imaging Interstitial Fibrosis, Left Ventricular Remodeling, and Function in Stage A and B Heart Failure |
| Q90948524 | Imaging Is the Cornerstone of the Management of Aortic Valve Stenosis |
| Q47892288 | Imaging Ischemic and Reperfusion Injury in Acute Myocardial Infarction: Putting the Pieces Together With CMR. |
| Q38801299 | Imaging Microvascular Dysfunction and Mechanisms for Female-Male Differences in CAD. |
| Q88631906 | Imaging Needs in Novel Transcatheter Tricuspid Valve Interventions |
| Q38748000 | Imaging Registries and Single-Center Series |
| Q88631909 | Imaging Right-Left Ventricular Interactions |
| Q92411419 | Imaging Risk in Multisystem Inflammatory Diseases |
| Q86321399 | Imaging acute MI in the 21st century |
| Q61804313 | Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis |
| Q98186786 | Imaging and Impact of Myocardial Strain in Myocarditis |
| Q84560923 | Imaging and cardiac ablation: improving on success |
| Q87438618 | Imaging and the Valley of Death: Developing the Evidence Base for the Use of Imaging in Follow-Up |
| Q86542173 | Imaging at the 2014 ACC Legislative Conference: a debrief |
| Q37542387 | Imaging cardiac resynchronization therapy |
| Q86249299 | Imaging findings in aortic intramural hematoma |
| Q89028772 | Imaging for Mitral Interventions: Methods and Efficacy |
| Q104794269 | Imaging for Native Mitral Valve Surgical and Transcatheter Interventions |
| Q97589599 | Imaging for Patient's Selection and Guidance of LAA and ASD Percutaneous and Surgical Closure |
| Q90948492 | Imaging for Predicting and Assessing Prosthesis-Patient Mismatch After Aortic Valve Replacement |
| Q91894916 | Imaging for Predicting, Detecting, and Managing Complications After Transcatheter Aortic Valve Replacement |
| Q57058598 | Imaging for Risk Stratification of Sudden Cardiac Death in Patients With Arrhythmogenic Cardiomyopathy |
| Q98629449 | Imaging for Tricuspid Valve Repair and Replacement |
| Q53360188 | Imaging for coronary risk assessment: ready for prime time? |
| Q44836621 | Imaging for improving therapy: a stop on the way to improve outcomes? |
| Q26830025 | Imaging for planning of cardiac resynchronization therapy |
| Q85295624 | Imaging hemodynamics: the next frontier for CMR |
| Q83629559 | Imaging highlights from the 2008 Scientific Session of the American College of Cardiology |
| Q51130806 | Imaging highlights from the European Association of Echocardiography and the Society of Cardiovascular Magnetic Resonance. |
| Q83629474 | Imaging highlights of the American Heart Association 2007 scientific sessions |
| Q90857320 | Imaging in Cardio-Oncology: Where Are We and Where Should We Be Going? |
| Q57058578 | Imaging in Heart Transplant Patients |
| Q45221256 | Imaging in aortic stenosis--let the data talk |
| Q37821577 | Imaging in pulmonary hypertension. |
| Q43260660 | Imaging inflammation in atherosclerosis another step forward |
| Q53196874 | Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride. |
| Q53058878 | Imaging mechanical dyssynchrony with 3-dimensional echocardiography: a promise still to be fulfilled. |
| Q84216640 | Imaging modalities and radiation: benefit has its risks... |
| Q92771002 | Imaging of Aortic Valve Cusps Using Commissural Alignment: Guidance for Transcatheter Leaflet Laceration With BASILICA |
| Q49896705 | Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [68Ga]Pentixafor-PET/CT in Correlation With Cardiac MRI. |
| Q92524497 | Imaging of Diastolic Dysfunction in Community-Based Epidemiological Studies and Randomized Controlled Trials of HFpEF |
| Q38827220 | Imaging of Inflammation in Unexplained Cardiomyopathy |
| Q53085890 | Imaging of adult atrial septal defects with CT angiography. |
| Q44800900 | Imaging of arterial inflammation: keeping our cool on a hot topic |
| Q27008169 | Imaging of low-gradient severe aortic stenosis |
| Q53196869 | Imaging of pharmacologic intervention decoding therapeutic mechanism or defining effectiveness? |
| Q53142388 | Imaging of prosthetic heart valve dysfunction: complementary diagnostic value of TEE and MDCT? |
| Q36795745 | Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury |
| Q92047639 | Imaging the Crevasse of Left Ventricular Assist Device Infection |
| Q58071222 | Imaging the Migration of Therapeutically Delivered Cardiac Stem Cells |
| Q92176440 | Imaging the Vulnerable Plaque on Coronary CTA |
| Q43577003 | Imaging the future of transcatheter aortic valve replacement |
| Q53237634 | Imaging the left atrial appendage prior to, during, and after occlusion. |
| Q49191813 | Imaging vascular nicotine receptors: a new window onto vascular disease |
| Q88430417 | Imaging-Based Surveillance for Graft Rejection Following Heart Transplantation: Ready for Prime Time? |
| Q50852451 | Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure. |
| Q91307408 | Imaging-Guided Therapies for Pericardial Diseases |
| Q90466886 | Imaging-Verified Disease Stages: Branching Off Into the Landscape of Possibilities |
| Q88747679 | Impact of AVR on LV Remodeling and Function in Paradoxical Low-Flow, Low-Gradient Aortic Stenosis With Preserved LVEF |
| Q92038081 | Impact of Age and Sex on Cardiovascular Magnetic Resonance Measurements: After Tetralogy of Fallot Repair |
| Q94953557 | Impact of Agreement and Discrepancies in Interpretations of Stress Echocardiography: Insights From the PROMISE Trial |
| Q102319444 | Impact of Chronic Total Occlusion Revascularization on Left Ventricular Function Assessed by Cardiac Magnetic Resonance |
| Q98629451 | Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified Ischemia |
| Q50204584 | Impact of End-Stage Renal Disease on Left and Right Ventricular Mechanics: Does Kidney Transplantation Reverse the Abnormalities? |
| Q53279273 | Impact of Exercise on the Relationship Between CAC Scores and All-Cause Mortality. |
| Q53223319 | Impact of In-Stent Tissue Type on Periprocedural Myocardial Infarction and 2-Year Clinical Outcomes After Treatment of Coronary Artery Restenosis. |
| Q39258436 | Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study. |
| Q90553720 | Impact of Interventricular Interactions on Left Ventricular Function, Stroke Volume, and Exercise Capacity in Children and Adults With Ebstein's Anomaly |
| Q96615834 | Impact of Left Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Insights From Cardiac Magnetic Resonance Feature Tracking |
| Q50064006 | Impact of Left Ventricular Trabeculations and Papillary Muscles on Mass, Geometry, and Association With Incident Adverse Cardiovascular Events: The Framingham Heart Study |
| Q92135618 | Impact of Liver Diseases on Heart and Lungs |
| Q46051316 | Impact of Longitudinal Lesion Geometry on Location of Plaque Rupture and Clinical Presentations. |
| Q92203179 | Impact of Measurement Variations in Right Atrial Structure and Function on Outcomes |
| Q99575264 | Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After Mitraclip Implantation: Results From the Mitra-FR Trial |
| Q90040202 | Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI |
| Q104504909 | Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure |
| Q50064019 | Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study |
| Q90948512 | Impact of Pre-Intervention Transaortic Flow Rate Versus Stroke Volume Index on Mortality Across the Hemodynamic Spectrum of Severe Aortic Stenosis: Implications for a New Hemodynamic Classification of Aortic Stenosis |
| Q99623488 | Impact of Proportionality of Secondary Mitral Regurgitation on Outcome After Transcatheter Mitral Valve Repair |
| Q87807949 | Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus: Insights From the PROSPECT Study |
| Q104504912 | Impact of Temporal Changes in Left Ventricular Systolic Function on Outcomes in Takotsubo Cardiomyopathy |
| Q90384168 | Impact of Weight Reduction During Adolescence on Parameters of Cardiac Geometry and Function in Obese Children |
| Q43878354 | Impact of a reduced tube voltage on CT angiography and radiation dose: results of the PROTECTION I study |
| Q83629613 | Impact of additional ballooning on plaque prolapse after stent implantation in patients with acute myocardial infarction |
| Q43717132 | Impact of aortic regurgitation after transcatheter aortic valve implantation: results from the REVIVAL trial |
| Q34093447 | Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. |
| Q44973599 | Impact of coronary artery calcium characteristics on accuracy of CT angiography. |
| Q51645459 | Impact of degree of commissural opening after percutaneous mitral commissurotomy on long-term outcome. |
| Q34314171 | Impact of gender on the myocardial metabolic response to obesity. |
| Q33760779 | Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study |
| Q45938230 | Impact of myocardial salvage assessed by (99m)Tc-sestamibi scintigraphy on cardiac autonomic function in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. |
| Q84182447 | Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis |
| Q53671090 | Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study. |
| Q46887976 | Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT. |
| Q43028486 | Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy |
| Q47194833 | Impact of regurgitant orifice height for mechanism of aortic regurgitation |
| Q83461319 | Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS |
| Q99623481 | Impact of the Arterial Input Sampling Location on CMR First-Pass Myocardial Perfusion Quantification |
| Q90040197 | Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events: A PROSPECT Substudy |
| Q83636987 | Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria |
| Q83863102 | Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers |
| Q91465458 | Impaired Cardiac Reserve and Abnormal Vascular Load Limit Exercise Capacity in Chronic Thromboembolic Disease |
| Q46198245 | Impaired RV global longitudinal strain is associated with poor long-term clinical outcomes in patients with acute inferior STEMI. |
| Q50725657 | Impaired Right Heart and Pulmonary Vascular Function in HFpEF: Time for More Risk Markers? |
| Q46637942 | Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification. |
| Q30415445 | Impaired resting myocardial annular velocities are independently associated with mental stress-induced ischemia in coronary heart disease |
| Q89125761 | Imperfect Data Can Still Provide Important Answers |
| Q103042426 | Implementing Coronary Computed Tomography Angiography in the Catheterization Laboratory |
| Q45026880 | Implementing Multimodality Imaging in the Future |
| Q88558453 | Implementing Quality Control of LV Longitudinal Strain Measurement |
| Q47746154 | Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis |
| Q90554240 | Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis |
| Q102319410 | Implications of the Plaque Density Paradox for Risk Assessment in 2020 |
| Q49896857 | Importance of Sex-Specific Regression Models to Estimate Synthetic Hematocrit and Extracellular Volume Fraction. |
| Q82428330 | Important Echocardiographic Features of Takotsubo or Stress-Induced Cardiomyopathy That Can Aid Early Diagnosis |
| Q89380880 | Improved Detection by Delayed-Enhancement CMR of LV Thrombus Post-MI: Is This the Answer to Stroke Prevention? |
| Q94953576 | Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? |
| Q44489954 | Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. |
| Q83661544 | Improved prospects for IVUS in identifying vulnerable plaques? |
| Q92411365 | Improvement in the Assessment of Aortic Valve and Aortic Aneurysm Repair by 3-Dimensional Echocardiography |
| Q47242963 | Improving Plaque Classification With Optical Coherence Tomography |
| Q92771038 | Improving Prognostic Accuracy of Myocardial Perfusion Imaging With Quantitative Assessment |
| Q57058594 | Improving Risk Stratification by Cardiac Magnetic Resonance Imaging in Heart Failure: Is Strain the Missing Link? |
| Q46673465 | Improving the CAC Score by Addition of Regional Measures of Calcium Distribution: Multi-Ethnic Study of Atherosclerosis |
| Q90857307 | In Search of a Less Invasive Approach to Cardiac Tumor Diagnosis: Multimodality Imaging Assessment and Biopsy |
| Q101137746 | In Search of the Holy Grail: Evidence of Amyloid Fibril Regression in ATTR Cardiac Amyloidosis |
| Q52986285 | In Sickness and in Health: Coronary Artery Calcium or Risk Factors. |
| Q53117022 | In Vivo Calcium Detection by Comparing Optical Coherence Tomography, Intravascular Ultrasound, and Angiography. |
| Q51630629 | In Vivo Imaging of Hypoxia in Atherosclerotic Plaques in Humans. |
| Q46523414 | In hot blood: quantifying the arterial input function |
| Q53520605 | In pursuit of the holy grail. |
| Q92411424 | In the Heart of Stiffness: Are Natural Heart Vibrations Reliable Enough to Assess Myocardial Stiffness, The New Holy Grail in Echocardiography? |
| Q87703077 | In the footsteps of Virchow |
| Q84182457 | In vivo assessment of high-risk coronary plaques at bifurcations with combined intravascular ultrasound and optical coherence tomography |
| Q37311902 | In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques |
| Q30539291 | In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium |
| Q45753902 | In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study |
| Q50696816 | In-line automated tracking for ventricular function with magnetic resonance imaging. |
| Q39065590 | Incidence, Predictors, and Mid-Term Outcomes of Possible Leaflet Thrombosis After TAVR. |
| Q38993493 | Incidental LV LGE on CMR Imaging in Atrial Fibrillation Predicts Recurrence After Ablation Therapy. |
| Q88333101 | Incorporating Coronary Artery Calcium Into Global Risk Scoring |
| Q88168506 | Increased Flow, Dam Walls, and Upstream Pressure: The Physiological Challenges and Atrial Consequences of Intense Exercise |
| Q87841442 | Increased Iron Deposition Is Directly Associated With Myocardial Dysfunction in Patients With Sickle Cell Disease |
| Q87841461 | Increased Lipid Length, Macrophage Infiltration, and Neovascularization in Coronary Atheroma From Patients With Chronic Kidney Disease |
| Q57815523 | Increased Myocardial Stiffness Detected by Intrinsic Cardiac Elastography in Patients With Amyloidosis: Impact on Outcomes |
| Q30300980 | Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone |
| Q33703129 | Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging |
| Q34674525 | Increased pericardial fat volume measured from noncontrast CT predicts myocardial ischemia by SPECT. |
| Q43275228 | Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. |
| Q49896790 | Incremental Benefit of CT Perfusion to CT Coronary Angiography: Another Step to the One-Stop-Shop? |
| Q48517590 | Incremental Diagnostic Value of Left Atrial Strain Over Left Atrial Volume: An Analogy of Glucose Level and Glycosylated Hemoglobin? |
| Q49896762 | Incremental Diagnostic Value of Stress Computed Tomography Myocardial Perfusion With Whole-Heart Coverage CT Scanner in Intermediate- to High-Risk Symptomatic Patients Suspected of Coronary Artery Disease. |
| Q93192415 | Incremental Predictive Value of Left Atrial Parameters Over Clinical Risk Scores for Subsequent Atrial Fibrillation: Function Beyond Size |
| Q88333118 | Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Asymptomatic Patients With Significant Chronic Aortic Regurgitation and Preserved Left Ventricular Ejection Fraction |
| Q90384155 | Incremental Prognostic Value of Myocardial Blood Flow Quantified With Stress Dynamic Computed Tomography Perfusion Imaging |
| Q53114477 | Incremental Prognostic Value of Stress Echocardiography With Carotid Ultrasound for Suspected CAD. |
| Q98629436 | Incremental Value of 3D Printing in the Preoperative Planning of Complex Congenital Heart Disease Surgery |
| Q47557435 | Incremental Value of Subtended Myocardial Mass for Identifying FFR-Verified Ischemia Using Quantitative CT Angiography: Comparison With Quantitative Coronary Angiography and CT-FFR. |
| Q44793525 | Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction |
| Q53035742 | Incremental prognostic value of estimated LV end-diastolic volume by cardiac CT. |
| Q37637823 | Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF |
| Q60461352 | Independent Impact of RV Involvement on In-Hospital Outcome of Patients With Takotsubo Syndrome |
| Q88430449 | Index of Microcirculatory Resistance and Infarct Size |
| Q58008962 | Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI |
| Q43032147 | Indexes of subclinical atherosclerosis: signposts on the highway to disease |
| Q84377393 | Indications for TEE before cardioversion for atrial fibrillation: implications for appropriateness criteria |
| Q90566500 | Individualized Patient Risk Stratification Using Machine Learning and Topological Data Analysis |
| Q49896713 | Infective Endocarditis After Bentall Surgery: Usefulness of New Imaging Modalities and Outcomes |
| Q99623498 | Inferior Fragmented QRS as a New Predictor of Ventricular Arrhythmias in Patients With Nonischemic Cardiomyopathy |
| Q43963176 | Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease |
| Q42400208 | Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X. |
| Q53492944 | Inflammatory Burden Is Related to an Early Reduction of LV Functional Reserve in Psoriatic Arthritis. |
| Q99575277 | Inflammatory Episodes of Desmoplakin Cardiomyopathy Masquerading as Myocarditis: Unique Features on Cardiac Magnetic Resonance Imaging |
| Q60637194 | Influence of Aortic Dilation on the Regional Aortic Stiffness of Bicuspid Aortic Valve Assessed by 4-Dimensional Flow Cardiac Magnetic Resonance |
| Q102319427 | Influence of Coronary Artery Calcium Score on Computed Tomography-Derived Fractional Flow Reserve: A Meta-Analysis |
| Q50617747 | Influence of Coronary Artery Diameter on Intracoronary Transluminal Attenuation Gradient During CT Angiography. |
| Q52991457 | Influence of Coronary Calcification on the Diagnostic Performance of CT Angiography Derived FFR in Coronary Artery Disease: A Substudy of the NXT Trial. |
| Q92676946 | Influence of Coronary Calcium on Diagnostic Performance of Machine Learning CT-FFR: Results From MACHINE Registry |
| Q64927306 | Influence of Myocardial Hemorrhage on Staging of Reperfused Myocardial Infarctions With T2 Cardiac Magnetic Resonance Imaging: Insights Into the Dependence on Infarction Type With Ex Vivo Validation. |
| Q43260666 | Influence of abnormal glucose metabolism on coronary microvascular function after a recent myocardial infarction |
| Q84560919 | Influence of atrial function and mechanical synchrony on LV hemodynamic status in heart failure patients on resynchronization therapy |
| Q47315998 | Influence of chronic tethering of the mitral valve on mitral leaflet size and coaptation in functional mitral regurgitation. |
| Q85445684 | Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure |
| Q42215956 | Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry |
| Q56774601 | Informed consent and AUC: bare it all... |
| Q92676881 | Inline Quantitative Myocardial Perfusion by CMR: Coming Online Soon? |
| Q97565968 | Innovative Transthoracic Echocardiographic Imaging on Prone Ventilated Patients With COVID-19 Using a Transesophageal Probe |
| Q30457469 | Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study. |
| Q92569253 | Insight Obtained From Instantaneous Left Ventricular Wall Stress |
| Q93192409 | Insights From Autopsies: Potential Role of Thrombus in Structural Valve Deterioration |
| Q101137752 | Insufficient Mitral Leaflet Remodeling in Relation to Annular Dilation and Risk of Residual Mitral Regurgitation After MitraClip Implantation |
| Q43455656 | Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial |
| Q87578754 | Integrated 3D Echo-X-Ray navigation to predict optimal angiographic deployment projections for TAVR |
| Q53291368 | Integrated 3D echo-x ray to optimize image guidance for structural heart intervention. |
| Q30421946 | Integrated IVUS-OCT for real-time imaging of coronary atherosclerosis |
| Q43243354 | Integrated assessment of diastolic and systolic ventricular function using diagnostic cardiac magnetic resonance catheterization: validation in pigs and application in a clinical pilot study |
| Q52954439 | Integrating CT Myocardial Perfusion and CT-FFR in the Work-Up of Coronary Artery Disease. |
| Q91123636 | Integrating Patient-Specific Information in the Noninvasive Quest for the Vulnerable Patient |
| Q39629831 | Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity |
| Q43124991 | Integration of CMR scar imaging and electroanatomic mapping: the future of VT ablation? |
| Q38932987 | Integration of Flow-Gradient Patterns Into Clinical Decision Making for Patients With Suspected Severe Aortic Stenosis and Preserved LVEF: A Systematic Review of Evidence and Meta-Analysis |
| Q83629423 | Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography |
| Q38162539 | Intelligent platforms for disease assessment: novel approaches in functional echocardiography |
| Q44179327 | Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population |
| Q38632204 | Interobserver Agreement of the Echocardiographic Diagnosis of LV Hypertrabeculation/Noncompaction |
| Q90566397 | Interpatient Similarities in Cardiac Function: A Platform for Personalized Cardiovascular Medicine |
| Q91307405 | Interplay of Coronary Artery Calcium and Risk Factors for Predicting CVD/CHD Mortality: The CAC Consortium |
| Q86581102 | Interval from the onset of transmitral flow to annular velocity is a marker of LV filling pressure |
| Q48554412 | Intervendor Differences in the Accuracy of Detecting Regional Functional Abnormalities: A Report From the EACVI-ASE Strain Standardization Task Force |
| Q50064009 | Intervention Versus Observation in Symptomatic Patients With Normal Flow-Low Gradient Severe Aortic Stenosis |
| Q84893623 | Interventional CMR: great promise, but a long road ahead |
| Q47667865 | Interventional Correction of Sinus Venosus Atrial Septal Defect and Partial Anomalous Pulmonary Venous Drainage: Procedural Planning Using 3D Printed Models. |
| Q30478948 | Interventional cardiovascular magnetic resonance imaging: a new opportunity for image-guided interventions. |
| Q58867566 | Intra-Aortic Balloon Pump Optimizes Myocardial Function During Cardiogenic Shock |
| Q48505887 | Intra-Atrial Dyssynchrony During Sinus Rhythm Predicts Recurrence After the First Catheter Ablation for Atrial Fibrillation |
| Q58814936 | Intracardiac Echocardiographic Detection of Mobile Echodensities Adherent to the Intracardiac Leads |
| Q54545586 | Intracardiac echo and reduced radiocontrast requirements during TAVR. |
| Q53091495 | Intracoronary transluminal attenuation gradient in coronary CT angiography for determining coronary artery stenosis. |
| Q49721053 | Intraluminal Assessment of Coronary Arteries With Ferumoxytol-Enhanced Magnetic Resonance Angiography. |
| Q88114540 | Intramural Course of Coronary Arteries: A Bridge Too Far No More |
| Q46011758 | Intraoperative fluorescence imaging system for on-site assessment of off-pump coronary artery bypass graft. |
| Q92770993 | Intraplaque Hemorrhage as a Marker of Stroke Risk |
| Q59516038 | Intraplaque Hemorrhage as a Stimulator of Episodic Growth of Advanced, But Nonsymptomatic Atherosclerotic Lesions |
| Q51299872 | Intraplaque hemorrhage, RBC-derived cholesterol, and plaque progression: time to move from conjecture to evidence? |
| Q84811070 | Intraplaque hemorrhage: most dangerous is the wound that bleedeth inwardly… |
| Q92203164 | Intraprocedural Imaging of Transcatheter Tricuspid Valve Interventions |
| Q53001862 | Intraprocedural TAVR Annulus Sizing Using 3D TEE and the "Turnaround Rule". |
| Q53720210 | Intravascular Assessment of Arterial Disease Using Compensated OCT in Comparison With Histology. |
| Q50138518 | Intravascular Optical Molecular Imaging of a Macrophage Subset Within Intraplaque Hemorrhages. |
| Q92676909 | Intravascular Polarimetry in Patients With Coronary Artery Disease |
| Q84730986 | Intravascular and extravascular microvessel formation in chronic total occlusions a micro-CT imaging study |
| Q38424945 | Intravascular imaging of coronary calcification and its clinical implications |
| Q26852822 | Intravascular optical imaging technology for investigating the coronary artery |
| Q46098624 | Intravascular ultrasound tissue characterization: messages from the heart |
| Q43175078 | Introduction of new tests: low are the mountains, high the expectations |
| Q53360203 | Invasive versus noninvasive evaluation of coronary artery disease. |
| Q52982115 | Investigating Patients for CAD Before Cardiac Valve Surgery: Is CT Angiography Enough? |
| Q41534056 | In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. |
| Q83200593 | Iodine-123 mIBG Imaging for Predicting the Development of Atrial Fibrillation |
| Q42334386 | Is Biventricular Fibrosis the Mediator of Late Complications in Tetralogy of Fallot? |
| Q53311239 | Is CT the better angiogram? Coronary interventions and CT imaging. |
| Q95561376 | Is Echocardiography Adequate to Identify the Severity of Anomalous Coronary Arteries? |
| Q88558449 | Is FFRCT Ready to Assume the Crown Jewels of Invasive FFR? |
| Q48511976 | Is Global Longitudinal Strain a Superior Parameter for Predicting Outcome After Myocardial Infarction? |
| Q95561373 | Is Global Longitudinal Strain a Superior Predictor of Outcomes in HFrEF? |
| Q62646747 | Is Myocardial Native T1 the One Answer for All?∗ |
| Q91406548 | Is Negative Coronary CT Angiogram a No Cardiovascular Event Warranty Over 10 Years? |
| Q91170712 | Is Older Age Truly a Predictor of SVD? |
| Q57785925 | Is Qualitative Cardiac Perfusion MRI “Good Enough”? ∗ |
| Q58394405 | Is Quantitation a Good Value? |
| Q47659674 | Is Seeing The Same As Knowing: The Dilemma of Imaging |
| Q91123607 | Is T1 Mapping Ready for Rejection Surveillance After Heart Transplantation? |
| Q53223878 | Is TAG a Technical Imaging Bias, a Misunderstanding, or Another Facet of Multifaceted Coronary Physiology? |
| Q88088182 | Is There Added Value of the Third Imaging Dimension in Cardio-Oncology? |
| Q46070625 | Is There More to the Calcium Scan Than Just Coronary Calcium? |
| Q92047603 | Is a Picture Worth a Thousand Guidelines? |
| Q82917107 | Is cardiac autonomic neuropathy the basis of nonischemic diabetic cardiomyopathy? |
| Q86141394 | Is cardiac hypertrophy good or bad? The answer, of course, is yes |
| Q44562449 | Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? |
| Q45008200 | Is it T1me for tissue characterization in myocarditis? |
| Q59076612 | Is it Time for a New Paradigm in Calcific Aortic Valve Disease?⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American Coll |
| Q89157158 | Is it Time to Look Beyond the Valve and Ventricular Function for Assessing Patients With Aortic Stenosis? |
| Q33852156 | Is low CACs really different from zero…: a report from the CACTI study |
| Q83179381 | Is mechanical dispersion a raven of ventricular arrhythmias? |
| Q84748265 | Is myocardial perfusion imaging an important predictor of mortality in women and if so, is this likely cost effective? |
| Q86718894 | Is new grade Ia of diastolic dysfunction relevant at the population level? |
| Q86546924 | Is one better than two?: T1 mapping in myocarditis |
| Q87331792 | Is the Heart Really Stressed Out of Energy? |
| Q91894952 | Is the Majority Benefitting at the Costs of the Minority Among Patients Undergoing CTA as the First-Line Diagnostic in Highly Suspected Coronary Artery Disease? |
| Q45738521 | Is the inferior vena cava really superior? |
| Q83629562 | Is the magnet a better crystal ball for predicting response to cardiac resynchronization therapy? |
| Q49191871 | Is viability imaging still relevant in 2012? |
| Q99575276 | Ischemia and Infarction in Isolated Chronic Total Coronary Artery Occlusion Assessed by Cardiovascular Magnetic Resonance |
| Q89455913 | Ischemia and Viability Testing in Ischemic Heart Disease: The Available Evidence and How We Interpret It |
| Q84567934 | Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction |
| Q50682932 | Ischemic Heart Disease in Women: A Need for Sex-Specific Diagnostic Algorithms. |
| Q97589593 | Ischemic Myocardial Burden Subtended by Computed Tomography-Derived Fractional Flow Reserve (APPROACHFFRCT): An Exploratory Analysis on Diagnostic Performance |
| Q50973503 | Ischemic episode and hanging on to a painful memory... |
| Q45000352 | Ischemic mitral regurgitation: in search of the culprit |
| Q86718882 | It is all about timing! |
| Q51139045 | Iterative reconstruction to preserve image quality and diagnostic accuracy at reduced radiation dose in coronary CT angiography: an intraindividual comparison. |
| Q52604077 | JACC: Cardiovascular Imaging 2.0: The Next Decade in Digital. |
| Q93129801 | Journal Editors and Altmetrics: Moth to the Flame? |
| Q38566209 | Journey in evolution of nuclear cardiology: will there be another quantum leap with the F-18-labeled myocardial perfusion tracers? |
| Q54324539 | Juxta-Lesional Cavitary Formation in Coronary Intervention: Imaginary, Incidental, or Iatrogenic? |
| Q86718900 | Keeping off the wrong track on the right side: planning for transcatheter caval valve implantation |
| Q92747756 | LA Mechanics in Decompensated Heart Failure: Insights From Strain Echocardiography With Invasive Hemodynamics |
| Q39065881 | LA Phasic Volumes and Reservoir Function in the Elderly by Real-Time 3-D Echocardiography: Normal Values, Prognostic Significance, and Clinical Correlates |
| Q47324267 | LA Size in Former Elite Athletes |
| Q48582186 | LA Strain When Ejection Fraction Is Preserved: A New Measure of Diastolic Function? |
| Q38778250 | LA Strain for Categorization of LV Diastolic Dysfunction |
| Q87668467 | LA emptying fraction improves diagnosis of paroxysmal AF after cryptogenic ischemic stroke: results from the SURPRISE study |
| Q54737966 | LA volume by CMR distinguishes idiopathic from pulmonary hypertension due to HFpEF. |
| Q36693486 | LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study |
| Q46064905 | LAD coronary artery myocardial bridging and apical ballooning syndrome. |
| Q61913838 | LBBB and High Afterload |
| Q87985685 | LGE Means Better Selection of HCM Patients for Primary Prevention Implantable Defibrillators |
| Q53095077 | LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis. |
| Q48782797 | LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs. |
| Q84567949 | LGE and the risk of sudden death in HCM |
| Q98186776 | LGE for Risk Stratification in Primary Prevention in Children With HCM |
| Q86249272 | LGE patterns in pulmonary hypertension do not impact overall mortality |
| Q96615827 | LV Global Function Index Provides Incremental Prognostic Value Over LGE and LV GLS in HCM |
| Q38653274 | LV Mass Independently Predicts Mortality and Need for Future Revascularization in Patients Undergoing Diagnostic Coronary Angiography |
| Q41440898 | LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes |
| Q54464287 | LV Noncompaction Cardiomyopathy or Just a Lot of Trabeculations? |
| Q87286672 | LV Noncompaction in Ebstein's anomaly in infants and outcomes |
| Q30451602 | LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice |
| Q83863079 | LV mechanical dyssynchrony in heart failure with preserved ejection fraction complicating acute coronary syndrome |
| Q38280389 | LV mechanics in mitral and aortic valve diseases: value of functional assessment beyond ejection fraction |
| Q46066492 | LV outflow tract area in discrete subaortic stenosis and hypertrophic obstructive cardiomyopathy: a real-time 3-dimensional transesophageal echocardiography study |
| Q84567953 | LV segmentation and mechanics in HCM: twisting the Rubik's Cube into perfection! |
| Q37047155 | LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. |
| Q47892299 | LVH and CAD: New Steps Down an Old Path |
| Q82917154 | La septal pouch as a source of thromboembolism: innocent until proven guilty? |
| Q102319449 | Label-Free Visualization and Quantification of Biochemical Markers of Atherosclerotic Plaque Progression Using Intravascular Fluorescence Lifetime |
| Q87701444 | Lack of Stroke Volume Determined Flow Reserve Does Not Always Preclude Assessment of Severity of Aortic Stenosis in Low-Flow Low-Gradient State During Dobutamine Echocardiography |
| Q85195422 | Large LV Aneurysm and Multiple Diverticula in a Patient With Normal Coronary Arteries: Another Form of Cardiomyopathy? |
| Q36672304 | Late gadolinium enhancement among survivors of sudden cardiac arrest |
| Q84948087 | Late loss: should we lose it? |
| Q44363966 | Layer-specific quantification of myocardial deformation by strain echocardiography may reveal significant CAD in patients with non-ST-segment elevation acute coronary syndrome |
| Q50781649 | Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT. |
| Q53243871 | Lead aVR: dead or simply forgotten? |
| Q62597283 | Leaflet Thrombosis in Surgically Explanted or Post-Mortem TAVR Valves |
| Q53074206 | Leaning heavily on PET myocardial perfusion for prognosis. |
| Q50655923 | Learning from our European imaging colleagues. |
| Q92770962 | Left Atrial Appendage Morphology Is Associated With Cryptogenic Stroke: A CTA Study |
| Q92411450 | Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis |
| Q90040148 | Left Atrial Dynamics in Mitral Regurgitation: When Exercise Runs to the (Left Atrial) Buffers |
| Q89281520 | Left Atrial Function Dynamics During Exercise in Heart Failure: Pathophysiological Implications on the Right Heart and Exercise Ventilation Inefficiency |
| Q36552403 | Left Atrial LGE and Arrhythmia Recurrence Following Pulmonary Vein Isolation for Paroxysmal and Persistent AF. |
| Q96615842 | Left Atrial Late Gadolinium Enhancement is Associated With Incident Atrial Fibrillation as Detected by Continuous Monitoring With Implantable Loop Recorders |
| Q90040124 | Left Atrial Mechanical Function and Incident Ischemic Cerebrovascular Events Independent of AF: Insights From the MESA Study |
| Q90566447 | Left Atrial Reservoir and Booster Function in HFrEF: Implications for Diastolic Function |
| Q39068819 | Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance. |
| Q98629443 | Left Atrial Strain Impairment Precedes Geometric Remodeling as a Marker of Post-Myocardial Infarction Diastolic Dysfunction |
| Q98282926 | Left Atrial Strain Measurement: A New Normal for Diastolic Assessment? |
| Q91123577 | Left Atrial Strain Performance and its Application in Clinical Practice |
| Q98629437 | Left Atrial Strain Predicts Heart Failure and Cardiovascular Death in Patients Undergoing Coronary Artery Bypass Grafting |
| Q100431011 | Left Atrial Strain and Subclinical Cerebrovascular Disease in Older Adults |
| Q97589592 | Left Atrial Strain as a Predictor of New-Onset Atrial Fibrillation in Patients With Heart Failure |
| Q49887204 | Left Atrial Strain to Address the Cryptogenic Puzzle |
| Q100502934 | Left Atrial Strain: Part of the Solution to Taming the Vicious Twins |
| Q38533120 | Left Atrium Size in Elite Athletes |
| Q90080795 | Left Bundle Branch Block and Dyssynchrony in CRT Response: Does it Take Two to Tango? |
| Q92411445 | Left Ventricular Contractility and Wall Stress in Patients With Aortic Stenosis With Preserved or Reduced Ejection Fraction |
| Q93080592 | Left Ventricular Diastolic Function: Understanding Pathophysiology, Diagnosis, and Prognosis With Echocardiography |
| Q49896753 | Left Ventricular Dysfunction and Exercise Capacity Trajectory: Implications for Subclinical Heart Failure Staging Criteria |
| Q91123572 | Left Ventricular Dyssynchrony and the Mitral Valve Apparatus: An Orchestra That Needs to Play in Sync |
| Q91123628 | Left Ventricular Dyssynchrony: Prognostic Marker or Disease Mechanism? |
| Q90857295 | Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low? |
| Q91018911 | Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention |
| Q38721108 | Left Ventricular Geometry Determines Prognosis and Reverse J-Shaped Relation Between Blood Pressure and Mortality in Ischemic Stroke Patients |
| Q49086066 | Left Ventricular Geometry, Blood Pressure, Arterial Hemodynamics, and Mortality After Ischemic Stroke |
| Q96615836 | Left Ventricular Global and Regional Deformation in Arrhythmic Myxomatous Bileaflet Mitral Valve Prolapse Syndrome |
| Q88006091 | Left Ventricular Hypertrophy Diagnosed on ECG Also Predicts Early Mortality After Stroke |
| Q92747853 | Left Ventricular Intramyocardial Fat Detected on Cardiac Computed Tomography in Patients With Stable Chest Pain |
| Q53072335 | Left Ventricular Longitudinal Strain and Strain Rate Values According to Sex and Classifications of Sports in the Young University Athletes Who Participated in the 2015 Gwangju Summer Universiade. |
| Q102319408 | Left Ventricular Mass-To-Strain Ratio Predicts Cardiac Amyloid Subtype |
| Q57743949 | Left Ventricular Noncompaction |
| Q90040144 | Left Ventricular Noncompaction: Meglio solo che mal accompagnati: Italian proverb: "Better Alone Than in Bad Company" |
| Q90566469 | Left Ventricular Remodeling After Transcatheter Versus Surgical Therapy in Adults With Coarctation of Aorta |
| Q92770922 | Left Ventricular Remodeling Is No Longer a Relevant Outcome After Myocardial Infarction |
| Q91123676 | Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction Patients With Depressed Left Ventricular Ejection Fraction After Cardiac Rehabilitation |
| Q91647705 | Left Ventricular Spherical Index Is an Independent Predictor for Clinical Outcomes in Patients With Nonischemic Dilated Cardiomyopathy |
| Q99575279 | Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery |
| Q90040162 | Left Ventricular Systolic Function and Outcome in Aortic Stenosis: The Long- and Short-Axis of it |
| Q83863095 | Left atrial emptying reserve: a mirror of LV diastolic function that predicts prognosis? |
| Q53196882 | Left atrial function and mortality in patients with NSTEMI an MDCT study. |
| Q87482683 | Left atrial function in mitral regurgitation: guilt by association |
| Q37637819 | Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia |
| Q87883225 | Left atrial volumes: should we reset the reference standard? |
| Q84392184 | Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease:the Dallas Heart Study |
| Q50681460 | Left ventricular mechanical dyssynchrony in acute onset cardiomyopathy: association of its resolution with improvements in ventricular function. |
| Q37828258 | Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. |
| Q37482656 | Left ventricular torsion: an expanding role in the analysis of myocardial dysfunction |
| Q48848239 | Left ventricular untwisting is an important determinant of early diastolic function |
| Q49135794 | Leg Lifting in HFrEF, Frank-Starling, and Mitral Regurgitation |
| Q43442408 | Leg lifts to assess atrial function: ready for clinical use in HFpEF? |
| Q50134296 | Lesion-Specific and Vessel-Related Determinants of Fractional Flow Reserve Beyond Coronary Artery Stenosis |
| Q85616556 | Less Is More, More the Merrier, or More From Less? |
| Q90566490 | Less Means More: Right Atrial Pacing in Cardiac Resynchronization Therapy |
| Q46056348 | Lessons from the development of new adenosine A2A receptor agonists |
| Q88088197 | Let's Join Them! |
| Q50057854 | Leveraging Mobile Technology to Reduce Resource-Related Health Care Disparities: Challenges and Opportunities. |
| Q30573314 | Libman-Sacks endocarditis and embolic cerebrovascular disease. |
| Q98230860 | Life Interrupted: On the Front Lines With COVID-19 |
| Q102319442 | Limb Perfusion Imaging in Peripheral Artery Disease |
| Q30439764 | Limb stress-rest perfusion imaging with contrast ultrasound for the assessment of peripheral arterial disease severity |
| Q34810668 | Linking pediatric obesity to subclinical alterations in cardiac structure and function |
| Q56986501 | Lipid-Rich Obstructive Coronary Lesions |
| Q85913027 | Lipid-rich versus fibrous intimal hyperplasia in transplant vasculopathy |
| Q89125738 | Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia |
| Q43109174 | Lipoprotein-associated phospholipase A2 and aortic stenosis: biomarker or new target for an old foe? |
| Q45747871 | Live 3D echocardiography to guide closure of residual ASD. |
| Q47844519 | Liver Stiffness Reflecting Right-Sided Filling Pressure Can Predict Adverse Outcomes in Patients With Heart Failure |
| Q38964689 | Localization of Coronary High-Intensity Signals on T1-Weighted MR Imaging: Relation to Plaque Morphology and Clinical Severity of Angina Pectoris |
| Q46102225 | Localization of ventricular tachycardia exit site and subsequent contraction sequence and functional effects with bedside radionuclide angiography |
| Q43884944 | Localizing mitral valve perforations with 3D transesophageal echocardiography |
| Q83636995 | Location of thrombus in atrial fibrillation |
| Q104504896 | Long Journey of Intravascular Imaging: What and How to Look at the Atheroma in Coronary Artery |
| Q91730611 | Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake |
| Q90040225 | Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000: Results From the CAC Consortium |
| Q41118322 | Long-Term Clinical Impact of Coronary CT Angiography in Patients With Recent Acute-Onset Chest Pain: The Randomized Controlled CATCH Trial |
| Q48576184 | Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI. |
| Q89728088 | Long-Term LV Characterization Using CMR in Patients With Spontaneous Coronary Artery Dissection |
| Q54505444 | Long-Term Outcome After CRT in the Presence of Mechanical Dyssynchrony Seen With Chronic RV Pacing or Intrinsic LBBB. |
| Q90384160 | Long-Term Outcome of Active Surveillance in Severe But Asymptomatic Primary Mitral Regurgitation |
| Q88430426 | Long-Term Outcome of Patients With Low/Intermediate Risk Myocarditis Is Related to the Presence of Left Ventricular Remodeling in Addition to the MRI Pattern of Delayed Gadolinium Enhancement |
| Q91647717 | Long-Term Outcomes After Aortic Valve Surgery in Patients With Asymptomatic Chronic Aortic Regurgitation and Preserved LVEF: Impact of Baseline and Follow-Up Global Longitudinal Strain |
| Q103042409 | Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance |
| Q54129599 | Long-Term Prognosis of Patients With Intramural Course of Coronary Arteries Assessed With CT Angiography. |
| Q59843519 | Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction |
| Q39446673 | Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus |
| Q39378171 | Long-Term Prognostic Value of Coronary CT Angiography in Asymptomatic Type 2 Diabetes Mellitus |
| Q49887165 | Long-Term Structural Integrity and Durability of the Medtronic CoreValve System After Transcatheter Aortic Valve Replacement. |
| Q39065583 | Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial |
| Q53494733 | Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation. |
| Q45889383 | Long-term prognostic value of dobutamine stress CMR. |
| Q92038069 | Longitudinal Assessment of Cardiac Involvement in Fabry Disease Using Cardiovascular Magnetic Resonance Imaging |
| Q40279603 | Longitudinal Changes in LV Structure and Diastolic Function in Relation to Arterial Properties in General Population. |
| Q86691933 | Longitudinal Strain and Type 1 Diabetes Mellitus: Are We on the Wrong Track? |
| Q86940728 | Longitudinal Strain as Risk Factor for Outcome in Pediatric Dilated Cardiomyopathy |
| Q48636824 | Longitudinal Strain: "Think Globally, Track Locally". |
| Q44079627 | Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes |
| Q89210667 | Look Backwards But Live Forwards |
| Q51558256 | Look Before You Leap: Optimizing Outcomes of Atrial Fibrillation Ablation. |
| Q90948537 | Looking Beyond the Valve: Myocardial Dysfunction in Aortic Stenosis |
| Q83629561 | Looking into the vessel: the more you see, the more you want to see |
| Q89432551 | Losing Track by Tracking Speckles |
| Q43759338 | Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: evaluation by color M-mode echocardiography. |
| Q93192393 | Low Gradient Aortic Stenosis: Who Benefits From Intervention? |
| Q92176428 | Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis |
| Q53078539 | Low Transvalvular Flow Rate Predicts Mortality in Patients With Low-Gradient Aortic Stenosis Following Aortic Valve Intervention. |
| Q88742600 | Low Transvalvular Flow and Prognosis in the SEAS Trial |
| Q56774604 | Low quality and lack of clarity of current informed consent forms in cardiology: how to improve them |
| Q37100862 | Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease |
| Q47630701 | Low-Gradient Aortic Stenosis: Are We Getting Closer to Solving a Diagnostic and Therapeutic Dilemma? |
| Q34623958 | Low-dose dual-source CT angiography with iterative reconstruction for coronary artery stent evaluation |
| Q45938247 | Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. |
| Q33577638 | Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? |
| Q99575272 | Lower Cardiorespiratory Fitness Is Associated With a Smaller and Stiffer Heart: The Sedentary's Heart |
| Q92038056 | Lower Ischemic Heart Disease Diagnostic Costs With Treadmill Stress CMR vs. SPECT: A Multicenter, Randomized Trial |
| Q50505941 | Lower Transaortic Flow Rate Is Associated With Increased Mortality in Aortic Valve Stenosis. |
| Q86122458 | Lumen Measurements From Quantitative Coronary Angiography and IVUS: A PROSPECT Substudy |
| Q92676986 | Lung Ultrasound During Stress Echocardiography Aids the Evaluation of Valvular Heart Disease Severity |
| Q97589591 | Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography |
| Q58564597 | Lung Ultrasound for the Cardiologist |
| Q45942268 | Lung cancer screening CT-based prediction of cardiovascular events. |
| Q43505109 | Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography |
| Q53337621 | MDCT assessment of mechanical circulatory support device complications. |
| Q87843436 | MDCT for Cardiovascular Evaluation: Are There 2 "One-Stop Shops"? |
| Q44239497 | MDCT in TAVR for better implant angle and outcomes |
| Q82919191 | MR Imaging and Cardiac Amyloidosis Where to Go From Here? |
| Q38769372 | MR Imaging of Coronary Arteries and Plaques |
| Q88464447 | MR Quantification of Plaque Lipid Content: T2 Mapping Added to the Armamentarium |
| Q30355301 | MR and CT Imaging for the Evaluation of Pulmonary Hypertension |
| Q30417972 | MR cine DENSE dyssynchrony parameters for the evaluation of heart failure: comparison with myocardial tissue tagging |
| Q51618667 | MR imaging in patients with pacemakers and other devices: engineering the future. |
| Q36800049 | MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course |
| Q42578659 | MR imaging-verified plaque delipidation with lipid-lowering therapy important questions remain |
| Q36182417 | MR molecular imaging of aortic angiogenesis. |
| Q84811067 | MR scar imaging and intraprocedural registration into an electroanatomic mapping system in post-MI patients |
| Q45390420 | MR spectroscopy of cholesteryl ester in human atherosclerosis |
| Q46006079 | MR/PET Imaging of the Cardiovascular System. |
| Q39320113 | MRI-Derived Myocardial Strain Measures in Normal Subjects |
| Q52985179 | MSCT Identification of Vulnerable Plaque. |
| Q101137750 | Machine Learning Adds to Clinical and CAC Assessments in Predicting 10-Year CHD and CVD Deaths |
| Q92411297 | Machine Learning Using CT-FFR Predicts Proximal Atherosclerotic Plaque Formation Associated With LAD Myocardial Bridging |
| Q90554156 | Machine Learning for Data-Driven Discovery: The Rise and Relevance |
| Q103042322 | Machine Learning for Ischemia Prediction in CTA: Perspective Toward the Noninvasive One-Stop Shop for Stable CAD? |
| Q91307432 | Machine Learning for Pretest Probability of Obstructive Coronary Stenosis in Symptomatic Patients |
| Q91307419 | Machine Learning in Medical Imaging: All Journeys Begin With a Single Step |
| Q90202247 | Machine-Learning CT-FFR and Extensive Coronary Calcium: Overcoming the Achilles Heel of Coronary Computed Tomography Angiography |
| Q30436299 | Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis |
| Q34979629 | Macrophages and intravascular OCT bright spots: a quantitative study. |
| Q37642641 | Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study |
| Q91647757 | Magnetic Resonance Imaging of Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction: Ready for Prime Time? |
| Q103042442 | Magnetic Resonance Mapping of Catheter Ablation Lesions After Post-Infarction Ventricular Tachycardia Ablation |
| Q89432564 | Magnetic Resonance Perfusion Imaging to Guide Management of Patients With Stable Ischemic Heart Disease |
| Q94545826 | Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? |
| Q37474978 | Magnetic [corrected] resonance imaging [corrected] features of the disruption-prone and the disrupted carotid plaque |
| Q44326047 | Magnetic resonance adenosine perfusion imaging in patients after coronary artery bypass graft surgery |
| Q83629649 | Magnetic resonance assessment of pulmonary artery compliance: a promising diagnostic and prognostic tool in pulmonary hypertension? |
| Q46056315 | Magnetic resonance cardiac vein imaging: relation to mitral valve annulus and left circumflex coronary artery |
| Q82552440 | Magnetic resonance imaging in cardiac amyloidosis |
| Q42789579 | Magnetic resonance labeling of stem cells: is positive tracking a plus or a minus? |
| Q36759533 | Magnetic resonance measurement of turbulent kinetic energy for the estimation of irreversible pressure loss in aortic stenosis |
| Q37438784 | Magnetic resonance spectroscopy in myocardial disease |
| Q98282924 | Making a Splash: Stress Lung Ultrasound and the Rising Tide of Lung Water |
| Q56966431 | Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement |
| Q103042346 | Mammography, Breast Density, and Major Adverse Cardiac Events: Potential Buy-One-Get-One-Free Lifesaving Bonus Finding |
| Q84569497 | Man must measure: except for cardiologists! |
| Q86691914 | Management Implications for Anomalous Aortic Origin of Coronary Arteries |
| Q83629622 | Management decisions in aortic regurgitation: has the time for exercise assessment finally arrived? |
| Q92770971 | Management of Asymptomatic Severe Aortic Stenosis: Evolving Concepts in Timing of Valve Replacement |
| Q38162538 | Management of mitral stenosis using 2D and 3D echo-Doppler imaging |
| Q91783627 | Mandatory Minimums in Cardiac Imaging: Applying Thresholds With Evidence |
| Q92411313 | Manifestations of Cardiovascular Disorders on Doppler Interrogation of the Hepatic Veins |
| Q46746932 | Manifestations of cardiac disease in carotid duplex ultrasound examination |
| Q47800817 | Many Faces of Fabry Cardiomyopathy |
| Q87070515 | Many Paths Lead to CV Outcomes: A Potential Need for Image-Guided Precision Medicine |
| Q33946227 | Mapping myocarditis: still searching for the north star |
| Q46301381 | Maternal Obesity and Cardiac Development in the Offspring: Study in Human Neonates and Minipigs. |
| Q57815540 | Maternal-Fetal Parabiosis in Obesity Exposes Unexpected Roles for Cardiac Metabolism |
| Q53760186 | Maximizing the Prognostic Value of Cardiac PET in Patients With Suspected Cardiac Sarcoidosis: A Simple Semiquantitative Score May Help. |
| Q52983594 | Measurement of LV Volumes and Function Using Oxygen-15 Water-Gated PET and Comparison With CMR Imaging. |
| Q39309074 | Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events |
| Q53080733 | Measuring myocardial scar by CMR. |
| Q92747761 | Mechanical Effects on Right Ventricular Function From Left Bundle Branch Block and Cardiac Resynchronization Therapy |
| Q45283200 | Mechanical abnormalities detected with conventional echocardiography are associated with response and midterm survival in CRT. |
| Q84085628 | Mechanical and structural characteristics of carotid plaques by combined analysis with echotracking system and MR imaging |
| Q48823082 | Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia |
| Q48687853 | Mechanical dispersion by strain echocardiography: a predictor of ventricular arrhythmias in subjects with lamin A/C mutations |
| Q91647809 | Mechanism of Abnormal Septal Motion in Left Bundle Branch Block: Role of Left Ventricular Wall Interactions and Myocardial Scar |
| Q53526715 | Mechanism of aortic valve opening: beyond the pressure gradient. |
| Q42391980 | Mechanism of asymmetric leaflet tethering in ischemic mitral regurgitation: 3D analysis with multislice CT |
| Q51057769 | Mechanisms of Effort Intolerance in Patients With Rheumatic Mitral Stenosis: Combined Echocardiography and Cardiopulmonary Stress Protocol. |
| Q86514840 | Mechanisms of Mitral Valve Dysfunction Following Mitral Valve Repair for Degenerative Disease |
| Q57815554 | Mechanisms of Myocardial Infarction in Patients With Nonobstructive Coronary Artery Disease: Results From the Optical Coherence Tomography Study |
| Q57779401 | Mechanisms of Recurrent Aortic Regurgitation After Aortic Valve Repair |
| Q82551785 | Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography |
| Q46291476 | Medial Arterial Calcification: Active Reversible Disease in Human Breast Arteries |
| Q45006224 | Medical imaging: the new Rosetta stone |
| Q47769487 | Mental Stress, Exercise, and Other Determinants of Elevation in High-Sensitivity Troponin Levels: A Call for Standardization of Laboratory Protocols |
| Q48550054 | Mentees, mentors, and the mentorship…. |
| Q58564606 | Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections |
| Q102319423 | Meta-Analysis of the Diagnostic Performance of 18F-FDG-PET/CT Imaging in Native Valve Endocarditis |
| Q92411265 | Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction |
| Q53449130 | Meta-analysis of MACE in MI: what's the MO? |
| Q42905582 | Meta-iodobenzylguanidine iodine-123 and cardiac adrenergic activity in familial dilated cardiomyopathy. |
| Q35891907 | Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study |
| Q34186965 | Micro-CT for characterization of murine CV disease models |
| Q92411386 | Micro-Optical Coherence Tomography for Endothelial Cell Visualization in the Coronary Arteries |
| Q91123592 | Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study |
| Q99623486 | Mid-Cancer Left Ventricular Function Measures Predict Long-Term Post-Cancer Left Ventricular Ejection Fraction |
| Q50990173 | Midterm Sapien Transcatheter Valve Durability: Ready for Prime Time or Waiting to Fail? |
| Q57058574 | Mismatch Between Diameter Stenosis and Plaque Atheroma Volume: Challenging Glagov Phenomenon? |
| Q50928518 | Mitral Annular Dimensions and Geometry in Patients With Functional Mitral Regurgitation and Mitral Valve Prolapse: Implications for Transcatheter Mitral Valve Implantation. |
| Q92676843 | Mitral Annular Disjunction in a Large Cohort of Patients With Mitral Valve Prolapse and Significant Regurgitation |
| Q54079421 | Mitral Annular Disjunction: The Forgotten Component of Myxomatous Mitral Valve Disease. |
| Q53011662 | Mitral Annular Evaluation With CT in the Context of Transcatheter Mitral Valve Replacement. |
| Q99575266 | Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes |
| Q90040158 | Mitral Regurgitation Flow Variation: The End of a Single Time-Point Assessment? |
| Q101137719 | Mitral Regurgitation Following Balloon Mitral Valvuloplasty: A New Twist on an Old Problem |
| Q49721037 | Mitral Valve Adaptation to Isolated Annular Dilation: Insights Into the Mechanism of Atrial Functional Mitral Regurgitation. |
| Q88285423 | Mitral Valve Regurgitation in the Contemporary Era: Insights Into Diagnosis, Management, and Future Directions |
| Q84378403 | Mitral and tricuspid annular velocities in constrictive pericarditis and restrictive cardiomyopathy: correlation with pericardial thickness on computed tomography |
| Q33723616 | Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation |
| Q54600669 | Mitral paravalvular leak: description and assessment of a novel anatomical method of localization. |
| Q43180096 | Mitral valve prolapse: a deeper look |
| Q90948501 | Moderate Aortic Stenosis and Heart Failure With Reduced Ejection Fraction: Can Imaging Guide Us to Therapy? |
| Q30473382 | Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype |
| Q94953570 | Molecular Imaging of Amyloid Deposits for Early Diagnosis of Cardiac Amyloidosis and Monitoring Treatment Response |
| Q49896798 | Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden |
| Q49896837 | Molecular Imaging of Apoptosis in Cancer Therapy-Related Cardiac Dysfunction Before LVEF Reduction |
| Q90566458 | Molecular Imaging of Cardiac Allograft Rejection: Targeting Apoptosis With Radiolabeled Duramycin |
| Q91320392 | Molecular Imaging of Myocardial Inflammation With Positron Emission Tomography Post-Ischemia: A Determinant of Subsequent Remodeling or Recovery |
| Q52988407 | Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction. |
| Q52986278 | Molecular Imaging: From Deep Pearl Diving to Enlightenment. |
| Q33493246 | Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent |
| Q50619482 | Molecular and cellular correlates of cardiac function in end-stage DCM: a study using speckle tracking echocardiography. |
| Q46056301 | Molecular imaging and the failing heart: through the looking glass |
| Q46056304 | Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling |
| Q34125754 | Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease |
| Q43098193 | Molecular imaging of coronary inflammation: overcoming hurdles one at a time... |
| Q36036217 | Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence |
| Q54314865 | Molecular imaging of human ACE-1 expression in transgenic rats. |
| Q37693460 | Molecular imaging of myocardial and vascular disorders with ultrasound |
| Q45035023 | Molecular imaging of native HDL in human coronary plaques by color fluorescent angioscopy |
| Q48031302 | Molecular imaging of the remodeling heart: the next step forward |
| Q57058588 | Monitoring the Response to Statin Therapy: One Scan at a Time |
| Q46708318 | More may not always be better |
| Q92203139 | Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications |
| Q92855893 | Morphological Assessment of the Tricuspid Apparatus and Grading Regurgitation Severity in Patients With Functional Tricuspid Regurgitation: Thinking Outside the Box |
| Q86184434 | Morphological Characteristics of Coronary Arteries in Patients With Vasospastic Angina: Another Form of Atherosclerosis? |
| Q46246126 | Morphological assessment of RVOT: CT and CMR imaging. |
| Q102319396 | Mortality Prediction by Quantitative PET Perfusion Expressed as Coronary Flow Capacity With and Without Revascularization |
| Q35510014 | Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification |
| Q92747778 | Mosaic Bioprostheses May Mimic Infective Endocarditis by PET/CTA: Trust the Uptake Pattern to Avoid Misdiagnosis |
| Q88609475 | Moving From Multimodality Diagnostic Tests Toward Multimodality Risk Stratification in ARVC |
| Q46859868 | Moving beyond binary grading of coronary arterial stenoses on coronary computed tomographic angiography: insights for the imager and referring clinician |
| Q115192746 | Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis |
| Q90857302 | Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient |
| Q102319437 | Multi-Tracer Positron Emission Tomography Quantification of Sympathetic Innervation: Tracer Similarity But Not Equivalence |
| Q50057820 | Multibiomarker Strategies in Aortic Stenosis |
| Q88737788 | Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial |
| Q37865119 | Multidetector computed tomography in transcatheter aortic valve implantation |
| Q85097997 | Multimodal imaging of a transcatheter aortic valve implantation within an isolated heart |
| Q97532936 | Multimodality Cardiovascular Imaging in the Midst of the COVID-19 Pandemic: Ramping Up Safely to a New Normal |
| Q88430432 | Multimodality Cardiovascular Imaging of Unroofed Coronary Sinus Defects |
| Q94953559 | Multimodality Imaging Demonstrates Reduced Right-Ventricular Function Independent of Pulmonary Physiology in Moderately Preterm-Born Adults |
| Q92505462 | Multimodality Imaging Markers of Adverse Myocardial Remodeling in Aortic Stenosis |
| Q92411307 | Multimodality Imaging for Best Dealing With Patients in Atrial Arrhythmias |
| Q48083954 | Multimodality Imaging for CAD Detection Before Renal Transplantation |
| Q38889321 | Multimodality Imaging for Guiding EP Ablation Procedures |
| Q38801290 | Multimodality Imaging for Spontaneous Coronary Artery Dissection in Women |
| Q96615907 | Multimodality Imaging in Cardiac Masses: To Standardize Recommendations, The Time Is Now! |
| Q38733936 | Multimodality Imaging in Individuals With Anomalous Coronary Arteries |
| Q38611242 | Multimodality Imaging in the Context of Transcatheter Mitral Valve Replacement: Establishing Consensus Among Modalities and Disciplines |
| Q102319421 | Multimodality Imaging of Atrial Remodeling and Risk of Atrial Fibrillation in Patients With Cardiac Sarcoidosis |
| Q91647709 | Multimodality Imaging of Suspected Mechanical Prosthetic Valve Obstruction: Importance of the Patient and the Clinical Context |
| Q89028775 | Multimodality Imaging of Thoracic Aortic Diseases in Adults |
| Q92203160 | Multimodality Imaging of the Tricuspid Valve and Right Heart Anatomy |
| Q45827417 | Multimodality Intravascular Imaging to Evaluate Sex Differences in Plaque Morphology in Stable CAD. |
| Q53311243 | Multimodality comparison of quantitative volumetric analysis of the right ventricle. |
| Q84731018 | Multimodality imaging atlas of coronary atherosclerosis |
| Q38219911 | Multimodality imaging of aortitis |
| Q37764500 | Multimodality imaging of pericardial diseases |
| Q44690729 | Multimodality imaging, the wave of the future: multidiscipline attack on a complex disease |
| Q85749212 | Multimodality imaging: opportunities and challenges |
| Q93192432 | Multiorgan Imaging of Comorbidity and Cardiovascular Risk |
| Q92505458 | Multiparametric CMR in Cardiomyopathies: Beyond Diagnosis and Toward Prognosis |
| Q92411357 | Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation |
| Q101373465 | Multiparametric Cardiac Magnetic Resonance for Chronic Kidney Disease: Mapping the Footprints of a "Silent Killer"? |
| Q92176417 | Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis |
| Q96615823 | Multiparametric Mapping Approach for Detection of Cardiac Involvement in Systemic Sarcoidosis |
| Q98186777 | Multiplanar "En Face" Reconstruction of the Aortic Valve: Impact on Aortic Valve Calcium Scoring |
| Q49191925 | Multiplanar visualization of blood flow using echocardiographic particle imaging velocimetry |
| Q86141446 | Multiple simultaneous plaque erosion in 3 coronary arteries |
| Q38492418 | Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events |
| Q92676812 | Myocardial Amyloidosis: The Exemplar Interstitial Disease |
| Q50941070 | Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis. |
| Q91123703 | Myocardial Blood Flow as a Holistic Metric for Predicting Remodeling and Clinical Outcomes After a Myocardial Infarction? |
| Q85362535 | Myocardial Bridges: Lessons in Clinical Coronary Pathophysiology |
| Q53087876 | Myocardial CT perfusion imaging in a large animal model: comparison of dynamic versus single-phase acquisitions. |
| Q50138528 | Myocardial Cannabinoid Receptor Imaging in Obesity |
| Q52982676 | Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model. |
| Q38930232 | Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot. |
| Q92176438 | Myocardial Efficiency: A Fundamental Physiological Concept on the Verge of Clinical Impact |
| Q85362533 | Myocardial Enhancement Defects on CT Angiograms: Promising Prognosticator or Water Under the Bridge? |
| Q89728085 | Myocardial Evaluation of Post-Preeclamptic Women by CMR: Is Early Risk Stratification Possible? |
| Q41333072 | Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MI. |
| Q92176479 | Myocardial Extracellular and Cardiomyocyte Volume Expand After Doxorubicin Treatment Similar to Adjuvant Breast Cancer Therapy |
| Q36083893 | Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. |
| Q91406539 | Myocardial Fibrosis Due to Exorbitant Exercise or Just Undetected Post-Inflammatory Stages? |
| Q47096657 | Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis |
| Q89281508 | Myocardial Fibrosis in Aortic Stenosis |
| Q47563791 | Myocardial Fibrosis in Competitive Triathletes Detected by Contrast-Enhanced CMR Correlates With Exercise-Induced Hypertension and Competition History. |
| Q90566411 | Myocardial Function in Patients With Radiation-Associated Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Layer-Specific Strain Analysis Study |
| Q100385415 | Myocardial Impairment and Acute Respiratory Distress Syndrome in Hospitalized Patients With Coronavirus Disease-2019: The ECHOVID-19 Study |
| Q37696752 | Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials |
| Q99623490 | Myocardial Infarction Associates With a Distinct Pericoronary Adipose Tissue Radiomic Phenotype: A Prospective Case-Control Study |
| Q62075646 | Myocardial Infarction With Nonobstructed Coronary Arteries |
| Q98629428 | Myocardial Infarction With Nonobstructive Coronary Arteries: Getting to the Heart of the Matter |
| Q57815512 | Myocardial Infarction With Nonobstructive Coronary Atherosclerosis: The Need for Precision Medicine |
| Q92747864 | Myocardial Inflammation and Edema in People Living With Human Immunodeficiency Virus |
| Q87841446 | Myocardial Inflammation: An Important Pitfall During CMR T1 Mapping for the Quantification of Diffuse Fibrosis in Heart Failure |
| Q90566477 | Myocardial Injury and Compromised Cardiomyocyte Integrity Following a Marathon Run |
| Q60606971 | Myocardial Kinetics of a Novel [18F]-Labeled Sympathetic Nerve PET Tracer LMI1195 in the Isolated Perfused Rabbit Heart |
| Q92771055 | Myocardial Mechanics in Patients With Normal LVEF and Diastolic Dysfunction |
| Q49721045 | Myocardial Metabolism in Endurance Exercise-Induced Left Ventricular Hypertrophy |
| Q98282914 | Myocardial Native T1 Predicts Load-Independent Left Ventricular Chamber Stiffness In Patients With HFpEF |
| Q85195418 | Myocardial Perfusion Imaging in Hypertrophic Cardiomyopathy |
| Q48850897 | Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy |
| Q91018945 | Myocardial Perfusion, Fibrosis, and Contractility in Children With Kawasaki Disease |
| Q49887177 | Myocardial Stiffness Assessment Using Shear Wave Imaging in Pediatric Hypertrophic Cardiomyopathy. |
| Q100426516 | Myocardial Stiffness Assessment by Ultrasound: Are We Ready for the Clinical "Lift Off"? |
| Q52650693 | Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults. |
| Q91307428 | Myocardial Strain Imaging by Echocardiography for the Prediction of Cardiotoxicity in Chemotherapy-Treated Patients: A Meta-Analysis |
| Q91123605 | Myocardial Strain in Hypertrophic Cardiomyopathy: A Force Worth Pursuing? |
| Q88737771 | Myocardial Strain in Prediction of Outcomes After Surgery for Severe Mitral Regurgitation |
| Q88407754 | Myocardial Strain in the Identification of Tachycardia-Induced Cardiomyopathy: Unscrambling the Egg |
| Q92135554 | Myocardial Strain, Subarachnoid Hemorrhage, and the Expanding Spectrum of Stress-Induced Cardiomyopathy |
| Q92771029 | Myocardial T1 Mapping in Heart Disease: Research Tool or New Cardiac Biomarker? |
| Q90202216 | Myocardial T1 and ECV Measurement: Underlying Concepts and Technical Considerations |
| Q50975973 | Myocardial T1: the rise of a novel biomarker continues. |
| Q89210651 | Myocardial T2 Mapping Increases Noninvasive Diagnostic Accuracy for Biopsy-Proven Myocarditis |
| Q92676936 | Myocardial Tissue Characterization With CMR for the Definitive Diagnosis of Infiltrative Cardiomyopathies |
| Q90202231 | Myocardial Tissue Characterization and Fibrosis by Imaging |
| Q47353172 | Myocardial Viability and Remodeling: Does Size Matter? |
| Q41852077 | Myocardial blood volume is associated with myocardial oxygen consumption: an experimental study with cardiac magnetic resonance in a canine model |
| Q38570550 | Myocardial contrast echocardiography: a wondrous journey! |
| Q37160629 | Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction |
| Q84240646 | Myocardial edema imaging of the area at risk in acute myocardial infarction: seeing through water |
| Q83636985 | Myocardial edema in acute ischemic injury |
| Q30421950 | Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation |
| Q36931178 | Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions |
| Q87112227 | Myocardial extracellular volume measurement by cardiac magnetic resonance |
| Q39435924 | Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. |
| Q84567946 | Myocardial imaging for mitochondrial membrane potential |
| Q53171021 | Myocardial imaging for mitochondrial membrane potential. |
| Q47446883 | Myocardial infarct size reduction with pexelizumab: the role of chance is patently clear |
| Q45844952 | Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus |
| Q47842155 | Myocardial mechanics in noncontiguous HCM. |
| Q44896158 | Myocardial perfusion imaging is a strong predictor of death in women |
| Q42905584 | Myocardial perfusion imaging using ultrasound contrast agents: now or never? |
| Q37693452 | Myocardial perfusion imaging with contrast ultrasound |
| Q30423725 | Myocardial perfusion using arterial spin labeling CMR: promise and challenges |
| Q82770730 | Myocardial salvage by CMR correlates with LV remodeling and early ST-segment resolution in acute myocardial infarction |
| Q48854744 | Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range |
| Q43175085 | Myocardial sympathetic innervation and long-term left ventricular mechanical unloading |
| Q53243866 | Myocardial viability by dual-energy delayed enhancement computed tomography. |
| Q49191699 | Myocardial viability: dead or alive is not the question! |
| Q92770901 | Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties |
| Q97551342 | Myocarditis in Relation to Angiographic Findings in Patients With Provisional Diagnoses of MINOCA |
| Q88407752 | Myocardium at Risk by Early Gadolinium Enhancement MR Imaging: A Moving Target? |
| Q57448726 | Myocardium at Risk in ST-Segment Elevation Myocardial Infarction |
| Q46011772 | Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. |
| Q49721157 | Müller Maneuver as a Tool for Stress Echocardiography: Evaluation of Exercise Capacity in Patients With Dilated Cardiomyopathy |
| Q50532112 | NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography. |
| Q102319404 | NIRS-IVUS for Differentiating Coronary Plaque Rupture, Erosion and Calcified Nodule in Acute Myocardial Infarction |
| Q103042453 | NIRS-IVUS: One Imaging System May Fit All |
| Q57815530 | Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis |
| Q53314171 | Napkin-ring necrotic cores: defining circumferential extent of necrotic cores in unstable plaques. |
| Q39450578 | Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome |
| Q120754838 | National Trends in Coronary Artery Disease Imaging |
| Q30993230 | Nationwide Laboratory Adherence to Myocardial Perfusion Imaging Radiation Dose Reduction Practices: A Report From the Intersocietal Accreditation Commission Data Repository |
| Q50204782 | Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy |
| Q46048518 | Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions |
| Q53341359 | Native T1 Mapping for Myocardial Infarction: Time to Throw Out the Gadolinium? |
| Q91123696 | Native T1 Mapping in the Diagnosis of Cardiac Allograft Rejection: A Prospective Histologically Validated Study |
| Q96132202 | Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis |
| Q88088242 | Native T1 and Extracellular Volume in Transthyretin Amyloidosis |
| Q41603688 | Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. |
| Q53116428 | Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. |
| Q38442488 | Native T1 mapping in transthyretin amyloidosis |
| Q57725632 | Natural History of Diabetic Coronary Atherosclerosis by Quantitative Measurement of Serial Coronary Computed Tomographic Angiography |
| Q91123649 | Natural History of Functional Tricuspid Regurgitation: Implications of Quantitative Doppler Assessment |
| Q91593227 | Natural History of Mitral Stenosis in Patients With Mitral Annular Calcification |
| Q46522889 | Natural History of Myocardial Function in an Adult Human Population: Serial Longitudinal Observations From MESA. |
| Q92047500 | Natural History of Myocardial Late Gadolinium Enhancement Predicts Adverse Clinical Events in Heart Transplant Recipients |
| Q53097209 | Natural history of coronary atherosclerosis by multislice computed tomography. |
| Q43990538 | Natural history of left ventricular mechanics in transplanted hearts: relationships with clinical variables and genetic expression profiles of allograft rejection |
| Q91465469 | Navigating a Career in Structural Heart Disease Interventional Imaging |
| Q43098200 | Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions |
| Q96608105 | Necessity of 45-Day Transesophageal Echocardiography After the WATCHMAN Procedure Amid the COVID-19 Pandemic |
| Q103042359 | Neo-LVOT and Transcatheter Mitral Valve Replacement: Expert Recommendations |
| Q83629546 | Nephrogenic systemic fibrosis: considerations for the cardiologist |
| Q37957344 | Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases |
| Q53117013 | Net Health Benefit: Positive for CAC Scanning. |
| Q91406529 | Network Tomography for Understanding Phenotypic Presentations in Aortic Stenosis |
| Q92135559 | Neurocardiac Injury Assessed by Strain Imaging Is Associated With In-Hospital Mortality in Patients With Subarachnoid Hemorrhage |
| Q90636149 | Neurocardiac Injury in Patients With Subarachnoid Hemorrhage |
| Q28081120 | New Applications of Cardiac Computed Tomography: Dual-Energy, Spectral, and Molecular CT Imaging |
| Q53672129 | New Concepts in an Old Disease: Exercise Intolerance in Moderate Mitral Stenosis. |
| Q53103964 | New Conversion Factors for Estimating Effective Doses During Cardiac CTA. |
| Q90040207 | New Multiparametric Analysis of Cardiac Dyssynchrony: Machine Learning and Prediction of Response to CRT |
| Q42905581 | New Opportunities and Challenges for Clinical Application of mIBG Imaging |
| Q87883244 | New strategic plan charts next chapter in College's history: implications for the cardiovascular imager |
| Q30448381 | Newer methods for noninvasive assessment of myocardial perfusion: cardiac magnetic resonance or cardiac computed tomography? |
| Q51224812 | Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study. |
| Q87438604 | Nonatherosclerotic Coronary Artery Narrowing |
| Q38449219 | Noncardiac pathology on clinical cardiac magnetic resonance imaging |
| Q53291366 | Noncontrast 3D CMR imaging for aortic valve annulus sizing in TAVR. |
| Q92771032 | Noncontrast CMR for Detecting Early Myocardial Tissue Injury in a Swine Model of Anthracycline-Induced Cardiotoxicity |
| Q92770915 | Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis |
| Q49887213 | Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis |
| Q96615886 | Noncontrast Quantitative Imaging Biomarkers Reflecting Myocardial Tissue Heterogeneity: The Future of Cardiac Magnetic Resonance Imaging? |
| Q38452328 | Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. |
| Q52980031 | Noncoronary Measures Enhance the Predictive Value of Cardiac CT Above Traditional Risk Factors and CAC Score in the General Population. |
| Q37438729 | Noncoronary applications of cardiac multidetector row computed tomography |
| Q58564626 | Noninvasive Assessment of Coronary Anatomy and its Hemodynamic Consequences During a Single Test: Are We There Yet? |
| Q57740100 | Noninvasive Assessment of Coronary Artery Disease |
| Q88088209 | Noninvasive Assessment of Hemodynamic Status in HeartWare Left Ventricular Assist Device Patients: Validation of an Echocardiographic Approach |
| Q93192497 | Noninvasive Assessment of Hemodynamics in Left Ventricular Assist Device Patients: Echocardiographic Accuracy and Clinical Outcome Implications |
| Q51754282 | Noninvasive CT-Derived FFR Based on Structural and Fluid Analysis: A Comparison With Invasive FFR for Detection of Functionally Significant Stenosis. |
| Q48577395 | Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects |
| Q30277401 | Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology |
| Q92505482 | Noninvasive Evaluation of Diastolic Function in Left Ventricular Assist Device Carriers |
| Q50657502 | Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. |
| Q53373106 | Noninvasive FFRCT After STEMI: Looking for the Guilty Bystander. |
| Q52990212 | Noninvasive Follow-Up of Patients With Spontaneous Coronary Artery Dissection With CT Angiography. |
| Q31008012 | Noninvasive Fractional Flow Reserve Derived From Coronary CT Angiography: Clinical Data and Scientific Principles |
| Q98629444 | Noninvasive Hemodynamic Assessment of Shock Severity and Mortality Risk Prediction in the Cardiac Intensive Care Unit |
| Q92524516 | Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled |
| Q36676994 | Noninvasive Imaging of Flow and Vascular Function in Disease of the Aorta |
| Q53103959 | Noninvasive Imaging of the Coronary Vasculature Using Ultrafast Ultrasound. |
| Q92676981 | Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease Activity: Coronary and Carotid Applications |
| Q33841979 | Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. |
| Q64911560 | Noninvasive LV pressure estimation using subharmonic emissions from microbubbles. |
| Q40796619 | Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction |
| Q36585526 | Noninvasive Multimodality Imaging in ARVD/C |
| Q91647741 | Noninvasive Precursors of Coronary Chronic Total Occlusions: Fantasy or Reality? |
| Q52990979 | Noninvasive Prediction of Atherosclerotic Progression: The PROSPECT-MSCT Study. |
| Q85412998 | Noninvasive Quantitative Tissue Characterization of Carotid Plaques Using Color-Coded Mapping Based on Ultrasound Integrated Backscatter |
| Q91123712 | Noninvasive Testing in Patients With End-Stage Liver Disease: When and How? |
| Q91320376 | Noninvasive Tissue Characterization of Post-Infarction Myocardium |
| Q48721565 | Noninvasive assessment of LV contraction patterns using CMR to identify responders to CRT. |
| Q45938232 | Noninvasive assessment of coronary artery bypass graft disease: the potential role of contrast-enhanced cardiac magnetic resonance. |
| Q51775599 | Noninvasive assessment of pulmonary artery flow and resistance by cardiac magnetic resonance in congenital heart diseases with unrestricted left-to-right shunt. |
| Q53132853 | Noninvasive diagnosis of ischemia-causing coronary stenosis using CT angiography: diagnostic value of transluminal attenuation gradient and fractional flow reserve computed from coronary CT angiography compared to invasively measured fractional flow |
| Q83629633 | Noninvasive differentiation between active and healed myocarditis by cardiac magnetic resonance: are we there yet? |
| Q84948059 | Noninvasive estimation of LV filling pressures in heart failure and reduced ejection fraction: revisited and verified |
| Q45760737 | Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. |
| Q86134083 | Noninvasive evaluation of bone-forming activity within the calcified atherosclerotic lesions by Tc 99m HMDP scintigraphy |
| Q37363322 | Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance |
| Q53080729 | Noninvasive evaluation of coronary reperfusion by CT angiography in patients with STEMI. |
| Q83629515 | Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement |
| Q40507037 | Noninvasive imaging of angiotensin receptors after myocardial infarction |
| Q27024715 | Noninvasive imaging of cardiovascular injury related to the treatment of cancer |
| Q82428301 | Noninvasive imaging of plaque inflammation: role of contrast-enhanced MRI |
| Q46056307 | Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness |
| Q37009598 | Noninvasive monitoring of oxidative stress in transplanted mesenchymal stromal cells |
| Q46520284 | Noninvasive risk stratification of patients with transthyretin amyloidosis. |
| Q44018135 | Noninvasive voltage and activation mapping of ARVD/C using ECG imaging |
| Q46197032 | Nonobstructive Coronary Artery Disease by Coronary CT Angiography Improves Risk Stratification and Allocation of Statin Therapy |
| Q93084418 | Normal Global Longitudinal Strain: An Individual Patient Meta-Analysis |
| Q99623484 | Normal Range of Global Longitudinal Strain in the Elderly: The Impact of Subclinical Disease |
| Q47303835 | Normalized end-systolic volume and pre-load reserve predict ventricular dysfunction following surgery for aortic regurgitation independent of body size |
| Q42371272 | Not All Body Fat Weighs Equally in the Acceleration of Coronary Artery Disease |
| Q90678632 | Not All Plaque Erosions Are Equal: Novel Insights From 1,660 Patients With STEMI: A Clinical, Angiographic, and Intravascular OCT Study |
| Q91465482 | Not Quite Chronic Thromboembolic Pulmonary Hypertension But More Than a SOB Story |
| Q48741878 | Novel Approach for In Vivo Detection of Vulnerable Coronary Plaques using Molecular 3-T CMR Imaging with an Albumin-Binding Probe |
| Q99575271 | Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis |
| Q52572452 | Novel PET and Near Infrared Imaging Probes for the Specific Detection of Bacterial Infections Associated With Cardiac Devices. |
| Q91465464 | Novel Use for Intracardiac Echocardiography: Evaluation of Patients With Continuous Flow Left Ventricular Assist Devices |
| Q53574328 | Novel Use of Cardiac Magnetic Resonance Imaging for the Diagnosis of Cobalt Cardiomyopathy. |
| Q50687725 | Novel insights into RV adaptation and function in hypoplastic left heart syndrome between the first 2 stages of surgical palliation. |
| Q53014769 | Novel risk model predicting high-risk coronary artery disease: let common sense prevail in medical decision making. |
| Q92047535 | Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure |
| Q91123659 | OCT Appraisal of Residual Thrombus Burden in Patients With STEMI Undergoing Intraprocedural Versus Post-Stenting Prolonged Bivalirudin Infusion: The MATRIX OCT Study |
| Q85623178 | OCT Images of Longitudinal Deformation Following BVS Implantation in the Right Coronary Ostium |
| Q53374774 | OCT Visualization of the Structure of Intimal Tissue After Drug-Eluting Balloon Deployment. |
| Q44020954 | OCT analysis in patients with very late stent thrombosis |
| Q98629453 | OCT and CMR for the Diagnosis of Patients Presenting With MINOCA and Suspected Epicardial Causes |
| Q84377402 | OCT assessment of allograft vasculopathy in heart transplant recipients |
| Q53064643 | OCT assessment of thin-cap fibroatheroma distribution in native coronary arteries. |
| Q37709726 | OCT characteristics of saphenous vein graft atherosclerosis |
| Q45251050 | OCT compared with IVUS in a coronary lesion assessment: the OPUS-CLASS study |
| Q51325796 | OCT findings in patients with recanalization of organized thrombi in coronary arteries. |
| Q38354155 | OCT for the identification of vulnerable plaque in acute coronary syndrome |
| Q87578747 | OCT imaging for the management of pulmonary hypertension |
| Q53642962 | OCT imaging of macrophages: a bright spot in the study of inflammation in human atherosclerosis. |
| Q83863114 | OCT of human carotid arterial plaques |
| Q46829264 | OCT versus IVUS: accuracy versus clinical utility |
| Q52662973 | OCT-Defined Morphological Characteristics of Coronary Artery Spasm Sites in Vasospastic Angina. |
| Q51826413 | OCT-based diagnosis and management of STEMI associated with intact fibrous cap. |
| Q53349930 | OCT-verified neoatherosclerosis in BMS restenosis at 10 years. |
| Q83461324 | OCT-verified neointimal hyperplasia is increased at fracture site in drug-eluting stents |
| Q85445700 | OCT-verified peri-strut low-intensity areas and the extent of neointimal formation after 3 years following stent implantation |
| Q61793387 | Obesity Paradox in the Clinical Significance of Effective Prosthetic Orifice Area After Aortic Valve Replacement |
| Q37082074 | Obesity and cardiac metabolism in women |
| Q47337799 | Objectively Measuring the Ghost in the Machine: B-Lines as Uncertain Measures on Which to Base Clinical Assessment. |
| Q88217134 | Observations With Simultaneous 18F-FDG PET and MR Imaging in Peripheral Artery Disease |
| Q96615845 | Occurrence of Cardiovascular Events and Progression of Cardiomyopathy in Muscular Dystrophy Patients: A CMR-Based Study |
| Q49887193 | On Books, Covers, and Judgments in Heart Failure. |
| Q43999519 | On Fishing Expeditions, Laws of Fishing, and Good Fishermen… |
| Q83220125 | On OCT and finding the uncovered tracks... |
| Q83200598 | On becoming an imaging investigator: opportunities, pathways, and challenges |
| Q85445734 | On tests, times, and the test of time... |
| Q57815536 | On the Pathophysiology of Coronary Artery Disease: We Were Told Where To Go but Not How To Get There |
| Q35133287 | On-line visualization of ischemic burden during repetitive ischemia/reperfusion. |
| Q89210647 | One Good Friend Is Better Than Many |
| Q91406555 | One In, One Out, Many More to Go |
| Q47381454 | One Size Does Not Fit All: A Cliché or a Hard Fact in Cardiac Chamber Quantification? |
| Q46011753 | One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. |
| Q88464516 | Onwards and Upwards |
| Q92411379 | Opposing Wall Pushing and Stretching: Response to Cardiac Resynchronization Therapy Requires Electrical Delay and Viability |
| Q48846713 | Opposing wall mechanics are significantly influenced by longitudinal cardiac rotation in the assessment of ventricular dyssynchrony. |
| Q46184807 | Optical Coherence Tomography Characterization of Coronary Lithoplasty for Treatment of Calcified Lesions: First Description |
| Q90384194 | Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry |
| Q103042391 | Optical Coherence Tomography to Predict Plaque Progression: A Glimpse Into the Crystal Ball? |
| Q50057876 | Optical Frequency Domain Imaging Versus Intravascular Ultrasound in Percutaneous Coronary Intervention (OPINION Trial): Results From the OPINION Imaging Study |
| Q46056299 | Optical coherence tomography to diagnose under-expansion of a drug-eluting stent |
| Q89125780 | Optimal Treatment of Stage B Heart Failure in Cardio-Oncology?: The Promise of Strain |
| Q86932865 | Optimal imaging for guiding TAVR: transesophageal or transthoracic echocardiography, or just fluoroscopy? |
| Q92676916 | Optimizing Cardiac CT Protocols for Comprehensive Acquisition Prior to Percutaneous MV and TV Repair/Replacement |
| Q93192422 | Optimizing the Assessment of Aortic Regurgitation: The Importance of Quantity and Quality |
| Q92047670 | Optimizing the Assessment of Patient Clinical Risk at the Time of Cardiac Stress Testing |
| Q98629452 | Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular Ultrasound |
| Q89455906 | Out With the Old Rule-Out: Raising the Bar for Acute Chest Pain Evaluation With Randomized Trials of Cardiac Imaging |
| Q91307430 | Out of Focus: Increase of the Excess Longitudinal Range in Coronary Computed Tomographic Angiography |
| Q91465437 | Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement |
| Q53196488 | Outcomes in mitral regurgitation due to flail leaflets a multicenter European study. |
| Q92038010 | Outcomes of Patients With Discordant High-Gradient Aortic Valve Stenosis |
| Q37465140 | Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute |
| Q38748005 | Outcomes-Based CV Imaging Research Endpoints and Trial Design: From Pixels to Patient Satisfaction |
| Q92676806 | PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers |
| Q98282928 | PET Flow Quantification: An Arbitrator in Patients With Ischemic Cardiomyopathy?: The Jury Is Still Out |
| Q87998932 | PET Imaging in Takayasu Disease Requiring Arterial Grafts |
| Q52986282 | PET Imaging of Leukocytes in Patients With Acute Myocardial Infarction. |
| Q61727654 | PET Imaging: Hot on the Trail of the HDL Particle ∗ |
| Q84085788 | PET measurement of absolute myocardial blood flow and LV function in dilated cardiomyopathy |
| Q52985717 | PET-MR Imaging in Evaluation of Cardiac and Paracardiac Masses With Histopathologic Correlation. |
| Q90678621 | PET/CMR: One More Step Toward Noninvasive Morphofunctional Diagnosis of Cardiac Malignancies |
| Q92135613 | PET/CT Imaging of Cardiac Angiotensin II Type 1 Receptors in Nonobstructive Hypertrophic Cardiomyopathy |
| Q53083524 | PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. |
| Q57815533 | PET/MR Illumination of Atherosclerosis Pathobiology: How a Nanobody Becomes Somebody |
| Q50138534 | PET/MR Imaging of Atherosclerosis: Insights Into Atheroma Structure and Biology |
| Q44880967 | PFO and the heart more than meets the eye! |
| Q87841420 | Pacemaker Implantation After TAVR |
| Q84240656 | Pacemaker therapy in refractory heart failure: a systematic approach to electromechanical optimization of diastolic function |
| Q101137737 | Pancoronary Plaque Characteristics in STEMI Caused by Culprit Plaque Erosion Versus Rupture: 3-Vessel OCT Study |
| Q91018921 | Papillary Muscle Dyssynchrony-Mediated Functional Mitral Regurgitation: Mechanistic Insights and Modulation by Cardiac Resynchronization |
| Q45956883 | Paradigm Shift in Medical Data Management: Big Data and Small Data. |
| Q88737756 | Paradigms of Noninvasive Assessment of Coronary Atherosclerosis in Diabetic Patients: Insights From the PARADIGM Registry |
| Q104504890 | Paravalvular Regurgitation According to Transcatheter Aortic Valve Prosthesis Type: Insights From the Randomized SOLVE-TAVI Trial |
| Q47644743 | Paravalvular Regurgitation After TAVR: A Doppler Dilemma |
| Q92676823 | Passivating High-Risk Plaques: Try, Try Again |
| Q87482686 | Patent foramen ovale: going beyond the bubbles |
| Q54704125 | Path to Cardiovascular Multimodality Imaging Subspecialty. |
| Q43688766 | Pathological Q waves in myocardial infarction in patients treated by primary PCI. |
| Q30975570 | Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis |
| Q91320401 | Patient Selection Criteria for Diagnostic Imaging for Ischemic Heart Disease: Desperately in Need of Revision |
| Q89281482 | Patient and Provider Attitudes on Appropriate Use Criteria for Myocardial Perfusion Imaging |
| Q101373510 | Patients Recovered From COVID-19 Show Ongoing Subclinical Myocarditis as Revealed by Cardiac Magnetic Resonance Imaging |
| Q54545594 | Pattern of ascending aortic dimensions predicts the growth rate of the aorta in patients with bicuspid aortic valve. |
| Q30573047 | Patterns and predictors of stress testing modality after percutaneous coronary stenting: data from the NCDR(®) |
| Q30434860 | Patterns of late gadolinium enhancement in chronic hemodialysis patients |
| Q83629570 | Patterns of ventricular remodeling after myocardial infarction: clues toward linkage between mechanism and morbidity |
| Q46594969 | Payment changes in CV imaging |
| Q87098250 | Peak Filling Rates Assessed by CMR Imaging Indicate Diastolic Dysfunction From Myocardial Iron Toxicity |
| Q89254873 | Percutaneous Bicuspidization of the Tricuspid Valve |
| Q90040234 | Percutaneous Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study |
| Q83432186 | Percutaneous aortic valves and imaging |
| Q83629552 | Percutaneous closure of atrial septal defect |
| Q38424952 | Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography |
| Q83629429 | Percutaneous left atrial appendage obliteration |
| Q53345215 | Percutaneous valve-in-valve procedure for severe paravalvular regurgitation in aortic bioprosthesis. |
| Q87286669 | Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts |
| Q92747816 | Performance Under Stress: Ischemia Assessment Post-STEMI |
| Q35738395 | Performance of CMR Methods for Differentiating Acute From Chronic MI. |
| Q92176471 | Performing Computed Tomography Instead of Invasive Coronary Angiography: Sex Effects in Patients With Suspected CAD |
| Q84571599 | Perfusion imaging without tunnel vision |
| Q91647785 | Peri-Coronary Adipose Tissue Density Is Associated With 18F-Sodium Fluoride Coronary Uptake in Stable Patients With High-Risk Plaques |
| Q84378421 | Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction |
| Q53411098 | Pericardial Fat and CVD: Is All Fat Created Equally? |
| Q39685959 | Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. |
| Q34159653 | Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. |
| Q46694478 | Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis |
| Q87638548 | Pericarditis and Recurrent Pericarditis: The Imaging Players Are Going to Fix the Poles |
| Q99416596 | Pericoronary Adipose Tissue Inflammation on Coronary Computed Tomography in Patients With Vasospastic Angina |
| Q92047488 | Periodontal Disease Associates With Arterial Inflammation Via Potentiation of a Hematopoietic-Arterial Axis |
| Q40365023 | Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study |
| Q49887174 | Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction: Implications for Left Ventricular Remodeling and Health Outcomes |
| Q61913965 | Personalized Medicine in Heart Failure |
| Q88430451 | Personalized Medicine in the Prevention of Reperfusion Injury? |
| Q104504900 | Personalizing Risk Assessment in Diabetes Mellitus and Metabolic Syndrome |
| Q90857312 | Pertuzumab/Trastuzumab Breast Cancer Therapy Is Associated With Complex Hemodynamic Abnormalities |
| Q43175087 | Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial |
| Q53690845 | Phenotypic Clustering of Left Ventricular Diastolic Function Parameters: Patterns and Prognostic Relevance. |
| Q113871718 | Phenotypic Features of Coronary Atheroma in Diabetic and Nondiabetic Patients With Low-Density Lipoprotein Cholesterol <55 mg/dL |
| Q87235303 | Physical Examination Is Still Necessary and Important |
| Q90313967 | Physical Function and Well-Being in HFpEF: The Constrained Mechanics and Compensatory Strategies |
| Q46135649 | Physical activity in older subjects is associated with increased coronary vasodilation: the ADVANCE study. |
| Q87482701 | Physical exercise reduces aortic regurgitation: exercise magnetic resonance imaging |
| Q53108462 | Physician certification in cardiovascular imaging: rationale, process, and benefits. |
| Q85098013 | Physician responsibility and the RVS update committee |
| Q43555015 | Physician-preferred versus policy-based testing: where do appropriate use criteria fit in? |
| Q48530500 | Physiological Determinants of Left Ventricular Mechanical Dispersion: A 2-Dimensional Speckle Tracking Echocardiographic Study in Healthy Volunteers. |
| Q83636982 | Physiological aging: window of opportunity |
| Q84948076 | Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve |
| Q43926840 | Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta |
| Q51331374 | Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging. |
| Q38469591 | Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging |
| Q89125751 | Pitfalls and Pearls for 3-Dimensional Printing of the Tricuspid Valve in the Procedural Planning of Percutaneous Transcatheter Therapies |
| Q84560933 | Pitfalls in plaque characterization by OCT: image artifacts in native coronary arteries |
| Q87638553 | Planning a Research Agenda to Incorporate Imaging Into Clinical Practice |
| Q34629135 | Planning transcaval access using CT for large transcatheter implants. |
| Q30275428 | Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events |
| Q88747673 | Plaque Composition in the Proximal SFA and Clinical Outcomes in Patients With Claudication: Have We Found the Answer? |
| Q57293572 | Plaque Compositional Syntax Score |
| Q88737799 | Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic Type 2 Diabetes: A Long-Term Observational Study |
| Q53095072 | Plaque Neovascularization Is Increased in Human Carotid Atherosclerosis Related to Prior Neck Radiotherapy: A Contrast-Enhanced Ultrasound Study. |
| Q92770937 | Plaque Permeability Assessed With DCE-MRI Associates With USPIO Uptake in Patients With Peripheral Artery Disease |
| Q47144705 | Plaque Rupture in Coronary Atherosclerosis Is Associated With Increased Plaque Structural Stress |
| Q86940734 | Plaque Volume of Carotid Endarterectomy Specimens Measured by 3D Ultrasound Technology |
| Q45769427 | Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients |
| Q84378433 | Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS |
| Q39639379 | Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes |
| Q34197234 | Plaque composition by intravascular ultrasound and distal embolization after percutaneous coronary intervention. |
| Q48570560 | Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study |
| Q38495630 | Plaque prolapse after stent implantation in patients with acute myocardial infarction: an intravascular ultrasound analysis |
| Q83629551 | Plaque prolapse after stenting in myocardial infarction: bad plaque--bad omen? |
| Q90678666 | Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis |
| Q49191955 | Platypnea-orthodeoxia syndrome due to PFO and aortic dilation |
| Q84748278 | Pocket-sized echo for evaluation of mitral and tricuspid regurgitation |
| Q98629439 | Polarimetric Signatures of Vascular Tissue Response to Drug-Eluting Stent Implantation in Patients |
| Q48632782 | Pondering the Prognosis and Pathology of Cardiac Amyloidosis: Answers Breed Questions |
| Q87590149 | Poor Correlation, Reproducibility, and Agreement Between Volumetric Versus Linear Epicardial Adipose Tissue Measurement: A 3D Computed Tomography Versus 2D Echocardiography Comparison |
| Q51288872 | Population-based reference values for 3D echocardiographic LV volumes and ejection fraction. |
| Q93129781 | Positron-Emission Tomography Quantitative Measurements of Myocardial Blood Flow: Just the Facts… |
| Q89934499 | Post-Extrasystolic Transaortic Valve Gradients Differentiate "Pseudo" and "True" Low-Flow, Low-Gradient Severe AS During Dobutamine Stress Echocardiography |
| Q85616536 | Post-Infarction LV Remodeling: Remote Changes Do Not Necessarily Occur Remotely From Time of Infarction |
| Q89728082 | Post-Systolic Shortening by Speckle Tracking Echocardiography Predicts Cardiac Events in Type 2 Diabetes |
| Q50973508 | Post-systolic shortening: a functional window into ischemic memory? |
| Q48517575 | Potential Usefulness and Clinical Relevance of Adding Left Atrial Strain to Left Atrial Volume Index in the Detection of Left Ventricular Diastolic Dysfunction |
| Q87593715 | Practical guidance in echocardiographic assessment of global longitudinal strain |
| Q51057773 | Pre-Load-Induced Changes in Forward LV Stroke and Functional Mitral Regurgitation: Echocardiographic Detection of the Descending Limb of Starling's Curve. |
| Q101137741 | Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study |
| Q91647764 | Pre-Operative Grade of Decompressing Systemic Venous Collaterals, But Not Jugular Venous Pressure, Predicts Short- and Medium-Term Outcome After Completion of the Total Cavopulmonary Connection |
| Q50057850 | Pre-Renal Transplant Risk Stratification: A Perpetual Quandary |
| Q85445725 | Pre-dismissal surveillance echocardiography second day after TAVR |
| Q88131347 | Pre-load stress echocardiography for predicting the prognosis in mild heart failure |
| Q46536338 | Pre-operative 3D CT imaging for virtual planning of minimally invasive aortic valve surgery |
| Q84748258 | Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery |
| Q64116771 | Precision Medicine for Aortic Stenosis: The Future of Cardiology Today |
| Q31155784 | Precision Phenotyping in Heart Failure and Pattern Clustering of Ultrasound Data for the Assessment of Diastolic Dysfunction |
| Q36264649 | Precursors of Hypertensive Heart Phenotype Develop in Healthy Adults: A High-Resolution 3D MRI Study |
| Q95561353 | Precursors of Hypertensive Heart Phenotype Develop in Healthy Adults: An Alternative Explanation |
| Q50137793 | Predicting Cardiac Prognosis in Asymptomatic Chronic Kidney Disease Patients. |
| Q37409846 | Predicting LVOT Obstruction After TMVR |
| Q95700972 | Predicting LVOT Obstruction in Transcatheter Mitral Valve Implantation: Concept of the Neo-LVOT |
| Q88737809 | Predicting Left Ventricular Outflow Tract Obstruction Despite Anterior Mitral Leaflet Resection: The "Skirt NeoLVOT" |
| Q101137726 | Predicting Long-Term Absence of Coronary Artery Calcium in Metabolic Syndrome and Diabetes: The MESA Study |
| Q85362525 | Predicting Mortality in Pulmonary Arterial Hypertension: Can It Really Be That Simple? |
| Q53470358 | Predicting Periprocedural Injury: Magnetic Resonance Imaging Stakes a Claim. |
| Q62815331 | Predicting Survival From Large Echocardiography and Electronic Health Record Datasets: Optimization With Machine Learning |
| Q110901711 | Predicting Survival in Repaired Tetralogy of Fallot |
| Q85097974 | Predicting benefit from CRT when is it too little, too late? |
| Q85749202 | Predicting impending rupture of the ascending aorta with bicuspid aortic valve: spatiotemporal flow and wall shear stress |
| Q87112212 | Predicting long-term outcomes in asymptomatic or minimally symptomatic patients with HCM: back to basics |
| Q102319443 | Predicting the Future From Scars of the Past |
| Q90678693 | Predicting the Need for Revascularization in Stable Coronary Artery Disease: Protons or Photons? |
| Q46976401 | Predicting the risk for acute type B aortic dissection in hypertensive patients using anatomic variables |
| Q104794271 | Prediction of AF in Heart Failure With Preserved Ejection Fraction: Incremental Value of Left Atrial Strain |
| Q92676976 | Prediction of Coronary Revascularization in Stable Angina: Comparison of FFRCT With CMR Stress Perfusion Imaging |
| Q90384174 | Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study |
| Q54450008 | Prediction of MACE after ACS: demographics and angiography versus imaging. |
| Q92770989 | Prediction of Stroke Risk by Detection of Hemorrhage in Carotid Plaques: Meta-Analysis of Individual Patient Data |
| Q91018956 | Prediction of Subclinical Coronary Artery Disease With Breast Arterial Calcification and Low Bone Mass in Asymptomatic Women: Registry for the Women Health Cohort for the BBC Study |
| Q92771017 | Prediction of Ventricular Arrhythmias With Left Ventricular Mechanical Dispersion: A Systematic Review and Meta-Analysis |
| Q35846083 | Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis |
| Q83661567 | Prediction of coronary events by intravascular imaging |
| Q33716227 | Prediction of high-risk plaque development and plaque progression with the carotid atherosclerosis score |
| Q51168389 | Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. |
| Q39908970 | Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database |
| Q44062720 | Prediction of prognosis in pulmonary hypertension using CMR: what happens where the right and left ventricles meet? |
| Q39728342 | Predictors and Outcomes of Prosthesis-Patient Mismatch After Aortic Valve Replacement |
| Q52985633 | Predictors for Paravalvular Regurgitation After TAVR With the Self-Expanding Prosthesis: Quantitative Measurement of MDCT Analysis. |
| Q44739675 | Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging |
| Q38993495 | Predictors of Interventional Success of Antegrade PCI for CTO. |
| Q41118328 | Predictors of Long-Term Healthy Arterial Aging: Coronary Artery Calcium Nondevelopment in the MESA Study |
| Q86514827 | Predictors of Plaque Rupture Within Nonculprit Fibroatheromas in Patients With Acute Coronary Syndromes: The PROSPECT Study |
| Q100431008 | Predictors of Rapid Plaque Progression: An Optical Coherence Tomography Study |
| Q34171552 | Predictors of inaccurate coronary arterial stenosis assessment by CT angiography |
| Q85649674 | Prenatal visualization of persistent 5th aortic arch artery |
| Q62818405 | Presence of Extensive LV Remodeling Limits the Benefits of CRT in Patients With Intraventricular Dyssynchrony |
| Q52990169 | Presence of Ischemia by FFR Without Significant Anatomic Stenosis Is Likely due to Concomitant Diffuse Disease and Not due to Impaired Vasodilation From Pharmacological Stress. |
| Q51039562 | Pressure fields by flow-sensitive, 4D, velocity-encoded CMR in patients with aortic coarctation. |
| Q84058438 | Presto untwisting and legato filling |
| Q90678682 | Prevalence and Prognosis of High-Risk Plaque on Coronary CT Angiography in Hospitalized Patients |
| Q90202236 | Prevalence and Prognostic Impact of Ascending Aortic Dilatation in Patients Undergoing TAVR |
| Q53675985 | Prevalence and Prognostic Significance of Lipomatous Metaplasia in Patients With Prior Myocardial Infarction. |
| Q64882737 | Prevalence and Significance of Tricuspid Regurgitation Post-Endocardial Lead Placement. |
| Q33994603 | Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. |
| Q90040244 | Prevalence of OCT-Defined TCFA in Relation to CFC Classified With Pressure-Temperature Sensor-Tipped Wire |
| Q42939305 | Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale |
| Q39629839 | Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. |
| Q100431010 | Prevalence, Correlates, and Prognostic Relevance of Mid-Wall Late Gadolinium Enhancement in Patients With Ischemic Cardiomyopathy |
| Q51809988 | Prevalence, Predictors, and Clinical Presentation of a Calcified Nodule as Assessed by Optical Coherence Tomography. |
| Q99575267 | Prevention and Treatment of Heart Failure: We Want to Pump You Up |
| Q46217705 | Preventive Interventions After Coronary Artery Calcium Scanning: Seeing is Believing |
| Q92047546 | Preventive Management of Nonobstructive CAD After Coronary CT Angiography in the Emergency Department |
| Q99575270 | Primary Aldosteronism: New Insights Into its Detection and Cardiac Involvement |
| Q99575260 | Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop |
| Q38747996 | Primary Prevention of CVD: The Role of Imaging Trials |
| Q92135576 | Primary Tumors of the Aorta and Pulmonary Arteries: Insights From Cardiovascular Magnetic Resonance |
| Q54408350 | Primary and Secondary Prevention, or Subclinical and Clinical Atherosclerosis. |
| Q53083034 | Probing transmural myocardial perfusion with CMR. |
| Q53095074 | Prognosis in Cardiac Amyloidosis by LGE: Ready for Prime Time? |
| Q48507520 | Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System |
| Q88813891 | Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis |
| Q90948517 | Prognostic Impact of FDG-PET/CT Images in Patients With Suspected Cardiac Sarcoidosis: Optimal Patient Preparation, Not Complex Unconventional Analytics, Is Key to Meaningful Data |
| Q41572397 | Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study |
| Q92176412 | Prognostic Impact of Ischemic Mitral Regurgitation Severity and Myocardial Infarct Quantification by Cardiovascular Magnetic Resonance |
| Q53279266 | Prognostic Impact of Low-Flow Severe Aortic Stenosis in Small-Body Patients Undergoing TAVR: The OCEAN-TAVI Registry. |
| Q90040131 | Prognostic Implications of Blunted Feature-Tracking Global Longitudinal Strain During Vasodilator Cardiovascular Magnetic Resonance Stress Imaging |
| Q48608881 | Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease |
| Q58546478 | Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study |
| Q91647770 | Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary Arteries |
| Q98629438 | Prognostic Significance of Cardiac Amyloidosis in Patients With Aortic Stenosis: A Systematic Review and Meta-Analysis |
| Q57448607 | Prognostic Significance of Remote Myocardium Alterations Assessed by Quantitative Noncontrast T1 Mapping in ST-Segment Elevation Myocardial Infarction |
| Q96615922 | Prognostic Utility of Left Ventricular Global Longitudinal Strain in Surgery for Primary Mitral Regurgitation: A Systematic Review |
| Q91647839 | Prognostic Utility of Oxygen-Sensitive Cardiac Magnetic Resonance Imaging in Diabetic and Nondiabetic Chronic Kidney Disease Patients With No Known Coronary Artery Disease |
| Q57448551 | Prognostic Value and Determinants of CMR-Derived Left Atrial Function Assessed in STEMI |
| Q92747840 | Prognostic Value of 18F-FDG PET Using Texture Analysis in Cardiac Sarcoidosis |
| Q54378069 | Prognostic Value of CMR-Verified Myocardial Scarring in Cardiac Sarcoidosis: What to Learn From a Systematic Review and Meta-Analysis? |
| Q98186779 | Prognostic Value of Cardiac Magnetic Resonance Estimates of Ventriculoarterial Coupling in Pulmonary Hypertension |
| Q45944746 | Prognostic Value of Combined Clinical and Myocardial Perfusion Imaging Data Using Machine Learning. |
| Q101137722 | Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis |
| Q48033665 | Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease |
| Q91307442 | Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISE |
| Q90566463 | Prognostic Value of Coronary Computed Tomographic Angiography in Patients With Nonalcoholic Fatty Liver Disease |
| Q50781661 | Prognostic Value of Demand Stress Real-Time Perfusion Imaging in Patients With Advanced Kidney Disease Undergoing Renal Transplantation. |
| Q46075608 | Prognostic Value of E/E′ Ratio in Patients With Unoperated Severe Aortic Stenosis |
| Q47819103 | Prognostic Value of Exercise-Stress Echocardiography in Asymptomatic Patients With Aortic Valve Stenosis |
| Q92771013 | Prognostic Value of Global Longitudinal Strain and Etiology After Surgery for Primary Mitral Regurgitation |
| Q91465426 | Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature |
| Q92770976 | Prognostic Value of Initial Left Ventricular Remodeling in Patients With Reperfused STEMI |
| Q39567060 | Prognostic Value of LGE-CMR in HCM: A Meta-Analysis |
| Q38938986 | Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis |
| Q90566474 | Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients |
| Q30276294 | Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis |
| Q98282912 | Prognostic Value of Quantitative Metrics From Positron Emission Tomography in Ischemic Heart Failure |
| Q47334138 | Prognostic Value of Quantitative Stress Perfusion Cardiac Magnetic Resonance. |
| Q102319424 | Prognostic Value of Radiotracer-Based Perfusion Imaging in Critical Limb Ischemia Patients Undergoing Lower Extremity Revascularization |
| Q91647832 | Prognostic Value of Relative Apical Sparing Pattern in Patients With Generalized Left Ventricular Hypertrophy |
| Q49896875 | Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement |
| Q62818229 | Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement |
| Q97565958 | Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19 |
| Q48659060 | Prognostic Value of Risk Factors, Calcium Score, Coronary CTA, Myocardial Perfusion Imaging, and Invasive Coronary Angiography in Kidney Transplantation Candidates |
| Q48511989 | Prognostic Value of Strain by Tissue Tracking Cardiac Magnetic Resonance After ST-Segment Elevation Myocardial Infarction |
| Q98282919 | Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function |
| Q89728069 | Prognostic Value of Stress Dynamic Computed Tomography Perfusion With Computed Tomography Delayed Enhancement |
| Q93192453 | Prognostic Value of Thoracic Aorta Calcification Burden in Patients Treated With TAVR |
| Q92747832 | Prognostic Value of Vasodilator Stress Perfusion CMR in Morbidly Obese Patients (BMI ≥40 kg/m2) Without Known CAD |
| Q46056330 | Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study |
| Q44134398 | Prognostic role of CMR in patients presenting with ventricular arrhythmias |
| Q53066780 | Prognostic significance of strain Doppler imaging in light-chain amyloidosis. |
| Q84571614 | Prognostic significance of strain imaging in amyloidosis |
| Q53343785 | Prognostic utility of coronary computed tomography angiography: are we looking at the correct outcomes and making appropriate comparisons? |
| Q35561924 | Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial |
| Q51163960 | Prognostic value of CT angiography in coronary bypass patients. |
| Q53213774 | Prognostic value of CT angiography in patients with inconclusive functional stress tests. |
| Q39354387 | Prognostic value of LA volumes assessed by transthoracic 3D echocardiography: comparison with 2D echocardiography. |
| Q39038820 | Prognostic value of LV deformation parameters using 2D and 3D speckle-tracking echocardiography in asymptomatic patients with severe aortic stenosis and preserved LV ejection fraction |
| Q46050573 | Prognostic value of PET myocardial perfusion imaging in obese patients |
| Q41743642 | Prognostic value of RV function before and after lung transplantation. |
| Q45927718 | Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. |
| Q46518997 | Prognostic value of coronary CT angiography |
| Q39537990 | Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients |
| Q88071487 | Prognostic value of coronary CTA in coronary bypass patients: a long-term follow-up study |
| Q43588497 | Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease |
| Q38387258 | Prognostic value of echocardiographic calcium score in patients with a clinical indication for stress echocardiography |
| Q87073896 | Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism |
| Q44655238 | Prognostic value of exercise echocardiography in patients with left bundle branch block |
| Q35754796 | Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study |
| Q30455362 | Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy |
| Q38248439 | Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients |
| Q51130804 | Prognostic value of number and site of calcified coronary lesions compared with the total score. |
| Q90553866 | Prognosticating in Cardiac Amyloidosis: Let Me Count the Ways |
| Q90313935 | Progress in Cardiovascular Imaging |
| Q91730629 | Progress in Cardiovascular Imaging |
| Q89380883 | Progress in Exercise Stress Imaging of the Pulmonary Circulation and RV |
| Q38845986 | Progression of CAC Score and Risk of Incident CVD. |
| Q103042447 | Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study |
| Q39804804 | Progression of coronary artery calcium predicts all-cause mortality |
| Q83876148 | Progression of coronary calcium scores: harder gets the evidence |
| Q51051973 | Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. |
| Q88168508 | Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based Chemotherapy |
| Q87843433 | Proliferation of Coronary Adventitial Vasa Vasorum in Patients With Spontaneous Coronary Artery Dissection |
| Q96132234 | Proportionality of Functional Mitral Regurgitation: Questioning the Model's Fundamentals and its Applicability in Clinical Practice |
| Q90553626 | Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials |
| Q99348959 | Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation (PRIME): A Checklist: Reviewed by the American College of Cardiology Healthcare Innovation Council |
| Q88737767 | Proposed Stages of Myocardial Phenotype Development in Fabry Disease |
| Q89728075 | Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network |
| Q96615924 | Prospective Comparison Between Saline and Radiocontrast for Intracoronary Imaging With Optical Coherence Tomography |
| Q89125746 | Prospective Comparison of FFR Derived From Coronary CT Angiography With SPECT Perfusion Imaging in Stable Coronary Artery Disease: The ReASSESS Study |
| Q52984809 | Prospective Evaluation of Cardiac CT in Reoperative Cardiac Surgery. |
| Q40720939 | Prospective Randomized Trial on Radiation Dose Estimates of CT Angiography Applying Iterative Image Reconstruction: The PROTECTION V Study |
| Q45938242 | Prospective electrocardiogram-gated delayed enhanced multidetector computed tomography accurately quantifies infarct size and reduces radiation exposure. |
| Q37438767 | Prospective evaluation of the clinical application of the American College of Cardiology Foundation/American Society of Echocardiography Appropriateness Criteria for transthoracic echocardiography |
| Q53146570 | Prospectively ECG-triggered rapid kV-switching dual-energy CT for quantitative imaging of myocardial perfusion. |
| Q89306198 | Prosthesis-Patient Mismatch: Another Reason for TAVR? |
| Q85098005 | Prosthetic heart valve ring thrombosis |
| Q86378667 | Prosthetic valve thrombosis: when and how should we lyse? |
| Q88071490 | Protected coronary arteries: do open grafts pave the way to survival? |
| Q30412848 | Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease |
| Q50063989 | Psoriasis-Related Visceral Adiposity and Arterial Inflammation: A New Adiposity Disease Entity? |
| Q86141468 | Publishing the most impactful imaging papers |
| Q46248829 | Pulling the RIPCORD: FFRCT to Improve Interpretation of Coronary CT Angiography |
| Q50063982 | Pulmonary Arterial Hypertension With Abnormal V/Q Single-Photon Emission Computed Tomography |
| Q92676887 | Pulmonary Artery Hypertension-Specific Therapy Improves Exercise Tolerance and Outcomes in Exercise-Induced Pulmonary Hypertension |
| Q91616174 | Pulmonary Hypertension Persistency in Severe Aortic Stenosis Patients Treated With TAVR |
| Q90554064 | Pulmonary Hypertension and Aortic Stenosis: Further Evidence That TAVR Is Not SAVR |
| Q52804542 | Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR. |
| Q91465487 | Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair |
| Q28083081 | Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group |
| Q90040150 | Putting the "I" in Infarction: Individualized Phenotyping for Risk Stratification Following Acute Myocardial Infarction |
| Q84733790 | Putting the face to a name: concurrent assessment of vascular morphology and biology |
| Q49574154 | QISS MR Angiography: An Alternative to CT Angiography for Peripheral Vascular Evaluation |
| Q58055379 | QRS Width and Mechanical Dyssynchrony for Selection of Patients for Cardiac Resynchronization Therapy |
| Q53059555 | Qualitative and quantitative scrutiny by regulatory process: is the truth subjective or objective? |
| Q53083032 | Qualitative characterization of adipose tissue by MDCT. |
| Q89455916 | Quality Improvement in Imaging: An Absence of Evidence May be Evidence of Absence |
| Q86812023 | Quality improvement using the AUC: is it this easy? |
| Q33887560 | Quantification of Lipid-Rich Core in Carotid Atherosclerosis Using Magnetic Resonance T2 Mapping: Relation to Clinical Presentation |
| Q37516791 | Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging. |
| Q37844253 | Quantification of coronary arterial stenoses by multidetector CT angiography in comparison with conventional angiography methods, caveats, and implications. |
| Q53360160 | Quantification of coronary artery stenoses by computed tomography. |
| Q37637806 | Quantification of extracellular matrix expansion by CMR in infiltrative heart disease |
| Q53062030 | Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance. |
| Q43769708 | Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography |
| Q34660562 | Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study |
| Q35169889 | Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network |
| Q91123685 | Quantifying Tricuspid Regurgitation Severity: A Comparison of Proximal Isovelocity Surface Area and Novel Quantitative Doppler Methods |
| Q30478452 | Quantifying the role of regional dyssynchrony on global left ventricular performance |
| Q89934518 | Quantitative Assessment of Myocardial Blood Flow in Cardiac Sarcoidosis: A Potential Next Step in the Further Integration of FDG-PET in Imaging Management? |
| Q96132216 | Quantitative Bone-Avid Tracer SPECT/CT for Cardiac Amyloidosis: A Crucial Step Forward |
| Q91123645 | Quantitative Evaluation of High-Risk Coronary Plaque by Coronary CTA and Subsequent Acute Coronary Events |
| Q56378349 | Quantitative Myocardial Perfusion CMR: Is the Game Worth the Candle? |
| Q59884040 | Quantitative Myocardial Perfusion Imaging Versus Visual Analysis in Diagnosing Myocardial Ischemia |
| Q87998937 | Quantitative PET Myocardial Blood Flow: "Trust, But Verify" |
| Q103042460 | Quantitative PET Perfusion Imaging: How to Interpret the Results? |
| Q83863106 | Quantitative PET measurements of myocardial blood flow in young, healthy volunteers what should we expect? |
| Q46820697 | Quantitative Pericardial Delayed Hyperenhancement Informs Clinical Course in Recurrent Pericarditis |
| Q47952098 | Quantitative Prediction of Paravalvular Leak in Transcatheter Aortic Valve Replacement Based on Tissue-Mimicking 3D Printing |
| Q88631898 | Quantitative Stress Perfusion Cardiac Magnetic Resonance Improves Prognostication: Crossroads for Increased Use of This Powerful Technology |
| Q37089925 | Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography |
| Q85445693 | Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT |
| Q38060007 | Quantitative assessment of mitral regurgitation: how best to do it. |
| Q47869483 | Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study |
| Q58564581 | RESPONSE: Collaboration and Collegiality: The Dual Pillars of Cardiovascular Imaging Now and in the Future |
| Q50204582 | ROC Cutpoints May Help Clinicians Predict the Need for Pacemakers Prior to TAVR. |
| Q52680478 | RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes. |
| Q46981005 | RV Dyssynchrony by Speckle Tracking Strain in Pulmonary Arterial Hypertension: Will This Outcome Variable Take Root? |
| Q87754207 | RV Function: Trying to Listen to Second Fiddle |
| Q53538008 | RV Longitudinal Deformation Correlates With Myocardial Fibrosis in Patients With End-Stage Heart Failure. |
| Q88583201 | RV Myocardial Strain During Pre-Load Augmentation Is Associated With Exercise Capacity in Patients With Chronic HF |
| Q39469984 | RV Remodeling in Olympic Athletes. |
| Q45894341 | RV contractility and exercise-induced pulmonary hypertension in chronic mountain sickness: a stress echocardiographic and tissue Doppler imaging study |
| Q44475883 | RV dysfunction after lung transplantation: a new prognostic marker or mainly a correlate of lung allograft function? |
| Q47910568 | RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness |
| Q34292516 | RV electrical activation in heart failure during right, left, and biventricular pacing |
| Q84392176 | RV electrical activation in heart failure during right, left, and biventricular pacing |
| Q53109225 | RV form and function: a piston pump, vortex impeller, or hydraulic ram? |
| Q54449999 | RV is doing well at high altitudes!--Always? |
| Q84377407 | RV volume measurements by CMR |
| Q52991690 | Radiation Dose Reduction in Coronary CT Angiography: Time to Buckle Down. |
| Q86514825 | Radiation Exposure in Medical Imaging: Is the Message Out or Just Being Ignored? |
| Q89028780 | Radiation Exposure of Downstream Testing |
| Q102319419 | Radiation Exposure of Dual-Source Cardiovascular Computed Tomography in Patients With Congenital Heart Disease |
| Q39313202 | Radiation Safety in Children With Congenital and Acquired Heart Disease: A Scientific Position Statement on Multimodality Dose Optimization From the Image Gently Alliance |
| Q63198791 | Radiation Therapy for Head and Neck Cancer and Angioneogenesis |
| Q53261353 | Radiation exposure from cardiac computed tomography. |
| Q90857298 | Radiation-Associated Cardiac Disease: A Practical Approach to Diagnosis and Management |
| Q39033193 | Radiobiology in Cardiovascular Imaging |
| Q49896899 | Radiolabeled Duramycin: Promising Translational Imaging of Myocardial Apoptosis. |
| Q42248546 | Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections |
| Q37085665 | Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium |
| Q96615918 | Radiolabeled-White Blood Cell Imaging in Cardiac Device-Related Infective Endocarditis: Worth All the Effort? |
| Q91123707 | Radiomic Analysis of Myocardial Native T1 Imaging Discriminates Between Hypertensive Heart Disease and Hypertrophic Cardiomyopathy |
| Q99623491 | Radiomic Assessment of Pericoronary Adipose Tissue: Detecting the Vulnerable Patient |
| Q92411259 | Radiomics in Hypertrophic Cardiomyopathy: The New Tool |
| Q92176497 | Radionuclide Image-Guided Repair of the Heart |
| Q102319430 | Radionuclide Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis: Different Sensitivity in Early-Onset V30M Mutation? |
| Q92047540 | Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients |
| Q92135569 | Randomized Trial Comparing Transdermal With Sublingual Nitroglycerin Administration for Coronary Vasodilation in CTA |
| Q89455920 | Randomized Trials in Cardiovascular Imaging: Where to Next? |
| Q33428357 | Randomized comparison of 64-slice single- and dual-source computed tomography coronary angiography for the detection of coronary artery disease |
| Q43243348 | Ranolazine and the myocardial demand-supply balance |
| Q45083293 | Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. |
| Q92038017 | Rapid Cardiovascular Magnetic Resonance for Ischemic Heart Disease Investigation (RAPID-IHD) |
| Q89125769 | Rate of Progression of Aortic Stenosis and its Impact on Outcomes in Patients With Radiation-Associated Cardiac Disease: A Matched Cohort Study |
| Q89125757 | Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial |
| Q56879198 | Real-Time 3D Fusion Echocardiography |
| Q82428324 | Real-Time 3D TEE Allows Optimized Guidance of Percutaneous Edge-to-Edge Repair of the Mitral Valve |
| Q51594574 | Real-Time 3D TEE for Diagnosis of Subvalvular Pannus Formation in Mechanical Aortic Valves: Comparison With Multidetector CT and Surgical Findings. |
| Q53058876 | Real-time 3-dimensional echocardiographic assessment of left ventricular dyssynchrony: pitfalls in patients with dilated cardiomyopathy. |
| Q53054706 | Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. |
| Q84399189 | Real-time 3-dimensional transesophageal echocardiography during double percutaneous mitral edge-to-edge procedure |
| Q53451407 | Real-time 3D TEE for multiperforated interatrial septum. |
| Q46218494 | Real-time 3D TEE for the diagnosis of right-sided endocarditis in patients with prosthetic devices |
| Q42686290 | Real-time 3D echo in patient selection for cardiac resynchronization therapy |
| Q84811026 | Real-time 3D echocardiographic quantification of left atrial volume: multicenter study for validation with CMR |
| Q51557410 | Real-time 3D transesophageal echocardiography for the evaluation of rheumatic mitral stenosis. |
| Q44574119 | Real-time CT-guided percutaneous placement of LV pacing leads. |
| Q46425725 | Real-time integration of MDCT-derived coronary anatomy and epicardial fat: impact on epicardial electroanatomic mapping and ablation for ventricular arrhythmias |
| Q83432200 | Real-time, fluoroless, anatomic-guided catheter navigation by 3D TEE during ablation procedures |
| Q91894941 | Reassessing the Meaning of Fractional Flow Reserve and Myocardial Perfusion Imaging: Hemodynamic Significance Does Not Equal Ischemia |
| Q52982817 | Recanalization of Organized Thrombi Demonstrated by Coronary CT Angiography Compared With OCT. |
| Q37731643 | Recent developments in heart failure imaging |
| Q102319402 | Recipe for Success in Transthyretin Cardiomyopathy: Monoclonal Protein Rule Out, SPECT Imaging, and Genetic Testing |
| Q93192492 | Reclassifying Risk in Familial Hypercholesterolemia: The Power of a Coronary Artery Calcium Score of Zero |
| Q53699389 | Recognizing Breast Arterial Calcification as Atherosclerotic CVD Risk Equivalent: From Evidence to Action. |
| Q89210634 | Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis |
| Q38378832 | Recommendations for comprehensive intraprocedural echocardiographic imaging during TAVR. |
| Q37244354 | Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study |
| Q50612487 | Redefining diastolic dysfunction grading: combination of E/A ≤0.75 and deceleration time >140 ms and E/ε' ≥10. |
| Q84569493 | Rediscovery of infarct imaging by cardiac CT |
| Q87482719 | Redrawing the borders: considering guideline revision in functional mitral regurgitation |
| Q92771051 | Reducing Radiation Dose in Coronary Computed Tomography Angiography: We Are Not There Yet |
| Q101137748 | Reduction in CMR Derived Extracellular Volume with Patisiran Indicates Cardiac Amyloid Regression |
| Q59221087 | Reduction of Circulating HLA-DR + T Cell Levels Correlates With Increased Carotid Intraplaque Neovascularization and Atherosclerotic Burden |
| Q88041982 | Reduction of SPECT MPI Radiation Dose Using Contemporary Protocols and Technology |
| Q49192062 | Reference citations in iJACC: litera scripta manet |
| Q43292397 | Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial |
| Q53020155 | Regadenoson versus dipyridamole hyperemia for cardiac PET imaging. |
| Q102319433 | Regional Distribution of Fluorine-18-Flubrobenguane and Carbon-11-Hydroxyephedrine for Cardiac PET Imaging of Sympathetic Innervation |
| Q57744121 | Regional Heterogeneity of LV Wall Thickness∗ |
| Q87590169 | Regional Left Ventricular Myocardial Mechanics in Degenerative Myxomatous Mitral Valve Disease: A Comparison Between Fibroelastic Deficiency and Barlow's Disease |
| Q92038062 | Regional Left Ventricular Myocardial Work Indices and Response to Cardiac Resynchronization Therapy |
| Q50057885 | Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality |
| Q84085798 | Regional differences in aortic geometry pathologic or compensatory? |
| Q40385483 | Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial |
| Q38459399 | Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin |
| Q98629445 | Regurgitant Volume/Left Ventricular End-Diastolic Volume Ratio: Prognostic Value in Patients With Secondary Mitral Regurgitation |
| Q86258643 | Regurgitant volume informs rate of progressive cardiac dysfunction in asymptomatic patients with chronic aortic or mitral regurgitation |
| Q98230879 | Relation Among Right Ventricular Dysfunction, Lung Damage, and Mortality in Patients With COVID-19 |
| Q83863098 | Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes |
| Q86134070 | Relation between the SYNTAX score and culprit vessel vulnerability in non-ST-segment elevation acute coronary syndrome |
| Q85413002 | Relation of Dimensionless Index to Long-Term Outcome in Aortic Stenosis With Preserved LVEF |
| Q35876106 | Relation of torsion and myocardial strains to LV ejection fraction in hypertension |
| Q91647791 | Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction |
| Q49896772 | Relationship Between Left Atrial Functional Measures and Incident Atrial Fibrillation in the General Population: The Copenhagen City Heart Study |
| Q93192361 | Relationship Between Left Ventricular Ejection Fraction and Mortality in Asymptomatic and Minimally Symptomatic Patients With Severe Aortic Stenosis |
| Q51507336 | Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy. |
| Q57779375 | Relationship Between Transmural Extent of Necrosis and Quantitative Recovery of Regional Strains After Revascularization |
| Q33577038 | Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis) |
| Q45828376 | Relationship between carotid disease on ultrasound and coronary disease on CT angiography |
| Q48006392 | Relationship between palpography and virtual histology in patients with acute coronary syndromes |
| Q85039919 | Relationship between previous training and experience and results of the certification examination in cardiovascular computed tomography |
| Q93160450 | Relationship of Anticoagulant Therapies on Coronary Plaque Progression: A Longitudinal CTA Analysis |
| Q36552398 | Relationship of Coronary Calcium on Standard Chest CT Scans With Mortality |
| Q91307421 | Relationship of Degree of Systolic Dysfunction to Variations in Exercise Capacity and Hemodynamic Status in HFpEF |
| Q83629564 | Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia |
| Q42089083 | Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. |
| Q91018936 | Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits |
| Q92047493 | Relative Contribution of Afterload and Interstitial Fibrosis to Myocardial Function in Severe Aortic Stenosis |
| Q57815521 | Relative Importance of Baseline and Longitudinal Evaluation in the Follow-Up of Vasodilator Therapy in Pulmonary Arterial Hypertension |
| Q90554088 | Relative Left Ventricular Apical Sparing of Longitudinal Strain in Cardiac Amyloidosis: Is it Just Amyloid Infiltration? |
| Q90202200 | Reliability of CAC Scoring on Nongated Compared With Gated Cardiac CT Scans From MESA |
| Q51055987 | Remote ultrasound: new opportunities. |
| Q49126140 | Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease |
| Q85649676 | Repeat routine differential pulmonary blood flow measurements in congenital heart disease by MR: interstudy variability and benchmark of a clinically relevant change |
| Q92203930 | Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis |
| Q56986180 | Reply |
| Q57298828 | Reply |
| Q62711716 | Reply |
| Q62818351 | Reply |
| Q104278749 | Reply to Letter |
| Q34625429 | Reply: A comprehensive evaluation of left atrial performance using volumetric analysis, strain, and strain rate imaging |
| Q43729791 | Reply: Asymptomatic cardiovascular risk assessment: the road less traveled |
| Q48717973 | Reply: B-lines: a nonspecific but highly informative sign of pulmonary congestion |
| Q48618353 | Reply: Bicuspid aortic valve phenotype and aortopathy: nomenclature and role of aortic hemodynamics |
| Q85814815 | Reply: CMR-Based Characterization of Cardiac Amyloidosis |
| Q52990869 | Reply: Comparison of Echocardiography and CT for the Assessment of Aortic Stenosis Valve Area. |
| Q87883236 | Reply: Diagnostic problem of LV hypertrabeculation/noncompaction? |
| Q86542170 | Reply: Diagnostic value of quantitative CMR in patients suspected of having myocarditis: a question of timing |
| Q87578761 | Reply: Effects of blood T1 on extracellular volume calculation |
| Q53470364 | Reply: Extracellular Volume and Cardiac Mechanics: Have We Found a Missing Puzzle Piece? |
| Q53422746 | Reply: From Plaque Morphology to Ischemia: Pushing the Limits of Spatial Resolution. |
| Q87235310 | Reply: Handheld Ultrasound is a Valuble Bedside Tool Which Can Supplement the Bedside Cardiac Exam but not Replace It |
| Q86718897 | Reply: Is new grade Ia of diastolic dysfunction relevant at the population level? |
| Q86691936 | Reply: Longitudinal Strain and Type 1 Diabetes Mellitus: Are We on the Wrong Track? |
| Q87259723 | Reply: MDCT in TAVR for better implant angle and outcomes |
| Q87112232 | Reply: Myocardial extracellular volume measurement by cardiac magnetic resonance |
| Q47337790 | Reply: Objectively Measuring the Ghost in the Machine: B-Lines as Uncertain Measures on Which to Base Clinical Assessment. |
| Q52990168 | Reply: Presence of Ischemia by FFR Without Significant Anatomic Stenosis Is Likely due to Concomitant Diffuse Disease and Not due to Impaired Vasodilation From Pharmacological Stress. |
| Q87482708 | Reply: Surgical threshold for bicuspid aortic valve-associated aortopathy: does the phenotype matter? |
| Q52991686 | Reply: The Role of 3D Printing in Structural Heart Disease: All That Glitters Is Not Gold. |
| Q53124392 | Reply: To PMID 22789937. |
| Q86581106 | Reply: To PMID 23236967 |
| Q42332517 | Reply: Tricuspid regurgitation severity associated with positioning of RV lead or other etiology assessed by intracardiac echocardiography |
| Q86932874 | Reply: Valvular disease, myocardial mechanics, and valve guidelines |
| Q44065896 | Reply: complexity of assessment and management of Tako-Tsubo cardiomyopathy |
| Q87703081 | Reply: in the footsteps of Virchow |
| Q87235300 | Reply: physical examination is still necessary and important |
| Q53051831 | Reply: the ethics of publishing dual exposure scans involving ionizing radiation when validated alternatives exist. |
| Q44062382 | Reply: what truly causes the adverse outcome in tako-tsubo cardiomyopathy? |
| Q92770950 | Reproducibility of Atrial Fibrosis Assessment Using CMR Imaging and an Open Source Platform |
| Q87431402 | Reproducibility of in vivo measurements for fibrous cap thickness and lipid arc by OCT |
| Q83179358 | Reproducibility of proximal isovelocity surface area, vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity |
| Q90857309 | Research to Practice: Assessment of Left Ventricular Global Longitudinal Strain for Surveillance of Cancer Chemotherapeutic-Related Cardiac Dysfunction |
| Q39639374 | Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention |
| Q83461320 | Resolution of inflammation, statins, and plaque regression |
| Q101137704 | Resolving the Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse Due to Barlow Disease: Insights From Cardiovascular Magnetic Resonance |
| Q37352184 | Respiratory-mode display of echocardiographic images highlights effects of pericardial disease. |
| Q86122442 | Resting Aortic Valve Area at Normal Transaortic Flow Rate Reflects True Valve Area in Suspected Low-Gradient Severe Aortic Stenosis |
| Q90080804 | Resurgence of Novel Research in Nuclear Cardiology |
| Q46056293 | Resurrection of thallium-201 for myocardial perfusion imaging |
| Q85065560 | Retraction. iSHOTS: aortic valve perforation diagnosed by 3-dimensional transesophageal echocardiogram |
| Q52650692 | Reveal the Concealed: The Quest For Early Disease Detection In Family Members At Risk Of Developing Arrhythmogenic Cardiomyopathy. |
| Q46831387 | Reversible TR in acute and chronic cardiomyopathy: medical versus surgical management? |
| Q51600515 | Reversing the Substrate for Atrial Fibrillation With CRT? |
| Q53704446 | Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle. |
| Q88088238 | Revisiting the End-Diastolic Forward Flow (Restrictive Physiology) in Tetralogy of Fallot: An Exercise, Echocardiographic, and Magnetic Resonance Study |
| Q48492825 | Rheumatoid arthritis: mapping the future. |
| Q57815553 | Right Atrial Phasic Function in Heart Failure With Preserved and Reduced Ejection Fraction |
| Q35738510 | Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension |
| Q87331808 | Right Heart Score for Predicting Outcome in PAH: Is It All Inclusive? |
| Q48669308 | Right Intraventricular Dyssynchrony in Idiopathic, Heritable, and Anorexigen-Induced Pulmonary Arterial Hypertension: Clinical Impact and Reversibility. |
| Q50061191 | Right Ventricle Dysfunction in Cardiomyopathy: To Measure Is to Know |
| Q87331781 | Right Ventricle Involvement in Tako-Tsubo Cardiomyopathy |
| Q92747738 | Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis |
| Q102319439 | Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension |
| Q95273600 | Right Ventricular Dilation in Hospitalized Patients with COVID-19 Infection |
| Q97565978 | Right Ventricular Function and Pulmonary Pressures as Independent Predictors of Survival in Patients With COVID-19 Pneumonia |
| Q93192501 | Right Ventricular Function in TAVR: The Right Hand Knows What the Left Hand Is Doing |
| Q91647749 | Right Ventricular Function: The Barometer of All That Lies Ahead |
| Q91123689 | Right Ventricular Junctional Late Gadolinium Enhancement Correlates With Outcomes in Pulmonary Hypertension |
| Q98230886 | Right Ventricular Longitudinal Strain: A New Prognostic Tool for COVID-19? |
| Q101137708 | Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension |
| Q90678603 | Right Ventricular Strain: A Better Window Into the Working of the Heart in Pulmonary Hypertension |
| Q83832392 | Right atrial volume index in chronic systolic heart failure and prognosis |
| Q53360156 | Right-sided origin of the left main coronary artery: typical variants and their visualization by cardiac computerized tomography. |
| Q51069433 | Risk Detection Among Asymptomatic Patients With Diabetes: Is It Time for a Varied Approach? |
| Q54034432 | Risk Factors for Development of Carotid Plaque Components. |
| Q92038114 | Risk Factors for the Development of Functional Tricuspid Regurgitation and Their Population-Attributable Fractions |
| Q52988667 | Risk Prediction Using CACS in Younger Populations: Theory or Valid Practice? |
| Q50499898 | Risk Stratification by Cardiovascular Magnetic Resonance After Reperfused ST-Segment Elevation Myocardial Infarction: Ready for Prime Time? |
| Q90040177 | Risk Stratification in ICD Candidates Beyond Ejection Fraction: Potential Role of Myocardial Deformation Imaging? |
| Q91320379 | Risk Stratification in Nonischemic Dilated Cardiomyopathy in the Era of Personalized Medicine: Can Cardiac Magnetic Resonance With Late Gadolinium Imaging "Enhance" Our Strategy? |
| Q45047194 | Risk of ASCVD and Secondhand Tobacco Exposure: All Smoke and Mirrors? No More |
| Q45938236 | Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. |
| Q83629644 | Risk stratification by stress echocardiography beyond wall motion analysis |
| Q98186781 | Risk-Stratifying COVID-19 Patients the Right Way |
| Q51055998 | Robot-assisted remote echocardiographic examination and teleconsultation: a randomized comparison of time to diagnosis with standard of care referral approach. |
| Q84182427 | Rock 'n roll ventricle of the dyssynchronous heart: clinical significance of rocking motion in selection of patient for cardiac resynchronization therapy |
| Q61913844 | Rocking and Flashing With RV Pacing |
| Q56985661 | Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis |
| Q38087672 | Role of CMR imaging in risk stratification for sudden cardiac death. |
| Q38827217 | Role of CMR in TAVR. |
| Q45069359 | Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy |
| Q47848331 | Role of Exercise Testing in Hypertrophic Cardiomyopathy |
| Q50951814 | Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. |
| Q102319413 | Role of FFR-CT for the Evaluation of Patients With Anomalous Aortic Origin of Coronary Artery |
| Q26800070 | Role of Imaging in the Evaluation of Patients at Risk for Sudden Cardiac Death: Genotype-Phenotype Intersection |
| Q47949935 | Role of Imaging in the Management of Stable Ischemic Heart Disease: An Evolving Paradigm Shift |
| Q30632030 | Role of LA shape in predicting embolic cerebrovascular events in mitral stenosis: mechanistic insights from 3D echocardiography |
| Q47667856 | Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT Study. |
| Q51507343 | Role of PET Imaging in Management of Implantable Electronic Device Infection. |
| Q47861129 | Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis |
| Q53313583 | Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. |
| Q48005199 | Role of echocardiography in percutaneous aortic valve implantation |
| Q38025825 | Role of echocardiography in percutaneous mitral valve interventions. |
| Q83629619 | Role of echocardiography in predicting onset of heart failure in patients with stable coronary artery disease: is the whole greater than the sum of its parts? |
| Q87286658 | Role of echocardiography in tako-tsubo cardiomyopathy: beyond diagnosis? |
| Q37677211 | Role of left ventricular twist mechanics in the assessment of cardiac dyssynchrony in heart failure |
| Q52604079 | Roles of Transesophageal Echocardiography and Cardiac Computed Tomography for Evaluation of Left Atrial Thrombus and Associated Pathology: A Review and Critical Analysis. |
| Q47599241 | Routine Clinical Quantitative Rest Stress Myocardial Perfusion for Managing Coronary Artery Disease: Clinical Relevance of Test-Retest Variability |
| Q92747732 | Routine Use of Cardiovascular Magnetic Resonance in the Work-Up of Patients With Ventricular Arrhythmias? |
| Q89028785 | Ruptures and Thickening: Optical Coherence Tomography as the Arbiter of the Fibrous Cap |
| Q90202228 | SPECT-Guided LV Lead Placement for Incremental CRT Efficacy: Validated by a Prospective, Randomized, Controlled Study |
| Q90384178 | STEMI, the Smoker's Paradox, and Cardiac Magnetic Resonance Imaging: It's All a Case of Smoke and Mirrors |
| Q51216306 | Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation. |
| Q87919865 | Safety and Feasibility of Contrast Echocardiography for ECMO Evaluation |
| Q83629521 | Safety and accuracy of 64-slice computed tomography coronary angiography in children after the arterial switch operation for transposition of the great arteries |
| Q53286040 | Safety and feasibility of contrast echocardiography for LVAD evaluation. |
| Q43275230 | Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients. |
| Q54103266 | Same Lesion, Different Artery, Different FFR!? |
| Q47737508 | Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study |
| Q89306207 | Scar Detection by Pulse-Cancellation Echocardiography: Validation by CMR in Patients With Recent STEMI |
| Q92747822 | Scar in Secondary MR, Another Piece to the Puzzle: Dead Meat Don't Beat |
| Q47303847 | Scout view X-ray attenuation versus weight-based selection of reduced peak tube voltage in cardiac CT angiography |
| Q52971903 | Screening CT Angiography in Asymptomatic Diabetes Mellitus? |
| Q39354266 | Screening CT Angiography of the Aorta, Visceral Branch Vessels, and Pelvic Arteries in Fibromuscular Dysplasia |
| Q27027690 | Screening and risk stratification of coronary artery disease in end-stage renal disease |
| Q37731641 | Screening for left ventricular systolic dysfunction: is imaging a solution? |
| Q104278748 | Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expert Consensus Statement |
| Q85814783 | Screening, diagnosis, and management of CAD in asymptomatic diabetic patients |
| Q98629431 | Searching for Underlying Causes of Myocardial Infarction With Multi-Modality Imaging |
| Q50866125 | Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification. |
| Q50445978 | Seeing or hearing to believe, or both? |
| Q84567933 | Seeing spirals |
| Q42560934 | Seeing the unseen fibrosis in heart failure with preserved ejection fraction |
| Q83629659 | Seeking remedy for Molly's woe: time for a thallium pill? |
| Q33860139 | Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis |
| Q85814775 | Selection for cardiac resynchronization therapy: all in a flash? |
| Q103042365 | Selective Heart Rate Inhibition Improves Single-Ventricular Stroke Volume, Function, and Efficiency During Exercise |
| Q90554227 | Selective Referral Using CCTA Versus Direct Referral for Individuals Referred to Invasive Coronary Angiography for Suspected CAD: A Randomized, Controlled, Open-Label Trial |
| Q41550912 | Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway. |
| Q93192371 | Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis |
| Q53074200 | Semiautomated quantification of aortic annulus dimensions on cardiac CT for TAVR. |
| Q37633183 | Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt |
| Q86249277 | Separating the VAT from the FAT: new insights into the cardiometabolic risks of obesity |
| Q34635322 | Septal pouch in the left atrium and risk of ischemic stroke |
| Q46203159 | Septal thrombus in the left atrium: is the left atrial septal pouch the culprit? |
| Q57815517 | Serial Assessment of Coronary Flow Reserve by Rubidium-82 Positron Emission Tomography Predicts Mortality in Heart Transplant Recipients |
| Q53411116 | Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded Arteries. |
| Q103042378 | Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography |
| Q84948058 | Serial Doppler echocardiography and tissue Doppler imaging in the detection of elevated directly measured left atrial pressure in ambulant subjects with chronic heart failure |
| Q91783854 | Serial Mapping for Evaluating Cardiac Therapies: Promising, But Not Perfect |
| Q53569801 | Serial Multimodality Evaluation of Aortocoronary Bypass Grafts During the First Year After CABG Surgery. |
| Q88114559 | Serial OCT Imaging in Vascular Healing After Everolimus-Eluting Stent Implantation |
| Q57815546 | Serial PET Measurements of Myocardial Blood Flow for Prognosis Assessment in Heart Transplant Patients: The Forest and the Trees |
| Q46011764 | Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. |
| Q42969235 | Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention |
| Q38179117 | Serial myocardial perfusion imaging: defining a significant change and targeting management decisions |
| Q53105659 | Serial quantitative assessment of absolute coronary flow and flow reserve with CAD progression to events. |
| Q57815550 | Setting the Standard for Prognostic Analysis |
| Q88114553 | Severe Aortic Stenosis: It Used to Be Simple |
| Q92411400 | Severe Bradycardia and Asystole Following Regadenoson in Pharmacological Myocardial Perfusion Imaging: Cases and Treatment Recommendations |
| Q91018951 | Severe Left Ventricular Outflow Tract Calcification Is Associated With Poor Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement |
| Q39004807 | Severe Mitral Annular Calcification: Multimodality Imaging for Therapeutic Strategies and Interventions |
| Q86249268 | Severe tricuspid valve regurgitation is not an innocent finding to be ignored! |
| Q36248209 | Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. |
| Q90202250 | Sex Difference in Left Ventricular Response to Aortic Stenosis |
| Q40812253 | Sex Differences in Cardiovascular Imaging |
| Q98629429 | Sex Differences in Compositional Plaque Volume Progression in Patients With Coronary Artery Disease |
| Q91123667 | Sex Differences in Coronary Artery and Thoracic Aorta Calcification and Their Association With Cardiovascular Mortality in Heavy Smokers |
| Q99623493 | Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCE |
| Q98629430 | Sex Differences in Coronary Plaque Composition and Progression: Will it Influence Clinical Management? |
| Q37171071 | Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial |
| Q89141595 | Sex Differences in Mitral Regurgitation Before and After Mitral Valve Surgery |
| Q96615838 | Sex Differences in Valve-Calcification Activity and Calcification Progression in Aortic Stenosis |
| Q52983800 | Sex Differences in the Progression of Aortic Stenosis and Prognostic Implication: The COFRASA-GENERAC Study. |
| Q47575590 | Sex Dimorphism in the Myocardial Response to Aortic Stenosis. |
| Q38801295 | Sex-Based Differences in Acute Coronary Syndromes: Insights From Invasive and Noninvasive Coronary Technologies |
| Q90948508 | Sex-Related Differences in Low-Gradient, Low-Ejection Fraction Aortic Stenosis: Results From the Multicenter TOPAS Study |
| Q92676868 | Sex-Related Differences in the Extent of Myocardial Fibrosis in Patients With Aortic Valve Stenosis |
| Q37291811 | Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry |
| Q51112108 | Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN. |
| Q88742595 | Shaking and Breaking Calcified Plaque: Lithoplasty, a Breakthrough in Interventional Armamentarium? |
| Q54322349 | Sharpening the Focus on Causes of Ethnic Differences in Aortic Stiffness. |
| Q94953588 | Shear Stress Estimated by Quantitative Coronary Angiography Predicts Plaques Prone to Progress and Cause Events |
| Q100414001 | Shear Wave Elastography Using High-Frame-Rate Imaging in the Follow-Up of Heart Transplantation Recipients |
| Q30374319 | Shear Wave Imaging of Passive Diastolic Myocardial Stiffness: Stunned Versus Infarcted Myocardium |
| Q50781670 | Shedding Light on Cardiac Allograft Vasculopathy: OCT to Predict Progression of Disease. |
| Q92411455 | Shedding Light on Pathophysiology of Spontaneous Coronary Artery Dissection |
| Q111489905 | Shining Light on the Impact of Air Pollution |
| Q90313915 | Short DAPT Duration for Well-Covered Stents? |
| Q84571603 | Shortening without contraction: new insights into hibernating myocardium |
| Q96615912 | Should We Adjust Low-Density Lipoprotein Cholesterol Management to the Severity of Coronary Artery Disease? |
| Q61716611 | Should We Be Trying to Define Responders to Cardiac Resynchronization Therapy? |
| Q88352832 | Should We Reappraise Surgical Indications in Asymptomatic Severe High-Gradient Aortic Stenosis? |
| Q92770907 | Should We Test for Diastolic Dysfunction? How and How Often? |
| Q45686338 | Should old acquaintance be forgot: Auld Lang Syne Q waves! |
| Q87482696 | Should the guidelines for the assessment of the severity of functional mitral regurgitation be redefined? |
| Q83629446 | Should we operate on asymptomatic patients with severe mitral regurgitation? |
| Q46592826 | Sickle Cardiomyopathy: The Missing Forest in the Trees |
| Q84377399 | Side-by-side comparison of fluoroscopy, 2D and 3D TEE during percutaneous edge-to-edge mitral valve repair |
| Q53959918 | Similar Plaque Composition in Men and Women With Stable CAD: Another Myth Falls. |
| Q30403424 | Simultaneous right and left heart real-time, free-breathing CMR flow quantification identifies constrictive physiology |
| Q88737775 | Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy |
| Q37073532 | Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin |
| Q91123693 | Single-Center Experience With Catheter-Based Tricuspid Valve Replacement for Tricuspid Regurgitation: Procedural and Echocardiographic Findings |
| Q90553966 | Sinus Venosus Defects: Anatomic Variants and Transcatheter Closure Feasibility Using Virtual Reality Planning |
| Q43647423 | Sizing the Mitral Annulus: Is CT the Future? |
| Q43068937 | Skeletal muscle perfusion in peripheral arterial disease a novel end point for cardiovascular imaging |
| Q92135564 | Slow Untwisting May Identify Risk of Progression in Elderly With Stage A Heart Failure |
| Q101137747 | Softening the Stiff Heart: SGLT2 Inhibition and Diastolic Function |
| Q92021307 | Software Variability in Measurement of LV Mechanical Dispersion in Patients With LV Hypertrophy |
| Q88583204 | Some Laws Were Not Made to Be Broken: When Frank-Starling Reserve Is Lost in Heart Failure |
| Q99348957 | Spatial Distribution of Vulnerable Plaques: Comprehensive In Vivo Coronary Plaque Mapping |
| Q50585742 | Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents. |
| Q50685037 | Speckle-tracking echocardiography for predicting outcome in chronic aortic regurgitation during conservative management and after surgery. |
| Q57735979 | Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations |
| Q90202219 | Spleen Size and Appearance by Transesophageal Echocardiography in Patients With Suspected Infective Endocarditis |
| Q39061766 | Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. |
| Q92411447 | Spontaneous Coronary Artery Dissection: Pathophysiological Insights From Optical Coherence Tomography |
| Q62075663 | Spontaneous Multivessel Coronary Intramural Hematoma |
| Q57058591 | Spotlight on Strain Following Myocardial Infarction |
| Q92047679 | Stability of Distribution of F18 Flurpiridaz After Transient Coronary Occlusion in Pigs |
| Q90466890 | Stage B Aortic Regurgitation in Bicuspid Aortic Valve: New Observations on Progression Rate and Predictors |
| Q88737781 | Stage B Heart Failure: To Strain or Not to Strain |
| Q88217120 | Staging Cardiac Amyloidosis With CMR: Understanding the Different Phenotypes |
| Q38089285 | Standardized imaging for aortic annular sizing: implications for transcatheter valve selection |
| Q44558143 | Staphylococcus aureus Bloodstream Infection: When Is Transthoracic Echocardiography Sufficient? |
| Q50057859 | Stasis Mapping Using Ultrasound: A Prospective Study in Acute Myocardial Infarction. |
| Q92505466 | State-of-the-Art Deep Learning in Cardiovascular Image Analysis |
| Q95471863 | Statement on matching language to the type of evidence used in describing outcomes data |
| Q38721111 | Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA. |
| Q54329816 | Statin Use Is Associated With Fewer High-Risk Plaques on Coronary CT Angiography. |
| Q83661374 | Statin therapy for subclinical atherosclerosis in primary prevention: time to prove it? |
| Q54737972 | Statin therapy resolves coronary artery inflammation. |
| Q42872747 | Steadily straining toward clinical utility: real-time quantitative CMR of myocardial deformation during stress |
| Q86378701 | Stenosis of a mechanical mitral valve prosthesis by eccentric paraprosthetic aortic regurgitation |
| Q45847308 | Stenotic aortic valve area: should it be calculated from CT instead of echocardiographic data? |
| Q87408646 | Stiff by stress: operant LV diastolic stiffness assessed with pre-load stress echocardiography |
| Q87590203 | Stone Liver, Heart in Danger: Could the Liver Stiffness Assessment Improve the Management of Patients With Heart Failure? |
| Q98186782 | Strain Analysis Using Feature-Tracking CMR to Detect LV Systolic Dysfunction in Myocardial Iron Overload Disease |
| Q42426904 | Strain Echocardiography and LQTS Subtypes: Mechanical Alterations in an Electrical Disorder |
| Q53279260 | Strain Echocardiography: From Variability to Predictability. |
| Q91465498 | Strain by Feature Tracking: A Short Summary of the Journey of CMR in STEMI |
| Q45359883 | Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction |
| Q92135599 | Strain for Stress Testing: Is it a Featuring or Supporting Role in Cardiac Magnetic Resonance? |
| Q87131028 | Strain imaging in uncomplicated type 1 diabetes patients for risk stratification: it ain't as "sweet" as it sounds |
| Q43098205 | Strain-encoded CMR for the detection of inducible ischemia during intermediate stress |
| Q91647777 | Straining for New Prognostic Predictors in Asymptomatic Severe Aortic Regurgitation |
| Q48599475 | Straining the RV to predict the future |
| Q51721423 | Straining to justify strain measurement. |
| Q84731026 | Streptococcal pharyngitis-associated myocarditis mimicking acute STEMI |
| Q96615920 | Stress CMR Imaging for Stable Chest Pain Syndromes: Underused and Undervalued? |
| Q90566493 | Stress CMR and Combination Testing in the World of Multimodality Imaging |
| Q36818392 | Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care |
| Q37009593 | Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain |
| Q57815551 | Stress Computed Tomography Perfusion Versus Fractional Flow Reserve CT Derived in Suspected Coronary Artery Disease: The PERFECTION Study |
| Q61162314 | Stress Echocardiography to Assess Stenosis Severity and Predict Outcome in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis and Preserved LVEF |
| Q87841415 | Stress Echocardiography, Carotid Arteries, and More: Its Versatility for Our Imaging Times |
| Q90202203 | Stress Myocardial Blood Flow Ratio by Dynamic CT Perfusion Identifies Hemodynamically Significant CAD |
| Q50725653 | Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. |
| Q42939311 | Stress and rest dynamic myocardial perfusion imaging by evaluation of complete time-attenuation curves with dual-source CT. |
| Q37915743 | Stress myocardial CT perfusion: an update and future perspective |
| Q37637851 | Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. |
| Q84730992 | Stress myocardial perfusion imaging by computed tomography a dynamic road is ahead |
| Q30454789 | Stress myocardial perfusion imaging for assessing prognosis: an update |
| Q53108472 | Stress myocardial perfusion imaging- the beginning... |
| Q52876937 | Stress testing in the obese: are we finally getting the bigger picture? |
| Q46056295 | Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging |
| Q92747750 | Stress-Only Adenosine CMR Improves Diagnostic Yield in Stable Symptomatic Patients With Coronary Artery Calcium |
| Q94545839 | Stress-Only CMR |
| Q96615903 | Stress-Only SPECT Myocardial Perfusion Imaging for All? |
| Q91123561 | Stretch and Rebound in the Search for Cardiac Resynchronization Therapy Candidates |
| Q48570538 | Stroke: cause and effect--seek and ye shall find |
| Q102319452 | Structural and Functional Correlates of Gradient-Area Patterns in Severe Aortic Stenosis and Normal Ejection Fraction |
| Q90636144 | Structural and Physiological Imaging to Predict the Risk of Lethal Ventricular Arrhythmias and Sudden Death |
| Q97589601 | Structure Predicts (Dys)Function: Atrial Fibrosis, Function, and Incident Atrial Fibrillation |
| Q85949654 | Strut Coverage After Paclitaxel-Eluting Stent Implantation in the Superficial Femoral Artery |
| Q39360321 | Subclinical Myocardial Impairment in Metabolic Diseases |
| Q97551327 | Substrate Imaging to Guide Primary Prevention Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy: Fanciful or Realistic Aim? |
| Q89580462 | Substrate for Ventricular Arrhythmia: To See Is to Know? |
| Q92037966 | Substrate for the Myocardial Inflammation-Heart Failure Hypothesis Identified Using Novel USPIO Methodology |
| Q92676833 | Subtypes of Atrial Functional Mitral Regurgitation: Imaging Insights Into Their Mechanisms and Therapeutic Implications |
| Q53309386 | Successful transapical transcatheter valve implantation within a dysfunctional mitral bioprosthesis. |
| Q92176451 | Sudden Cardiac Death in Ischemic Heart Disease: From Imaging Arrhythmogenic Substrate to Guiding Therapies |
| Q82551790 | Sunflower artifact in OCT |
| Q53574320 | Superficial Calcium Fracture After PCI as Assessed by OCT. |
| Q37531284 | Superficial femoral artery plaque and functional performance in peripheral arterial disease: walking and leg circulation study (WALCS III) |
| Q62503595 | Superior Risk Stratification With Coronary Computed Tomography Angiography Using a Comprehensive Atherosclerotic Risk Score |
| Q48507343 | Superior doctor at a point-of-care: a call to change HF management |
| Q57915446 | Surgical Threshold for Bicuspid Aortic Valve–Associated Aortopathy |
| Q45302038 | Surgical repair of complex endocarditis |
| Q38170763 | Surgical thresholds for bicuspid aortic valve associated aortopathy |
| Q84560929 | Surgical ventricular reconstruction for heart failure: is there life after STICH? |
| Q49887209 | Surrogate Survival: Battle Between Left Ventricular Ejection Fraction and Global Longitudinal Strain |
| Q36174136 | Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. |
| Q47563797 | Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling |
| Q45768991 | Synchronicity of LV contraction as a determinant of LV twist mechanics: serial speckle-tracking analyses in WPW syndrome before and after radiofrequency catheter ablation. |
| Q90553822 | Syncope in Aortic Stenosis: Is it Too Late to Wait? |
| Q90554180 | Syncope: The Underestimated Threat in Severe Aortic Stenosis |
| Q33445810 | Synergistic effect of cardiovascular risk factors on necrotic core in coronary arteries: a report from the global intravascular radiofrequency data analysis registry |
| Q54806284 | Synthetic Myocardial Extracellular Volume Fraction |
| Q38733940 | Systematic CT Methodology for the Evaluation of Subclinical Leaflet Thrombosis |
| Q48031201 | Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study |
| Q84378456 | Systemic RV in hypoplastic left heart syndrome after surgical palliation |
| Q61913835 | Systolic Stretch Characterizes the Electromechanical Substrate Responsive to Cardiac Resynchronization Therapy |
| Q30665402 | T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging |
| Q83461325 | T(2)-weighted CMR: but where is Elvis in the end? |
| Q97551335 | T1 Mapping Tissue Heterogeneity Provides Improved Risk Stratification for ICDs without needing Gadolinium in Patients with Dilated Cardiomyopathy |
| Q41036082 | T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication |
| Q52572459 | T1 Mapping by Cardiac Magnetic Resonance and Multidimensional Speckle-Tracking Strain by Echocardiography for the Detection of Acute Cellular Rejection in Cardiac Allograft Recipients. |
| Q91894973 | T1 Mapping for Cardiac Allograft Rejection |
| Q30277761 | T1 Mapping: Basic Techniques and Clinical Applications |
| Q87070518 | T1 Maps in Nonischemic DCM: Do They Show Us the Way? |
| Q43475156 | T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy? |
| Q38451361 | T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique |
| Q86405696 | T1 mapping in cardiac amyloidosis: can we get there from here? |
| Q93192482 | T1 or ECV?: Depends on the Methods |
| Q40980282 | T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure |
| Q90566429 | T2 Mapping Identifies Early Anthracycline-Induced Cardiotoxicity in Elderly Patients With Cancer |
| Q64984668 | T2* magnetic resonance: iron and gold. |
| Q30425254 | T2-weighted imaging to assess post-infarct myocardium at risk |
| Q88737818 | TAC for TAVR: What Is the Score? |
| Q57815522 | TAG, You're Out |
| Q89455313 | TAVR and Thrombosis |
| Q89455291 | TAVR-Related Complications: Why Did We Forget the Design of a Normal Aortic Valve? |
| Q87482715 | TEE-guided transapical beating-heart neochord implantation in mitral regurgitation |
| Q45938234 | Taking the last hurdles: magnetic resonance myocardial perfusion imaging. |
| Q62396980 | Tako-Tsubo Cardiomyopathy: A Heart Stressed Out of Energy? |
| Q37764499 | Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology |
| Q88088220 | Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors |
| Q54231035 | Targeted Bacteria-Specific 18F-Fluoro-Maltohexaose but Not FDG PET Distinguishes Infection From Inflammation. |
| Q48505914 | Targeted Imaging for Cell Death in Cardiovascular Disorders |
| Q34537947 | Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green. |
| Q48031293 | Targeted imaging offers advantages over physiological imaging for evaluation of angiogenic therapy |
| Q37984866 | Targeted metabolic imaging to improve the management of heart disease |
| Q84377385 | Targeted molecular imaging: target significance and probe validation |
| Q98282915 | Teaching an Old Dog New Tricks: Using Cardiac CT for Comprehensive Imaging |
| Q53449118 | Teaching appropriate behavior, and what to consider if that fails. |
| Q46362184 | Temporal Change in CAC Score and Prognosis: Follow-Up Score Is Simpler and as Good as a Change in Score |
| Q98282929 | Temporal Trends in Detection and Outcomes of Low-Flow and Low-Gradient Aortic Stenosis |
| Q30467931 | Temporal characterization of the functional density of the vasa vasorum by contrast-enhanced ultrasonography maximum intensity projection imaging |
| Q44175696 | Temporal course of vessel healing and neoatherosclerosis after DES implantation |
| Q30512110 | Temporal enhancement of 3D echocardiography by frame reordering |
| Q37561116 | Temporal trends in the utilization of echocardiography in Ontario, 2001 to 2009. |
| Q57815541 | Ten-Year Follow-Up After Coronary Computed Tomography Angiography in Patients With Suspected Coronary Artery Disease |
| Q94953580 | Testing for Coronary Artery Spasm Noninvasively: Potentially Ideal, But Safe? |
| Q84068351 | Testing for myocardial ischemia: the end of surrogates? |
| Q93192511 | The "Native T1 Versus Extracellular Volume Fraction Paradox" in Cardiac Amyloidosis: Answer to the Million-Dollar Question? |
| Q54269424 | The 10-Year Prognostic Value of Zero and Minimal CAC. |
| Q92524502 | The 2016 Diastolic Function Guideline: Is it Already Time to Revisit or Revise Them? |
| Q97589600 | The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation |
| Q92747784 | The Added Value of 3D Real-Time Multiplanar Reconstruction for Intraprocedural Guidance of Challenging MitraClip Cases |
| Q92411411 | The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials |
| Q36880519 | The Association of Coronary Artery Calcium With Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis |
| Q88776368 | The Association of Secondhand Tobacco Smoke and CT Angiography-Verified Coronary Atherosclerosis |
| Q87331819 | The Author Replies |
| Q87438615 | The Author Replies |
| Q89455342 | The Author Replies |
| Q95406573 | The Author Replies |
| Q92524513 | The Author Reply |
| Q92505485 | The Author's Reply |
| Q57058562 | The Authors Reply |
| Q57058569 | The Authors Reply |
| Q87231549 | The Authors Reply |
| Q87331758 | The Authors Reply |
| Q87331763 | The Authors Reply |
| Q87438610 | The Authors Reply |
| Q87715417 | The Authors Reply |
| Q88927445 | The Authors Reply |
| Q89210630 | The Authors Reply |
| Q89580460 | The Authors Reply |
| Q90080800 | The Authors Reply |
| Q90313960 | The Authors Reply |
| Q90636152 | The Authors Reply |
| Q91730624 | The Authors Reply |
| Q91170713 | The Authors Reply |
| Q91406544 | The Authors Reply |
| Q92203173 | The Authors Reply |
| Q92505478 | The Authors Reply |
| Q94545833 | The Authors Reply |
| Q95388371 | The Authors Reply |
| Q95406570 | The Authors Reply |
| Q95410188 | The Authors Reply |
| Q95431652 | The Authors Reply |
| Q95431971 | The Authors Reply |
| Q95457988 | The Authors Reply |
| Q95484055 | The Authors Reply |
| Q95502209 | The Authors Reply |
| Q95502211 | The Authors Reply |
| Q95514381 | The Authors Reply |
| Q95514388 | The Authors Reply |
| Q95520462 | The Authors Reply |
| Q95520467 | The Authors Reply |
| Q95526094 | The Authors Reply |
| Q95553901 | The Authors Reply |
| Q95561348 | The Authors Reply |
| Q95561352 | The Authors Reply |
| Q95561357 | The Authors Reply |
| Q95561372 | The Authors Reply |
| Q95571732 | The Authors Reply |
| Q95577812 | The Authors Reply |
| Q95578886 | The Authors Reply |
| Q95578888 | The Authors Reply |
| Q95584357 | The Authors Reply |
| Q95597099 | The Authors Reply |
| Q96132229 | The Authors Reply |
| Q98230875 | The Authors Reply |
| Q98230883 | The Authors Reply |
| Q99348961 | The Authors Reply |
| Q100502933 | The Authors Reply |
| Q52984411 | The Authors Reply. |
| Q53080036 | The Authors Reply. |
| Q53115662 | The Authors Reply. |
| Q53132567 | The Authors Reply. |
| Q57679993 | The Authors Reply: |
| Q57680002 | The Authors Reply: |
| Q60597013 | The Authors Reply: |
| Q61651711 | The Authors Reply: |
| Q61651713 | The Authors Reply: |
| Q61651722 | The Authors Reply: |
| Q61651724 | The Authors Reply: |
| Q91783624 | The Authors Reply: Computed Tomography Angiography-Based Risk Discrimination: An Established Bright Future for Prognostication |
| Q91783632 | The Authors Reply: Mandatory Minimums in Cardiac Imaging: Applying Thresholds With Evidence |
| Q96132237 | The Authors Reply:: Proportionality of Functional Mitral Regurgitation: Questioning the Model's Fundamentals and its Applicability in Clinical Practice |
| Q90313949 | The Authors' Reply |
| Q91616181 | The Authors' Reply |
| Q91894933 | The Authors' Reply |
| Q91406552 | The Authors' Reply |
| Q92855904 | The Authors' Reply |
| Q93129795 | The Authors' Reply |
| Q95392487 | The Authors' Reply |
| Q95482203 | The Authors' Reply |
| Q95482219 | The Authors' Reply |
| Q95482228 | The Authors' Reply |
| Q95482236 | The Authors' Reply |
| Q30248626 | The Case For and Against a Coronary Artery Calcium Trial: Means, Motive, and Opportunity |
| Q50188147 | The Challenge of Effectively Reporting Coronary Angiography Results From Computed Tomography |
| Q46045384 | The Challenges of Diagnosing Cardiac Sarcoidosis |
| Q50057832 | The Changing Face of Heart Failure |
| Q100431016 | The Clinical Spectrum of Myocardial Infarction and Ischemia With Nonobstructive Coronary Arteries in Women |
| Q41044666 | The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR. |
| Q47208302 | The Coronary Artery Disease-Reporting and Data System (CAD-RADS): Prognostic and Clinical Implications Associated With Standardized Coronary Computed Tomography Angiography Reporting |
| Q97532943 | The Current State of Cardiovascular Imaging Training: Results of the Cardiovascular Imaging Program Directors' Survey |
| Q92047530 | The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy |
| Q54000429 | The Devilish Details of Cardiovascular Imaging for Heart Failure Prevention. |
| Q89934503 | The Difficulty of Determining Disease Activity in Large Artery Vasculitis |
| Q49896818 | The Dilemma of Exertional Dyspnea and Diagnosis of Heart Failure: Convergent and Discriminant Validity |
| Q53777144 | The Dye Don't Lie But May Not Tell the Truth: Combining Coronary Computed Tomography Angiography With Myocardial Perfusion Imaging. |
| Q92135593 | The Effect of Blood Composition on T1 Mapping |
| Q90040212 | The Effect of Systolic Variation of Mitral Regurgitation on Discordance Between Noninvasive Imaging Modalities |
| Q85814798 | The Eustachian ridge: not an innocent bystander |
| Q38721105 | The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial. |
| Q92569242 | The Eye of the Beholder: Aortic Stenosis Symptomatology and Outcomes After Aortic Valve Replacement |
| Q88813874 | The Fast and the Curious: Physiological Insights From Fast Frame Rate Imaging |
| Q45038760 | The Fault Is in Our Scars: LGE and Ventricular Arrhythmia Risk in LV Dysfunction |
| Q47941624 | The Female Side of the Heart: Sex Differences in Athlete's Heart |
| Q91123654 | The Forgotten Valve Finally Gets Some Respect |
| Q57815527 | The Frequency of Premature Coronary Artery Disease Identified on Coronary CT Angiography Among Patients Presenting With Chest Pain at a Single Institution |
| Q53008960 | The Functional Effects of Intramural Course of Coronary Arteries and its Relation to Coronary Atherosclerosis. |
| Q90553461 | The Functional Meaning of B-Profile During Stress Lung Ultrasound |
| Q48014510 | The Functional Significance of Paradoxical Low-Gradient Aortic Valve Stenosis: Hemodynamic Findings During Cardiopulmonary Exercise Testing. |
| Q38814089 | The Future of Cardiac Imaging: Report of a Think Tank Convened by the American College of Cardiology |
| Q92569230 | The Future of Cardiovascular Computed Tomography: Advanced Analytics and Clinical Insights |
| Q92047651 | The Hazardous Longitudinal Heterogeneity of Plaques: A Complex Mountain Range, Not a Single Volcano |
| Q104278761 | The Higher You Climb, the Better the View: Quantitative CMR Perfusion Mapping for CAD |
| Q92176435 | The Hypertrophic Cardiomyopathy Phenotype Viewed Through the Prism of Multimodality Imaging: Clinical and Etiologic Implications |
| Q38630128 | The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies: A Systematic Review and Meta-Analysis |
| Q83629608 | The Imaging Council of the American College of Cardiology |
| Q50057866 | The Immediate Effects of Statins on Coronary Atherosclerosis: Can Phenotype Explain Outcome? |
| Q45383752 | The Impact of Endurance Exercise Training on Left Ventricular Torsion |
| Q92771041 | The Impact of IAC-Echo Accreditation and Required Quality Assurance Initiatives on Transthoracic Echocardiogram Interpretation Errors |
| Q53120729 | The Impact of Infarct Location and Extent on LV Motion Patterns: Implications for Dyssynchrony Assessment. |
| Q97589602 | The Impact of Integrated Noninvasive Imaging in the Management of Takayasu Arteritis |
| Q90554108 | The Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction: What Phase of Diastole Is Helped? |
| Q91018959 | The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial |
| Q92037956 | The Importance and the Challenges of Predicting the Progression of Functional Tricuspid Regurgitation |
| Q90202211 | The Interstitium in the Hypertrophied Heart |
| Q57815525 | The Intraventricular Hemodynamic Forces Estimated Using Routine CMR Cine Images: A New Marker of the Failing Heart |
| Q113871715 | The Landscape of Primary Mitral Regurgitation Phenotypes |
| Q50137805 | The Location of Distal Coronary Artery Pressure Measurement Matters for Computed Tomography-Derived Fractional Flow Reserve |
| Q102319457 | The Look Inside: Is it Clinically Relevant? |
| Q45063941 | The Many Dimensions of Diastolic Function: A Curse or a Blessing? |
| Q53749413 | The Many Faces of EMF. |
| Q91170601 | The Myocardial Interstitium: The Principal Therapeutic Target of the 21st Century? |
| Q98186787 | The Myocardium in Aortic Stenosis Revisited: More Complex Than Just Myocytes and Interstitial Diffuse Fibrosis |
| Q36677979 | The Need for Standardized Methods for Measuring the Aorta: Multimodality Core Lab Experience From the GenTAC Registry |
| Q88609479 | The New Era of Computational Fluid Dynamics in CT Angiography: Far Beyond the FFR Number |
| Q91616188 | The New Wave of Cardiovascular Biomechanics |
| Q88813879 | The Normal Mitral Valve Annulus in Humans Defined Using 3-Dimensional Transesophageal Echocardiography |
| Q88583197 | The Ongoing Quest to Predict Plaque Rupture |
| Q91783639 | The Ongoing Quest to Better Detect High-Risk Coronary Plaques |
| Q91123620 | The Optics of Optical Coherence Tomography: Let the Race Begin! |
| Q57815555 | The Other Atrium in Heart Failure |
| Q83661587 | The PROSPECT of changing our approach to acute coronary syndromes |
| Q101137707 | The Paradox of Secondary Mitral Regurgitation: Why Less Is More |
| Q47812761 | The Pickelhaube Sign: Novel Echocardiographic Risk Marker for Malignant Mitral Valve Prolapse Syndrome |
| Q41693071 | The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update |
| Q92676892 | The Potential of PET in the Management of Peripheral Arterial Disease |
| Q100431004 | The Predictive Role of Left and Right Ventricular Speckle-Tracking Echocardiography in Coronavirus Disease 2019 |
| Q47809097 | The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy |
| Q39654961 | The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM. |
| Q88737753 | The Prognostic Role of Global Longitudinal Strain in Severe Primary Mitral Regurgitation: Moving Past the Proof-of-Concept Era |
| Q92047619 | The Prognostic Role of Late Gadolinium Enhancement in Aortic Stenosis: A Systematic Review and Meta-Analysis |
| Q92037974 | The Prognostic Value of 99mTc-HMPAO-Labeled Leucocyte SPECT/CT in Cardiac Device-Related Infective Endocarditis |
| Q90384183 | The Prognostic Value of Diastolic and Systolic Mechanical Left Ventricular Dyssynchrony Among Patients With Coronary Heart Disease |
| Q88430443 | The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis |
| Q52650699 | The Prognostic Value of Right Ventricular Deformation Imaging in Early Arrhythmogenic Right Ventricular Cardiomyopathy. |
| Q90636168 | The Promise of Imaging in MINOCA |
| Q87998927 | The Public Health Service Needs to Do More |
| Q30235352 | The Quantitative Science of Evaluating Imaging Evidence. |
| Q96615825 | The Quest to Better Quantitate Tricuspid Regurgitation |
| Q50057861 | The RAC Sign: Retroaortic Anomalous Coronary Artery Visualization by Transthoracic Echocardiography |
| Q87331745 | The Relation of Ejection Fraction and Global Longitudinal Strain in Amyloidosis: Implications for Differential Diagnosis |
| Q102319412 | The Relationship Between Coronary Calcification and the Natural History of Coronary Artery Disease |
| Q92135604 | The Relationship Between EF and Strain Permits a More Accurate Assessment of LV Systolic Function |
| Q98186785 | The Relationship Between Mechanical Dispersion and Late Gadolinium Enhancement in Patients With Nonischemic Cardiomyopathy |
| Q98629435 | The Relativity of Reference Values for Myocardial Perfusion Imaging |
| Q38889316 | The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR. |
| Q50061201 | The Right Ventricle: Unforgettable With Imaging |
| Q52991687 | The Role of 3D Printing in Structural Heart Disease: All That Glitters Is Not Gold. |
| Q91616152 | The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease |
| Q50137811 | The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Highly Trained Athletes. |
| Q37800233 | The Role of Echocardiography and Other Imaging Modalities in Patients With Left Ventricular Assist Devices |
| Q60923154 | The Role of Imaging in Measuring Disease Progression and Assessing Novel Therapies in Aortic Stenosis |
| Q91406533 | The Role of Imaging of Flow Patterns by 4D Flow MRI in Aortic Stenosis |
| Q88737796 | The Search for High-Risk Coronary Plaque in Patients With Diabetes |
| Q47676814 | The Shape of Imaging in the Future: Lessons Learned From the CRESCENT II Trial |
| Q86184431 | The Shape of LVH in Hypertension: What Does it Tell Us? |
| Q98282922 | The Stress CMR Top SPINS On and On |
| Q50057828 | The Stress of Plaque Prognostication |
| Q83629634 | The Tei index as an expression of right ventricular impairment and recovery: investment grade or subprime? |
| Q58867577 | The Thorny Way of 3D Strain From Research to Clinical Use |
| Q45025094 | The Tissue Issue: T1 Mapping and the Myocardium |
| Q53008955 | The Transmural Extent and Severity of Myocardial Hypoperfusion Predicts Long-Term Outcome in NSTEMI: An MDCT Study. |
| Q103042311 | The Trials and Tribulations of Conducting Stress CMR Quantitative Analysis Studies |
| Q91123662 | The Tricuspid Valve Relationship With the Right Ventricle and Pulmonary Vasculature |
| Q92411275 | The Unrelenting Search for Bioprosthetic Aortic Valve Durability |
| Q99575273 | The Usefulness of Cardiovascular Magnetic Resonance in the Assessment of Patients Before Pacemaker Implantation |
| Q92176468 | The Value of Strain in Familial Dilated Cardiomyopathy Screening |
| Q52988669 | The Whole Is Greater Than the Sum of its Parts: Combining CT Angiography and Highly Sensitive Troponin in the Diagnostic Work-Up of Patients With Acute Chest Pain. |
| Q37800234 | The Year in Coronary Artery Disease |
| Q37423120 | The advancing clinical impact of molecular imaging in CVD. |
| Q86321392 | The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT |
| Q43175089 | The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantation |
| Q42875922 | The basic science that is epidemiology |
| Q86141411 | The dawn of perfusion CMR: taking over from FFR in suspected coronary artery disease? |
| Q84730989 | The differences between neovascularization of chronic total occlusion and intraplaque angiogenesis |
| Q53051835 | The ethics of publishing dual exposure scans involving ionizing radiation when validated alternatives exist. |
| Q53085887 | The ethics of publishing medical imaging research. |
| Q53026534 | The exercise test is alive and well when coupled with coronary calcium scoring. |
| Q46102081 | The expanding frontier in valve imaging |
| Q53108465 | The first long-lasting use of echocardiography: a result of a false advertisement. |
| Q48482846 | The future of CV risk prediction: multisite imaging to predict multiple outcomes |
| Q39728670 | The future of molecular imaging |
| Q84058493 | The growth and growth of cardiac ultrasound for the evaluation of myocardial function |
| Q47836292 | The heart of the matter: prime time E/e' prime! |
| Q37438773 | The history of cardiovascular magnetic resonance |
| Q30476766 | The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q85097984 | The importance of regurgitant orifice shape in mitral regurgitation |
| Q83629617 | The interventional cardiologist and structural heart disease: the need for a team approach |
| Q88071511 | The last cover |
| Q27022553 | The left atrial appendage: anatomy, function, and noninvasive evaluation |
| Q27007142 | The limit of plausibility for predictors of response: application to biventricular pacing |
| Q83629557 | The multimodality imager: reality or fantasy? |
| Q43415318 | The myth of the mild vulnerable plaques |
| Q85649668 | The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography |
| Q53299957 | The napkin-ring sign: CT signature of high-risk coronary plaques? |
| Q34179251 | The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern |
| Q51698180 | The need for speed: accelerating CMR imaging assessment of cardiac function. |
| Q83629626 | The no-reflow phenomenon |
| Q53132847 | The one-stop shop offering both coronary anatomy and myocardial perfusion: may well be opening soon, around the corner. |
| Q84085644 | The prognostic value of cardiac CT after coronary artery bypass surgery as easy as 1, 2, 3? |
| Q42572426 | The prognostic value of global circumferential strain in patients with suspected myocardial disease |
| Q86405729 | The promise of myocardial fibrosis assessment by T1 mapping |
| Q84748270 | The reality of vulnerable plaque detection |
| Q45671783 | The red devil revisited |
| Q42777233 | The relationship of age with regional aortic stiffness and diameter |
| Q36190063 | The road connecting obesity and coronary vasomotor function: straight line or U-turn? |
| Q84058483 | The role of 3D transesophageal echocardiography during percutaneous closure of paravalvular mitral regurgitation |
| Q38205319 | The role of imaging in aortic dissection and related syndromes |
| Q37438735 | The role of imaging in chronic degenerative mitral regurgitation |
| Q37599041 | The role of multimodality cardiac imaging in the transplanted heart |
| Q86587390 | The shifting tides of coronary blood flow and medical imaging economics |
| Q87408652 | The sins of the fathers (and mothers) and the 2013 guidelines |
| Q86405710 | The slope of the segmental stretch-strain relationship as a noninvasive index of LV inotropy |
| Q86932876 | The symphony, the ensemble, and the interventional imager… |
| Q45760469 | The symptoms of aortic stenosis: a step closer to understanding their cause |
| Q84399181 | The umbilical cord: an ally in targeted imaging research? |
| Q87259714 | The uncertainties of certainty: using LV function to predict arrhythmic event after AMI |
| Q46077186 | The use of a learning community and online evaluation of utilization for SPECT myocardial perfusion imaging |
| Q46000502 | The value of image integration for epicardial catheter ablation of ventricular tachycardia. |
| Q84567927 | The vena contracta area: conquering quantification with a 3D cut? |
| Q84182463 | The vulnerable plaque "hypothesis": promise, but little progress |
| Q37516796 | The year in coronary artery disease |
| Q37542391 | The year in imaging related to electrophysiology |
| Q37779643 | The year in intracoronary imaging |
| Q36384680 | The year in molecular imaging |
| Q53289963 | The year in molecular imaging. |
| Q54911978 | The year in molecular imaging. |
| Q83629629 | The year that was: looking back with pride and a time to take stock |
| Q46056329 | Theranostic strategy against plaque angiogenesis |
| Q91123625 | Thinking Outside the Heart |
| Q57640295 | Thoracic Aortic Calcification: Diagnostic, Prognostic, and Management Considerations |
| Q38495624 | Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease events |
| Q96615840 | Three-Dimensional CT Planning for Cerebral Embolic Protection in Structural Interventions |
| Q58864277 | Three-Dimensional Printing of Mitral Valve Using Echocardiographic Data |
| Q30514141 | Three-dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience. |
| Q33779834 | Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging |
| Q44946644 | Three-dimensional echocardiography: is it ready for everyday clinical use? |
| Q102319417 | Thresholds for Abdominal Aortic Calcium That Predict Cardiovascular Disease Events in the Framingham Heart Study |
| Q37324445 | Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional Studies |
| Q102319431 | Thromboembolic Complications of Annuloplasty Rings |
| Q49896848 | Thrombus-Related Coronary High-Intensity Signal on T1-Weighted Magnetic Resonance Imaging Is a Potential Predictor of Adverse Cardiovascular Events After Stent Implantation |
| Q92676904 | Ticagrelor to Reduce Myocardial Injury in Patients With High-Risk Coronary Artery Plaque |
| Q89309726 | Timing of Cardiac Magnetic Resonance Imaging Impacts on the Detection Rate of Left Ventricular Thrombus After Myocardial Infarction |
| Q92047569 | Timing of Surgery for Primary MR: We're Not There Yet But We're Getting Closer |
| Q82770705 | Tissue Doppler image-derived measurements during isovolumic contraction predict exercise capacity in patients with reduced left ventricular ejection fraction |
| Q38677659 | Tissue Tracking Technology for Assessing Cardiac Mechanics: Principles, Normal Values, and Clinical Applications |
| Q37438763 | Tissue characterization of acute myocardial infarction and myocarditis by cardiac magnetic resonance |
| Q53235549 | To Be or Not to Be a Multimodality Imager! |
| Q53075276 | To MR or Not to MR: Is That the Question? |
| Q49721064 | Topographic Pattern of Valve Calcification: A New Determinant of Disease Severity in Aortic Valve Stenosis. |
| Q83629418 | Total coronary artery calcium score remains preferred metric to refine risk prediction in nearly all patients |
| Q92505474 | Toward Improving Our Understanding of the Relationship Between IMR and MVO in STEMI Patients |
| Q50725641 | Toward Noninvasive Assessment of CVP Variations Using Real-Time and Quantitative Liver Stiffness Estimation. |
| Q30499147 | Towards real-time intravascular endoscopic magnetic resonance imaging |
| Q50666223 | Tracking cell therapy: bioluminescence lighting the way. |
| Q48717780 | Tracking oxidatively stressed cardiac stem cells with molecular imaging: "insights" into fate, viability, and function |
| Q50687719 | Tracking the right ventricle work in progress. |
| Q88501792 | Training in Multimodality CV Imaging: Is There an Inclusive Model? |
| Q83629642 | Training in multimodality imaging: challenges and opportunities |
| Q88088246 | Transaortic Flow Rate Versus Stroke Volume Index in Low-Gradient Aortic Stenosis |
| Q61727641 | Transcatheter Aortic Heart Valves |
| Q92135544 | Transcatheter Aortic Valve Replacement: Role of Multimodality Imaging in Common and Complex Clinical Scenarios |
| Q91123589 | Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation Is Associated With Right Ventricular Reverse Remodeling in Patients With Right-Sided Heart Failure |
| Q90636139 | Transcatheter Interventions for Mitral Regurgitation: Multimodality Imaging for Patient Selection and Procedural Guidance |
| Q93192473 | Transcatheter Repair of Severe Functional Tricuspid Insufficiency Using a Mitral Clip System: Transgastric Views Are the Key for an Effective Guide |
| Q26799061 | Transcatheter Valve Implantation in Failed Surgically Inserted Bioprosthesis: Review and Practical Guide to Echocardiographic Imaging in Valve-in-Valve Procedures |
| Q53026529 | Transcatheter caval valve implantation using multimodality imaging: roles of TEE, CT, and 3D printing. |
| Q53074203 | Transcatheter solution for pure aortic insufficiency |
| Q37615631 | Transesophageal echocardiography for device closure of atrial septal defects: case selection, planning, and procedural guidance. |
| Q82919218 | Transesophageal echocardiography to help position and deploy a transcatheter heart valve |
| Q33651630 | Transmural myocardial mechanics during isovolumic contraction |
| Q50625008 | Transthoracic 3D Echocardiographic Left Heart Chamber Quantification Using an Automated Adaptive Analytics Algorithm. |
| Q49887188 | Transthoracic Echocardiographic Findings of Mitral Regurgitation Caused by Commissural Prolapse |
| Q47735903 | Transthoracic echocardiography guidance for TAVR under monitored anesthesia care |
| Q84182475 | Treatment of acute intravascular thrombi with diagnostic ultrasound and intravenous microbubbles |
| Q38916931 | Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions |
| Q52666123 | Trials and Tribulations of Assessing New Imaging Protocols: Combining Vasodilator Stress With Exercise. |
| Q39171417 | Trials of Imaging Use in the Emergency Department for Acute Chest Pain |
| Q39171425 | Trials of Quality Improvement in Imaging |
| Q57815535 | Tricuspid Annular Morphology: Focus on the Forgotten |
| Q92203195 | Tricuspid Regurgitation: A Voyage of Discovery |
| Q91123721 | Tricuspid Regurgitation: Moderate (or More) Is a Burden for the Right Ventricle |
| Q92855871 | Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease |
| Q92855885 | Tricuspid Valve Imaging and Intervention in Pediatric and Adult Patients With Congenital Heart Disease |
| Q98186780 | Tricuspid Valve-in-Valve and Bioprosthetic Surgical Tricuspid and Pulmonic Valve Degeneration: Lessons From Imaging and Histopathology |
| Q42621202 | Tricuspid regurgitation severity associated with positioning of RV lead or other etiology assessed by intracardiac echocardiography |
| Q88430429 | Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Vulnerable Plaque Features With Statin Therapy in Diabetic Patients With Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis |
| Q85616541 | Triple Rule Out CTA Scans or the Right Test for the Right Patient |
| Q53001857 | Triple Rule Out Versus Coronary CT Angiography in Patients With Acute Chest Pain: Results From the ACIC Consortium. |
| Q35617332 | Troponin T levels and infarct size by SPECT myocardial perfusion imaging |
| Q92038049 | Twenty-First Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient |
| Q37438746 | Twist mechanics of the left ventricle: principles and application |
| Q53675982 | Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds. |
| Q45133429 | U-shaped mechanical activation 4 U? |
| Q39915468 | Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography |
| Q91307437 | Ultrafast Ultrasound Imaging in Pediatric and Adult Cardiology: Techniques, Applications, and Perspectives |
| Q38239944 | Ultrafast cardiac ultrasound imaging: technical principles, applications, and clinical benefits |
| Q43765490 | Ultrasonographic measure of carotid plaque burden |
| Q89210627 | Ultrasound Contrast Quantification for the Diagnosis of Intracardiac Masses |
| Q43275229 | Ultrasound contrast agent safety: from anecdote to evidence |
| Q45927710 | Ultrasound mediated destruction of DNA-loaded microbubbles for enhancement of cell-based therapies: new promise amidst a confluence of uncertainties? |
| Q30416117 | Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles |
| Q45886981 | Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice |
| Q51837689 | Uncovered Culprit Plaque Ruptures in Patients With ST-Segment Elevation Myocardial Infarction Assessed by Optical Coherence Tomography and Intravascular Ultrasound With iMap. |
| Q90202198 | Understanding Coronary Physiology Through Dynamic CT Perfusion Imaging |
| Q54806417 | Understanding LV Remodeling Following Myocardial Infarction |
| Q97589597 | Understanding Quantitative Computed Tomography Coronary Artery Plaque Assessment Using Machine Learning |
| Q114163599 | Understanding the Prognostic Significance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy |
| Q89281486 | Understanding the Role of the LA in Functional Responses to Heart Failure |
| Q90553939 | Understanding the Tides of Myocardial Infarction |
| Q45361861 | Understanding the asymmetrical vena contracta area: the difficult relationship between 2D and 3D measurements |
| Q49896734 | Undiluted Contrast Media in the Pulmonary Veins and Left Atrium After Cavopulmonary Connection: CT Sign of a Right-to-Left Shunt |
| Q37438816 | Unparalleled contribution of technetium-99m to medicine over 5 decades |
| Q57815543 | Unraveling the Cardiovascular PROSPECTs of Patients With Prediabetes |
| Q50725636 | Unraveling the RV Ejection Doppler Envelope: Insight Into Pulmonary Artery Hemodynamics and Disease Severity. |
| Q52717758 | Unrecognized Myocardial Infarction: Time to Rectify Failures of Detection and Failures of Prevention. |
| Q88742591 | Untangling the Diagnosis and Clinical Implications of Calcified Coronary Nodules |
| Q47797779 | Updating Algorithms for Predicting Pre-Test Likelihood of Coronary Artery Disease: A Cure for Inappropriate Testing? |
| Q39818274 | Use of Angiographic CT Imaging in the Cardiac Catheterization Laboratory for Congenital Heart Disease |
| Q48517597 | Use of Atrial Strain to Predict Atrial Fibrillation After Cerebral Ischemia |
| Q92047661 | Use of Contemporary Imaging Techniques for Electrophysiological and Device Implantation Procedures |
| Q53411088 | Use of Echocardiography for Guiding Percutaneous Tricuspid Valve Procedures. |
| Q39171404 | Use of Imaging Endpoints in Clinical Trials |
| Q102319405 | Use of Routine Echocardiographic Screening for Structural Heart Disease in At-Risk Pregnant Women in India |
| Q38983243 | Use of Transthoracic Echocardiography in the Management of Low-Risk Staphylococcus aureus Bacteremia: Results From a Retrospective Multicenter Cohort Study |
| Q52605072 | Use of contrast enhancement and high-resolution 3D black-blood MRI to identify inflammation in atherosclerosis. |
| Q84969347 | Use of coronary artery calcium scanning to screen for coronary atherosclerosis among early middle-age adults |
| Q83863085 | Use of speckle-strain in a multiparametric approach to dyssynchrony imaging |
| Q91018917 | Usefulness of 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Infective Endocarditis in Daily Practice: Individualized Analysis of Each Potential Focus of Infection: A Prospective Cohort Study |
| Q57764200 | Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture |
| Q96615847 | Usefulness of Adding Echocardiography of the Right Heart to Risk-Assessment Scores in Prostanoid-Treated Pulmonary Arterial Hypertension |
| Q57243289 | Usefulness of Late Iodine Enhancement on Spectral CT in Acute Myocarditis |
| Q96615849 | Usefulness of Liver Magnetic Resonance Elastography for Estimating Right-Atrial Pressure in Heart Failure Patients |
| Q57785463 | Usefulness of TEE as the Primary Imaging Technique to Guide Transcatheter Transapical Aortic Valve Implantation |
| Q43734057 | Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for cardiac resynchronization therapy |
| Q99623494 | Using FFRCT to Guide Management Strategy in Women: Two Steps Forward and One Step Back |
| Q87807956 | Using Imaging to Identify the High-Risk Diabetic Patient: Are We Any Closer? |
| Q88333116 | Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status |
| Q37693457 | Utility contrast echocardiography in the emergency department |
| Q85412980 | Utility of CT Angiography to Guide Coronary Intervention of CTO |
| Q92770954 | Utility of Multimodality Intravascular Imaging and the Local Hemodynamic Forces to Predict Atherosclerotic Disease Progression |
| Q53360141 | Utility of nongated multidetector computed tomography for detection of left atrial thrombus in patients undergoing catheter ablation of atrial fibrillation. |
| Q46306712 | Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy |
| Q37438741 | Utilization management of cardiovascular imaging pre-certification and appropriateness |
| Q102319428 | Utilization of Inpatient Transthoracic Echocardiography in Response to the 2017 AHA/ACC/HRS Guidelines for Syncope |
| Q57058583 | V/Q-SPECT Scintigraphy in Pulmonary Hypertension: Predictor of Mortality Versus Trigger for Transplant, A British Versus American Perspective |
| Q46791297 | Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography |
| Q52990871 | Value of 3D TEE for LAA Morphology. |
| Q96615829 | Value of 3D Versus 2D Speckle-Tracking Echocardiography for RV Strain Measurement: Validation With Cardiac Magnetic Resonance |
| Q41441769 | Value of CACS compared with ETT and myocardial perfusion imaging for predicting long-term cardiac outcome in asymptomatic and symptomatic patients at low risk for coronary disease: clinical implications in a multimodality imaging world. |
| Q92037978 | Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD |
| Q56986105 | Value of CMR for the Differential Diagnosis of Cardiac Masses |
| Q86140260 | Value of CMR to Differentiate Cardiac Angiosarcoma From Cardiac Lymphoma |
| Q53037691 | Value of CT in patients undergoing self-expandable TAVR to assess outcomes of concomitant mitral regurgitation. |
| Q30278097 | Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies |
| Q89728077 | Value of Late Gadolinium Enhancement Imaging in Diagnosis of Myocardial Infarction and Unobstructed Coronary Arteries |
| Q48566950 | Value of Myocardial Perfusion Assessment With Coronary Computed Tomography Angiography in Patients With Recent Acute-Onset Chest Pain. |
| Q92770983 | Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients With Asymptomatic Dilated Cardiomyopathy |
| Q46056344 | Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women |
| Q27015479 | Valve Stress Echocardiography: A Practical Guide for Referral, Procedure, Reporting, and Clinical Implementation of Results From the HAVEC Group |
| Q86542156 | Valve regurgitation with LV dysfunction: how did we get there? |
| Q88737812 | Valve-in-Valve Procedure in Failed Transcatheter Aortic Valves |
| Q40897879 | Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study |
| Q86932871 | Valvular disease, myocardial mechanics, and valve guidelines |
| Q38772969 | Variability and Reproducibility of Segmental Longitudinal Strain Measurement: A Report From the EACVI-ASE Strain Standardization Task Force |
| Q86140253 | Variability of Tricuspid Annulus Diameter Measurement in Healthy Volunteers |
| Q53113281 | Variation in quantitative myocardial perfusion due to arterial input selection. |
| Q45927717 | Variation on a theme: CMR as the "one-stop shop" for risk stratification after infarction? |
| Q53786506 | Variations in coronary lumen dimensions measured in vivo. |
| Q89141599 | Vascular Function Tests in Women With no Obstructive CAD: A Few Pieces of the Puzzle |
| Q92770878 | Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study |
| Q42546038 | Vascular calcification, diabetes, and cardiovascular disease: connecting the dots |
| Q97589594 | Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease: A Large Retrospective Registry |
| Q101137714 | Vasodilator Stress CMR: Method of Choice in Patients With Atrial Fibrillation and Suspected Coronary Stenosis? |
| Q30434323 | Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients |
| Q87331755 | Vasospastic Angina and Hemodynamic Injury |
| Q91647729 | Velocities of Naturally Occurring Myocardial Shear Waves Increase With Age and in Cardiac Amyloidosis |
| Q85616533 | Velocity Acceleration in Aortic Stenosis Revisited |
| Q57815544 | Ventricular Response to Dobutamine Stress CMR Is a Predictor for Outcome in Fontan Patients |
| Q57744159 | Ventricular Torsion |
| Q89210655 | Ventriculoarterial Coupling and the Diagnosis of Early LV Dysfunction |
| Q50188163 | Veritas et Utilitas in Imaging |
| Q84216634 | Very late clinical cardiac event after BMS implantation: in vivo optical coherence tomography examination |
| Q84068354 | Very late stent thrombosis after drug-eluting stent in segment with neointimal tissue coverage |
| Q101373477 | Vessel Wall-Imaging Biomarkers of Carotid Plaque Vulnerability in Stroke Prevention Trials: A viewpoint from The Carotid Imaging Consensus Group |
| Q49192029 | Viability is in the eye of the beholder... |
| Q53306419 | Viability, Remodeling, and CABG: Another STICH in the Shroud of Observation-Based Paradigm? |
| Q43275227 | Viable: yes, no, or somewhere in the middle? |
| Q46332426 | Vini, vidi, vici... restructured format for condensed abstracts |
| Q52650697 | Virtual Coronary Intervention: A Treatment Planning Tool Based Upon the Angiogram. |
| Q47884794 | Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by (18)Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study |
| Q34715584 | Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study |
| Q37099548 | Visceral and subcutaneous fat quality and cardiometabolic risk |
| Q84216631 | Visualizing myocardial salvage: new methods, new insights |
| Q83220121 | Visualizing the RAGE molecular: imaging after MI provides insight into a complex receptor |
| Q85039906 | Visualizing the vascular glue "shearing" the barriers to atherosclerotic plaque imaging |
| Q100431007 | Volume Status Impacts CMR-Extracellular Volume Measurements and Outcome in AS Undergoing TAVR |
| Q86940731 | Vortex Formation Time Index in Patients With Hypertrophic Cardiomyopathy |
| Q87098263 | Vulnerable Plaque Detection: When OCT Is Not Enough |
| Q83863111 | Vulnerable plaque inside stent |
| Q83661402 | Vulnerable plaques: from PROSPECT to prospects… |
| Q99575274 | Wall Shear Stress and Plaque Vulnerability: Computational Fluid Dynamics Analysis Derived from cCTA and OCT |
| Q50876087 | Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound. |
| Q101137732 | Warranty Period of a Calcium Score of Zero: Comprehensive Analysis From the Multiethnic Study of Atherosclerosis |
| Q84948069 | Water doesn't run uphill (by itself) |
| Q53243863 | We are all for elevating VR…. |
| Q59516029 | Wear and Tear⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology |
| Q44812679 | Weighing the risks and benefits of cardiac imaging with ionizing radiation |
| Q89254863 | What Is Severe Aortic Stenosis and Why Do People Die From It? |
| Q90553768 | What Lies Within?: Imaging to Detect Ventricular Assist Device Infection |
| Q103042233 | What We Learn From Exercise: The Intersection of Diastolic and Renal Dysfunction |
| Q87331815 | What Will it Take to Retire Invasive Coronary Angiography? |
| Q84969340 | What if we could prevent heart failure? |
| Q46056365 | What is an abnormal blood glucose level? Combining lessons from epidemiology and in vivo plaque imaging |
| Q84571610 | What should be the principle imaging test in heart failure--CMR or echocardiography? |
| Q87408663 | What truly causes the adverse outcome in Tako-Tsubo cardiomyopathy? |
| Q52666122 | What's Old Is New Again: A Reminder of the Importance of Left Ventricular Geometry and Function as Markers of Risk. |
| Q53741065 | What's a Malignant Family History?: You'll Know It When You See It. |
| Q90202233 | What's in Your Wallet? |
| Q91320386 | When Can We Defer Testing for Patients With Stable Chest Pain? |
| Q88060496 | When Is an Image Telling the Truth? Discordant Lessons From Imaging TAVR |
| Q90857291 | When Left Ventricular Extracellular Volume Fraction Changes After Anthracyclines: Is it Due to a Change in the Numerator, Denominator, or Both? |
| Q52991688 | When Nothing Is Really Something: New Evidence of the Importance of Zero Coronary Calcium. |
| Q89283023 | When Should We Go With HALT? |
| Q86691918 | When and How to Agree in Disagreeing on the Diagnosis of Noncompaction by Echocardiography? |
| Q84748255 | When is a number not a number? Quality control arrives in the imaging laboratory |
| Q89210622 | When the Left Ventricle Rocks: Its Causes and Relevance |
| Q91894924 | Which Functional Imaging Should We Refer to When Encountering an Anatomically Intermediate Coronary Stenosis? |
| Q82428338 | Whither Catheter-Based Intravascular Magnetic Resonance Imaging of Atherosclerosis? |
| Q100431013 | Who Benefits From Transcatheter Edge-To-Edge Mitral Valve Repair and Who Does Not: The Enigma Continues |
| Q47376826 | Who is David and who is Goliath? There is an urgent need to improve the reference standards for estimation of myocardial infarct size |
| Q46820543 | Whole-Body Visualization of Ectopic Bone Formation of Arteries and Skin in Pseudoxanthoma Elasticum |
| Q92676939 | Why Clinicians Should Care About the Cardiac Interstitium |
| Q84571618 | Why all the focus on cardiac imaging? |
| Q93129770 | Why and How to Measure Aortic Valve Calcification in Patients With Aortic Stenosis |
| Q84748280 | Why delay intervention in STEMI? |
| Q44709996 | Why does CRT reduce the risk of arrhythmias? |
| Q87578765 | Why, when, and how often?: The next steps after defining the right tools for noninvasive imaging of cardiotoxicity |
| Q89432560 | Will Cardiac Magnetic Resonance Change the Management of Severe Aortic Stenosis Patients? |
| Q98230843 | Will Plaque Quantification on Coronary CTA End Our Infatuation With Lumen Stenosis? |
| Q98629433 | Will REFINE Resurrect the "Ischemia Hypothesis"? |
| Q50064024 | Will Reducing Inflammation Reduce Vascular Event Rates? |
| Q43610224 | Will high-sensitivity troponin improve the evaluation of patients with chest pain in the emergency department? |
| Q37686802 | Will imaging assist in the selection of patients with heart failure for an ICD? |
| Q82770761 | Will intravascular OCT shed light on vascular biology? |
| Q53142386 | Will procedural complexity cultivate interdisciplinary camaraderie? |
| Q83768259 | Witnessed coronary plaque rupture during cardiac catheterization |
| Q89141592 | Women Image Wisely: The 3 mSv Challenge for Nuclear Cardiology |
| Q83200591 | Women and ischemic heart disease paradox and pathophysiology |
| Q85814788 | Women are from SATURN and men are from an ASTEROID: deciphering the REVERSAL of coronary atheroma |
| Q46056342 | Women with chest pain: expanding the diagnostic armamentarium |
| Q50878103 | Workstation-Based Calculation of CTA-Based FFR for Intermediate Stenosis. |
| Q98629450 | Worldwide Diagnostic Reference Levels for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Findings From INCAPS |
| Q111901041 | Worldwide Variation in the Use of Nuclear Cardiology Camera Technology, Reconstruction Software, and Imaging Protocols |
| Q87629399 | Would an FFR by Any Technique Perform as Sweet? |
| Q36879107 | Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study |
| Q89210638 | Your Coronary Calcium Scan Is Positive: Now What? |
| Q58769248 | [ 18 F]-NaF PET/CT Identifies Active Calcification in Carotid Plaque |
| Q52986280 | [(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction. |
| Q98282921 | [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions |
| Q36278859 | hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial |
| Q83629590 | iJACC in the evolving world of integrated imaging: a spectator, a follower, or a trail blazer |
| Q87112236 | À LA mode atrioventricular mechanical coupling |
| Q50423640 | ν-net: Deep Learning for Generalized Biventricular Mass and Function Parameters Using Multicenter Cardiac MRI Data |
| JACC: Cardiovascular Imaging | wikipedia | |
| JACC: Cardiovascular Imaging | wikipedia | |
| JACC: Cardiovascular Imaging | wikipedia |
Search more.